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Abstract 
DivIVA plays multifaceted roles in Gram-positive organisms by associating with 
various cell division and non-cell division proteins.  While the interaction of DivIVA with other 
proteins has been studied in many Gram-positive bacteria, no information is available about 
DivIVA- associating proteins in E. faecalis. This research reports a novel DivIVAEf interacting 
protein named EF1025 (encoded by EF1025) (confirmed using Bacterial Two-Hybrid, 
Glutathione S-Transferase pull-down, and co-immunoprecipitation assays) that affects cell 
length and morphology in E. faecalis.  
EF1025 is predominantly conserved in Gram-positive bacteria and contains a conserved 
N-terminal DNA binding Helix-turn-Helix (HTH) domain and two Cystathionine β-Synthase 
(CBS) domains located centrally and at the C-terminus. The protein, EF1025, oligomerizes to 
form a higher-order oligomer and the two CBS domains are responsible for its self-interaction. 
Viable cells were recovered after insertional inactivation or deletion of EF1025 only through 
complementation of EF1025 in trans. These cells were longer than the average length of E. 
faecalis cells and had distorted shapes. Overexpression of EF1025 also resulted in cell 
elongation but had no effect on cell shape. Immuno-staining revealed comparable localization 
patterns of EF1025 and DivIVAEf in the later stages of division in E. faecalis cells. 
The EF1025 homologue in Bacillus subtilis, CcpN, is a transcriptional repressor in 
Bacillus subtilis. In the presence of glucose, CcpN binds to the promoter region of gapB and 
pckA and downregulates their expression. CcpN interacted with DivIVA of B. subtilis in B2H 
and GST-pull down assays. A heterologous interaction between EF1025 and DivIVABs was 
also identified in a GST-pull down assay. Insertional inactivation of ccpN leads to cell 
elongation and growth of cells in straight chains. These findings suggest an additional function 
of CcpN in B. subtilis, therefore, CcpN is a dual function performing protein involved in both 
gluconeogenesis and cell elongation. 
E. faecalis contains homologues of divisome proteins FtsZ, FtsA, FtsK, FtsQ, FtsL, FtsI 
and FtsB, however, the cell division interactome of E. faecalis, by contrast, is not presently 
known. This thesis also presents the unique interactome of E. faecalis divisome proteins (i.e. 
FtsZEf, FtsAEf, FtsQEf, FtsLEf, FtsIEf, FtsWEf, DivIVAEf, and FtsBEf), established using 
Bacterial-two hybrid system. The interaction of FtsA with FtsI, FtsL, and FtsZ, is common 
among E. faecalis, S. pneumoniae and S. aureus cell division interactomes. One unique 
iii 
 
interaction i.e. FtsZEf-FtsIEf was identified in E. faecalis cell division interactome. While 
studying the divisome interactome of E. faecalis, it was observed that EF1025 is not a part of 
the divisome machinery in E. faecalis as it did not interact with any divisome protein except 
DivIVAEf. 
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Chapter 1. General introduction 
1.1. Genus- Enterococcus 
Enterococci are facultative anaerobic, non-sporulating cocci, firmicute bacteria that 
belong to the low GC branch of Gram-positive bacteria and are commonly found growing in 
hostile conditions (Paulsen et al., 2003; Van Tyne and Gilmore, 2014). In the 19th century, 
Thiercelin described an intestinal saprophytic disease-causing coccus which was termed as 
“enterococcus” (Lebreton et al., 2014). The genus Enterococcus belongs to the 
Enterococcaceae family (Whitman et al., 2003), and includes species found in the 
gastrointestinal (GI) tracts of humans, animals, and insects (Mundt, 1961, 1963). The other 
habitats for enterococci include fermented food and dairy products (Lebreton et al., 2014), as 
well as soil, water and plants as well (Mundt, 1961; Mundt et al., 1962). In the fermentation 
industry, the members of this genus have been reported to play an important role in the ripening 
of food and the production of unique aromas of various cheeses and dry sausages (Franz et al., 
2003; Foulquié Moreno et al., 2006; Hammerum, 2012). Several strains of “enterococcus” 
produce bacteriocin/enterocin, an antimicrobial compound that is widely used in the food 
ripening industry as a food preservative (Vuyst and Vandamme, 1994; Cleveland et al., 2001; 
Yang et al., 2014; Kurushima et al., 2015). Initially, enterococci were classified as group D 
streptococci but later, Streptococcus faecalis and Streptococcus faecium were reclassified as 
Enterococcus faecalis and Enterococcus faecium, respectively (Schleifer and Kilpper-Bälz, 
1984). Although the genus Enterococcus consists of more than 40 ecologically different species 
(Jett et al., 1994; Huycke et al., 1998); approximately 90 per cent of enterococcal human 
infections are caused by two species: E. faecalis and E. faecium (Maki and Agger, 1988; 
Murray, 1990; Hidron et al., 2008).  
1.2. E. faecalis- an important human pathogen 
From a lethal case of endocarditis, MacCallum and Hastings were the first to describe 
a species and its pathogenic capabilities which we now call as E. faecalis (MacCallum and 
Hastings, 1899). E. faecalis is an opportunistic pathogen that among all Gram-positive cocci, 
lives most abundantly in the gastrointestinal tract of healthy humans or animals and is 
commonly associated with hospital-acquired infections (HAIs)/ nosocomial infections 
(Murray, 1990; Sievert et al., 2013). It has been known to cause various infectious diseases, 
including urinary infectious disease, bacteremia, meningitis, infective endocarditis, and 
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neonatal infections (Murray, 1990; Jett et al., 1994). Rare dental diseases such as periodontitis, 
periimplantitis and caries have also been found to involve E. faecalis  (Kouidhi et al., 2011; 
Dahlén et al., 2012; Rams et al., 2013). Recently Al-Ahmad et al., (2009, 2010) showed 
incorporation of E. faecalis from food into the oral biofilms in the human mouth leading to 
dental diseases. They also showed that consumption of cheese can lead to food-borne 
enterococci which can integrate into the oral biofilm (Al-Ahmad et al., 2009, 2010). Larsen et 
al. (2010) and Gelsomino et al. (2002) have reported transmission of E. faecalis of porcine 
origin through food to the human gastrointestinal tract (Gelsomino et al., 2002; Larsen et al., 
2011).  
1.3. Identification of E. faecalis in biological specimens 
The basic morphological and physiological characteristics for identifying E. faecalis 
include being Gram-positive, non-spore forming, spherical or ovoid cells that are arranged 
individually, in pairs, or in short chains (MacCallum and Hastings, 1899). E. faecalis is 
facultatively anaerobic, catalase-negative, fermentative chemoorganotroph that grows 
optimally at 35°C in a broth containing 6.5% NaCl, and bile esculin in the presence of 40% 
bile salts along with a number of amino acids (including Val, Leu, Ile, Ser, Met, Glu, Arg, His 
and Trp) and vitamins like biotin, nicotinic acid, pantothenate, pyridoxine, riboflavin, and folic 
acid (Lebreton et al., 2014).  
1.4. Virulence of E. faecalis 
E. faecalis colonizes both human tissue and medical devices (e.g., central venous 
catheters, endotracheal tubes and Foley catheters) by establishing surface communities 
(biofilms) (Sandoe et al., 2003; Arias-Moliz et al., 2012), which make them difficult to treat. 
Due to their additional ability to form a biofilm, catheter-related urinary tract infections are 
difficult to treat effectively with conventional antibiotics (Mohamed and Huang, 2007). 
Biofilms act as a barrier and prevent absorption and delivery of antibiotics from reaching their 
intended targets (Otto, 2006). The enterococcal surface protein (esp) is a large surface protein 
encoded by an Esp-containing pathogenicity island which aids in adsorption and colonization 
of cells on abiotic surfaces by biofilm formation (Toledo-Arana et al., 2001; Paganelli et al., 
2012). Likewise, aggregation substance (AS), an adhesin of proteinaceous nature, also aids in 
adherence and invasion of host cells and biofilm establishment (Kreft et al., 1992), Another 
important virulence factor is cytolysin (cyl, beta-hemolysin), a plasmid-encoded bacteriocin 
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(Gilmore et al., 1994; Van Tyne et al., 2013). Cytolysin is known to lyse a number of Gram-
positive bacteria using two extracellular proteins i.e. the activator and lytic components (Brock 
et al., 1963; Segarra et al., 1991). Similar to cytolysin, gelatinase (gelE), is an extracellular 
metalloprotease that hydrolyzes gelatin, collagen, and haemoglobin, which in turn furthers 
bacterial adherence and biofilm formation (Kayaoglu and Ørstavik, 2004). Hyaluronidase, a 
degradative enzyme, encoded by the chromosomal hyl gene, depolymerizes the 
mucopolysaccharide moiety of host tissue, thereby facilitating E. faecalis spread (Fisher and 
Phillips, 2009). Other virulence factors include extracellular superoxide (Huycke et al., 1996; 
Huycke and Gilmore, 1997), surface carbohydrates, (Guzmàn et al., 1989) and E. faecalis 
endocarditis antigen A (efaA) (Singh et al., 1998). The presence of these virulence factors 
makes E. faecalis a hypervirulent pathogen and provides a competitive edge to grow in hostile 
environments and resist host defences.  
1.5. Antibiotic resistance in E. faecalis 
The first case of antibiotic resistance in the treatment of enterococcal endocarditis using 
penicillin was reported in the early 1950s (Geraci Joseph E. and Martin William J., 1954). In 
1981, the first β-lactamase-producing E. faecalis isolates were identified in Texas (Murray, 
1990) and today, almost all enterococcal strains show low-levels of susceptibility to penicillin 
and ampicillin and resistance to cephalosporins and all semi-synthetic penicillins (Kristich et 
al., 2014). The first clinical isolate of vancomycin-resistant E. faecalis, strain V583, was 
isolated from the bloodstream of a patient in the United States (Sahm et al., 1989). Ever since, 
enterococcal resistance to vancomycin i.e. Vancomycin-resistant enterococci (VRE), has been 
growing (Gilmore et al., 2013). Outbreaks of VRE have since occurred in England, France and 
the United States (Leclercq et al., 1988; Uttley et al., 1988; Sahm et al., 1989). At that time, 
there was a lack of awareness about the emergence of antibiotic resistance among health-care 
workers, but a recent increase in the prevalence of antibiotic resistance to all antibiotics in E. 
faecalis is worrisome and poses a major setback in treating E. faecalis infections. The majority 
of clinical isolates of E. faecalis today are ampicillin-resistant and continue to carry high-level 
resistance (HLR) to aminoglycosides (e.g. gentamicin and streptomycin), vancomycin, and 
other glycopeptides, providing E. faecalis the status of “multidrug-resistant” (Murray, 2000; 
Kristich et al., 2014).  
The standard treatment protocol for E. faecalis infections involves administration of β-
lactam antibiotics such as the amino-penicillins (e.g. ampicillin) and ureidopenicillins (e.g. 
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piperacillin), along with penicillin G and carbapenems (Kristich et al., 2014). In the cases of β-
lactam allergy, vancomycin is reserved for treatment purposes (Kristich et al., 2014). In certain 
infections such as endocarditis, an association of a β-lactam with an aminoglycoside produces 
efficient bactericidal effects (Moellering and Weinberg, 1971). The usual regimen to treat VRE 
infections involves the administration of high-dose ampicillin, chloramphenicol alone or with 
rifampin (Mekonen et al., 1995; Norris et al., 1995; Murray, 2000). Other VRE treatment 
antibiotics include tetracycline and doxycline (Gransden et al., 1998).  
In addition to possessing specific virulence and resistance genes, E. faecalis is noted 
for incorporating mobile elements into its genome (Manson et al., 2010; Paganelli et al., 2012). 
This capability leads to the distribution and transmission of many genes responsible for 
conferring antibiotic resistance by horizontal gene transfer (Paganelli et al., 2012). Multidrug-
resistant enterococcal genomes consist of more than 25% of mobile elements representing a 
widespread accumulation of drug-resistant elements and virulence factors (Paulsen et al., 
2003). The transfer of vancomycin resistance genes from E. faecalis to methicillin-resistant 
Staphylococcus aureus has been recorded in the late 90s and early 2000 (Willems et al., 2001; 
Palmer et al., 2010).  
Enterococcal infections have become a major health care problem due to increasing 
numbers of multidrug-resistant isolates and difficulties in eradicating biofilms (Flemming and 
Wingender, 2010; Arias and Murray, 2012). The recent emergence of hypervirulent and 
multidrug-resistant E. faecalis strains, therefore, requires an in-depth understanding of the 
enterococcal biology, genetics and underlying factors contributing to the virulence of this 
pathogen (Stinemetz et al., 2017). New therapeutic targets (such as the process of cell division 
or metabolism pathway) and strategies need to be identified to combat enterococcal infections. 
Despite the status of “hypervirulent and multidrug-resistant” that E. faecalis has acquired over 
the past few decades, there have been only a few research studies that have dealt with the 
process of cell division in this pathogen  (Ramirez-Arcos, 2005; Rigden et al., 2008; Stinemetz 
et al., 2017).  
1.6. Division Cell Wall (dcw) Gene Cluster 
Due to evolutionary dynamics, there exist highly conserved gene clusters throughout 
bacterial genomes (Weber et al., 2016), such a cluster for cell division is called the dcw 
(division and cell wall) gene cluster (Ayala et al., 1994; Tamames et al., 2001). The 
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conservation of dcw genes, their regulation and, in general, their cluster structure, are 
remarkably conserved in bacterial groups of similar taxon and cell size (Tamames et al., 2001). 
Since the proteins encoded by the dcw genes are involved in cell division and peptidoglycan 
synthesis, bacterial dcw gene clusters are mostly essential (Boyle and Donachie, 1998; 
Kobayashi et al., 2003). In addition to regulatory mechanisms, their conserved gene order can 
ensure successful synchronization of growth and division (Mingorance et al., 2004). The 
filamentous temperature-sensitive (Fts) phenotype was first described in E. coli when the 
filamentous temperature-sensitive (fts) genes were mutated (Bi and Lutkenhaus, 1991). These 
mutations were found to be restricted to a region, which was later named the dcw cluster (Ayala 
et al., 1994; Vicente and Errington, 1996; Rothfield and Justice, 1997). The dcw genes have 
been studied intensively in model organisms such as B. subtilis and E. coli, but due to numerous 
regulatory features such as protein ratios, internal promoters and transcript stability, their 
regulation is not fully understood (Weber et al., 2016). 
Although the dcw cluster is highly conserved in bacterial species (Pucci et al., 1997), 
the organization of various genes within the dcw cluster varies in different bacterial species as 
found in E. coli, B. subtilis, S. aureus, E. faecalis, S. pyogenes, and S. pneumoniae (Fig. 1.1.) 
(Massidda et al., 1998; Francis et al., 2000; Snyder et al., 2001; Fadda et al., 2003; Ramirez-
Arcos, 2005; Real and Henriques, 2006). Genes like ftsZ and ftsA, are highly conserved 
between Gram-negative and Gram-positive bacteria, as are their position within the dcw 
cluster.  
1.6.1. dcw cluster of B. subtilis 
The first bacterial dcw cluster was deduced in the E. coli which comprises 16 genes (i.e. 
mraZEc, mraWEc, ftsLEc, ftsIEc, murEEc, murFEc, mraYEc, murDEc, ftsWEc, murGEc, murCEc, 
ddlBEc, ftsQEc, ftsAEc, ftsZEc and envAEc) (Ayala et al., 1994; Mingorance et al., 2004). The 
organization of the dcw cluster in B. subtilis, the Gram-positive model organism for studying 
cell division (Harwood, 2007), is similar to that in E. coli, the Gram-negative model organism, 
with respect to 17 different identified genes (mraZBs, mraWBs, ftsLBs, ftsIBs, spoVDBs, murEBs, 
murFBs, mraYBs, murDBs, ftsWBs, murGBs, murBBs, ftsQBs, ylxWBs, ylxXBs, ftsABs and ftsZBs) (Fig. 
1.1) (Mingorance et al., 2004; Real and Henriques, 2006). E. coli mraW is the antagonist of 
mraZEc, a highly conserved transcriptional regulator in most of the bacteria (Eraso et al., 2014). 
The mur genes, including mraYEc and ddlBEc, are essential genes for the synthesis of 
peptidoglycan precursors (Pilhofer et al., 2008). However, the B. subtilis dcw cluster also 
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contains, spoVDBs and spoVEBs, that encode sporulation-specific proteins for endospore cortex 
peptidoglycan synthesis (Daniel et al., 1994).  spoVDBs shares 33% identity with the upstream 
ftsIBs (Daniel et al., 1994; Vicente et al., 2004). The other difference is that there is an internal 
transcription terminator between ftsIBs and spoVDBs. An important cell division protein is 
DivIVABs, encoded by divIVABs which does not belong to the dcw cluster of B. subtilis. 
1.6.2. dcw cluster in other microorganisms 
The Gram-positive bacteria, S. pyogenes and S. pneumoniae have distinctive dcw 
cluster organization (Fig. 1.1) (Massidda et al., 1998). The S. pneumoniae dcw cluster is 
distributed into three separate regions on the chromosome where the first region, dcw1, 
contains eight genes i.e. pbp2bSp, recMSp, ddlSp, murFSp, mutTSp, orf1, ftsASp and ftsZSp. The 
second region contains five genes, murGSp, divIBSp, pyrFSp, and pyrESp, and the third region, 
dcw3, is composed of the yllCSp, yllDSp, pbp2xSp, and mraYSp genes (Massidda et al., 1998). 
Four putative genes are located downstream of ftsZSp (Massidda et al., 1998) and the protein 
encoded by the last gene shares 65% similarity with B. subtilis DivIVA which is involved in 
Gram-positive bacteria cell division (Cha and Stewart, 1997; Edwards and Errington, 1997).  
The dcw cluster of S. pyogenes is distributed in two clusters where dcw1 and dcw2, each 
contains five genes i.e. murGSpy, murDSpy, divIBSpy, ftsASpy and ftsZSpy, and yllCSpy, yllDSpy, 
pbpN-terSpy, pcpC-terSpy, and mraYSpy, respectively. Understanding the role of important 
proteins in the division of cells, however, is essential for understanding bacterial cell division 
initiation and regulation.  
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Figure 1.1. dcw clusters of E. faecalis (Ramirez et al., 2005), N. gonorrhoeae (Francis et al., 
2000), E. coli (Ayala et al., 1994; Mingorance et al., 2004), B. subtilis (Mingorance et al., 2004; 
Real and Henriques, 2006), S. pneumoniae (Vicente et al., 2004), S. pyogenes (Massidda et al., 
1998) and S. aureus (Massidda et al., 1998). Arrows indicate the direction of transcription of 
dcw cluster genes. Transcriptional terminators are indicated as two vertical lines. P- predicted 
promoter region.  
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1.7. Bacterial cell division  
Bacterial cells are critically dependent on their ability to divide for growth, 
development, and reproduction. Cell division is a complex mechanism orchestrated by the 
coordinated interaction of a large number of proteins forming a macromolecular complex 
called the divisome.  Divisome assembly happens in at least two steps (Gamba et al., 2009). 
First, in a spatially and temporally controlled manner, the Z ring is assembled on the 
cytoplasmic membrane between segregated chromosomes using membrane tethering proteins 
(Jensen et al., 2005).  In the second step, to form the complete divisome, other essential and 
non-essential cell division proteins are added to the Z ring depending on the bacterial species 
(Levin et al., 1999; Gueiros-Filho and Losick, 2002; Hamoen et al., 2006; Haeusser et al., 2007; 
Singh et al., 2007; Tavares et al., 2008; Lenarcic et al., 2009; Król et al., 2012; Cleverley et al., 
2014; Taguchi et al., 2019). The process of divisome assembly is followed by the third step 
that involves peptidoglycan (PG) remodelling so that the daughter cells can separate after septal 
cell wall synthesis has initiated (Domínguez-Escobar et al., 2011; Garner et al., 2011). This 
step is very tightly regulated so that cell wall degrading enzymes are only activated at the 
correct place and time (Uehara and Bernhardt, 2011). 
B. subtilis has served as a model organism for studying and understanding the process 
of cell division in Gram-positive bacteria for decades (Pavlendová et al., 2007; Errington and 
Wu, 2017; Barák et al., 2019). E. coli has served the same role for Gram-negative bacteria 
(Lutkenhaus and Du, 2017). The basic elements of the cytokinetic machinery that comprises a 
core of essential components used by many bacteria, were compared in these two species. The 
intensive investigation of these model organisms resulted in the development of many genetic 
tools, techniques and resources specifically for the investigation.   
1.7.1. Divisome assembly in B. subtilis 
In B. subtilis, the divisome assembles in two distinct steps where the first step involves 
FtsZBs-ring assembly along with the recruitment of “early” divisome proteins FtsABs, SepFBs, 
ZapABs and EzrABs in a sequential manner (Wang and Lutkenhaus, 1993; Gueiros-Filho and 
Losick, 2002; Anderson et al., 2004; Jensen et al., 2005; Hamoen et al., 2006; Singh et al., 
2007; Gamba et al., 2009). Cell division starts with the midcell assembly of a contractile ring 
by the central component of the divisome, FtsZBs, a structural and biochemical homologue of 
the eukaryotic tubulin (Anderson et al., 2004; Jensen et al., 2005; Gamba et al., 2009). FtsZBs 
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assembles into proto-filaments that self-interact and form a dynamic circumferential ring (i.e. 
Z-ring) which defines the site of cell division and recruits, directly or indirectly, multiple 
protein components of the divisome (Gamba et al., 2009). FtsZ assembles in vitro in a head to 
tail fashion to form single-stranded protofilaments, which can further assemble into bundles, 
sheets or rings at the Z-ring (Peters et al., 2007; Gamba et al., 2009). This ring undergoes cycles 
of turnover/polymerization, regulated by the binding and hydrolysis of GTP (Bi and 
Lutkenhaus, 1991; Peters et al., 2007).  
The Z-ring is tethered to the membrane by the recruitment of the “early” divisome 
proteins FtsABs or SepFBs which use their amphipathic helices to bind to the cell membrane 
(Fig. 1.2.) (Jensen et al., 2005; Hamoen et al., 2006). FtsABs and SepFBs specifically interact 
with the C-terminal domain of FtsZBs and forms high molecular weight (MW) dynamic 
complexes (Jensen et al., 2005; Ishikawa et al., 2006; Król et al., 2012). Sequentially, the two 
positive regulators i.e. ZapABs and EzrABs then interact with the Z-ring maintaining FtZBs 
polymerization (Levin et al., 1999; Gueiros-Filho and Losick, 2002; Singh et al., 2007; 
Cleverley et al., 2014). ZapABs acts as a promoter of FtsZBs bundling by interacting directly 
with FtsZBs and encouraging both FtsZBs polymerization and lateral connection in vitro, 
producing both single and bundled filaments (Gueiros-Filho and Losick, 2002; Low et al., 
2004). EzrABs anchors the membrane protofilaments and stops protofilament bundle formation 
locally (Haeusser et al., 2007; Land et al., 2014). 
The complex comprised of FtsZBs-FtsABs-SepFBs-ZapABs-EzrABs then recruits the 
‘late’ cell division proteins i.e. FtsWBs, PBP1Bs, PBP2BBs, DivIBBs, DivICBs and FtsLBs, 
DivIVABs and GpsBBs (Fig. 1.2.) (Perry and Edwards, 2004; Tavares et al., 2008; Gamba et al., 
2009; Lenarcic et al., 2009; den Blaauwen, 2018; Taguchi et al., 2019). These proteins do not 
directly interact with FtsZBs and are primarily proteins with major extracellular domains or 
integral membrane proteins (Ishikawa et al., 2006) which includes proteins for septal cell wall 
biosynthesis (FtsWBs, PBP1Bs, PBP2BBs) and scaffolding proteins (DivIBBs, DivICBs and 
FtsLBs) (Ishikawa et al., 2006; Taguchi et al., 2019).  DivIVABs and GpsBBs are recruited in the 
later stages of division in the presence of early and late divisive components (Halbedel and 
Lewis, 2019). Various other regulatory proteins, including MinJBs, MinDBs and MinCBs arrive 
at about the same time or slightly later, depending on the initiation of the membrane or PG 
ingrowth (Gamba et al., 2009).  
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Figure. 1.2. The two-step assembly of the divisome in B. subtilis. Adapted from (Halbedel and 
Lewis, 2019). Early cell division proteins are indicated in white font whereas late proteins are 
in black font.  
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1.7.2. S. pneumoniae divisome assembly 
Streptococcus pneumoniae is an important ovococcal opportunistic Gram-positive 
pathogen that causes a variety of infections including middle ear infections, sinusitis, 
pneumonia, bacteraemia and meningitis (Weiser et al., 2018). S. pneumoniae contains the 
majority of the cell division proteins present in B. subtilis and other Gram-positive bacteria 
(Errington and Wu, 2017). S. pneumoniae contains genes encoding homologues of 
YlmFSp/SepFSp and DivIVASp that are involved in chromosome segregation, cell morphology 
and cell division in various species (Massidda et al., 1998; Fadda et al., 2003, 2007; Flärdh, 
2003; Ramos et al., 2003; Miyagishima et al., 2005; Ramirez-Arcos, 2005; Hamoen et al., 
2006; Ishikawa et al., 2006; Kabeya et al., 2010). Two interdependently operating cell wall 
synthesis machineries are utilized by S. pneumoniae for peripheral growth and cell division 
(Lleo et al., 1990; Massidda et al., 1998; Morlot et al., 2003, 2004; Noirclerc-Savoye et al., 
2005; Le Gouëllec et al., 2008; Zapun et al., 2008). Although an exact order of recruitment of 
cell division proteins to mid cell has not yet been established, fluorescence studies show that 
like B. subtilis, divisome formation in pneumococci occurs in at least two steps (Fadda et al., 
2003; Morlot et al., 2004). 
The cell division initiator proteins FtsZSp and FtsASp localize to mid-cell first (Morlot 
et al., 2003; Lara et al., 2005) followed by the septal markers DivIBSp (FtsQSp), DivICSp 
(FtsBSp), FtsLSp, FtsWSp, PBP2XSp (FtsISp), PBP1aSp (Morlot et al., 2003, 2004b; Noirclerc-
Savoye et al., 2005), and the cell division protein DivIVASp (Fadda et al., 2007; Beilharz et al., 
2012). The exact function of these essential Fts proteins during the initial steps of cell division 
is not known (Mura et al., 2017). Z-ring formation requires about half of the cell cycle before 
septation can occur (Fadda et al., 2007) where FtsZSp and FtsASp self-interact and with each 
other (Lara et al., 2005; Maggi et al., 2008) and with other cell division proteins, including 
ZapASp and EzrASp (Song et al.; Thanassi et al., 2002). SepFSp, a crucial protein required for 
Z-ring stability in B. subtilis (Hamoen et al., 2006; Ishikawa et al., 2006), results in severe 
division defects when inactivated in S. pneumoniae (Massidda et al., 1998; Fadda et al., 2003). 
Maggi et al. (2008) used a bacterial two-hybrid system to study the interaction between various 
divisome proteins. They found that pneumcoccal FtsKSp interacts with itself, FtsZSp, ZapASp, 
FtsQSp and FtsLSp (Maggi et al., 2008). Other cell division proteins, FtsQSp (DivIBSp), FtsBSp 
(DivICSp) and FtsLSp (Buddelmeijer and Beckwith, 2004), form a trimeric complex by 
interacting with each other before this complex is incorporated into the S. pneumoniae 
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divisome (Fig. 1.3.) (Noirclerc-Savoye et al., 2005; Masson et al., 2009). S. pneumoniae FtsW, 
late cell division protein, interacts with FtsQSp (DivIBSp) and FtsLSp (Morlot et al., 2004; Maggi 
et al., 2008). 
 
 
Figure 1.3. Proposed assembly of cell division proteins in S. pneumoniae divisome. Derived 
from the data developed by Fadda et al. (2007) using the bacterial two-hybrid assay.  
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1.8. DivIVA- An important Gram-positive cell division protein 
DivIVA is a highly conserved, “late” cell division protein that is crucial for septum 
determination. Homologues of  B. subtilis DivIVA are present in most Gram-positive bacteria,  
especially in bacterial subgroups such as actinobacteria and the firmicutes interacting with 
different partners and performing a variety of functions (Fadda et al., 2003; Kang et al., 2008; 
Rigden et al., 2008; Donovan et al., 2012; Massidda et al., 2013; Kaval et al., 2014; Bottomley 
et al., 2017; Ni et al., 2018; Halbedel and Lewis, 2019). DivIVA homologues have also been 
reported to be present in extremophiles such as Deinococcus, Synergistaceae, Nitrospira, and 
Deltaproteobacteria species, and few of the Chlorobi/Fibrobacter/Bacteroidetes group 
(Halbedel and Lewis, 2019). Lluch-Senar et al., 2010 reported uncharacterized DivIVA 
homologues from Mycoplasma species (Lluch‐Senar et al., 2010). Although most of the divIVA 
genes from firmicutes are non-essential (Cha and Stewart, 1997; Fadda et al., 2003; Pinho and 
Errington, 2004; Claessen et al., 2008; Halbedel et al., 2012; Fleurie et al., 2014; Rismondo et 
al., 2016; Bottomley et al., 2017), exceptions exist (Ramirez-Arcos, 2005). The divIVA 
homologue in Actinobacteria, also called wag31 in mycobacteria, is essential for cell viability 
and growth (Kang et al., 2008). There are no DivIVA homologues in humans, making DivIVA 
an excellent target for novel antimicrobials (Halbedel and Lewis, 2019). 
1.8.1. DivIVA from B. subtilis 
DivIVABs is a crucial protein in B. subtilis which is involved in the differentiation of 
the cell poles (Edwards and Errington, 1997). DivIVABs localizes at the division site and cell 
poles upon divisome assembly by associating with the Min proteins (Edwards and Errington, 
1997). Although divIVABs is an important gene of B. subtilis, it is not located in the dcw cluster 
(Mingorance et al., 2004; Real and Henriques, 2006). DivIVABs is a small cytoplasmic protein 
that is homologous to eukaryotic cytoskeletal protein, myosin, a protein involved in cytokinesis 
(Edwards et al., 2000; Oliva et al., 2010). The N-terminus of DivIVABs is a highly conserved 
domain connected to the α-helical coiled-coil central and C-terminus region with a linker 
(Edwards et al., 2000; Oliva et al., 2010). DivIVABs self-interacts and oligomerizes using its 
coiled-coil region and utilizes its N-terminal region for interaction with lipid membranes 
(Muchová et al., 2002; Stahlberg et al., 2004; Rigden et al., 2008; Lenarcic et al., 2009; 
Rismondo et al., 2016). The interaction of DivIVABs with membrane uses a hairpin structure 
with conserved exposed basic and hydrophobic residues in the N-terminal protein domain 
(Oliva et al., 2010). DivIVABs oligomers have a high affinity for the negative curvature of the 
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membrane, which occurs in the invaginating division septa in dividing cells (Lenarcic et al., 
2009; Ramamurthi and Losick, 2009; Eswaramoorthy et al., 2014). Once the curvature has 
been generated, DivIVABs localizes to each side of the growing septum preventing the 
contraction of the divisome and division at polar sites in the dividing cell (Eswaramoorthy et 
al., 2011). In non-dividing B. subtilis cells, DivIVABs-GFP concentrated at the hemispheric cell 
poles (Eswaramoorthy et al., 2011). However, in dividing cells, DivIVABs remodelling took 
place and a portion of the DivIVABs molecules remained at the pole, while some protein 
migrated to the new division site (Bach et al., 2014).  
1.8.2. DivIVA interacting partners in B. subtilis 
B. subtilis DivIVA interacts with at least seven different interacting partners (Fig. 1.4.) 
(Perry and Edwards, 2006; Bramkamp et al., 2008; Patrick and Kearns, 2008; Lenarcic et al., 
2009; Briley et al., 2011; dos Santos et al., 2012; Halbedel et al., 2014; Schumacher, 2017; 
Halbedel and Lewis, 2019) utilizing different interacting sites (Halbedel and Lewis, 2019). 
Such a variety of interacting partners confer a variety of functions to DivIVABs in cellular 
processes that includes chromosome segregation (Perry and Edwards, 2006), cell division 
(Bramkamp et al., 2008; Patrick and Kearns, 2008), competence development (Briley et al., 
2011; dos Santos et al., 2012), sporulation (Lenarcic et al., 2009) and protein secretion (SecA) 
(Halbedel et al., 2014).  
DivIVABs acts as a "topological specificity" determinant for MinJ, RacA, and ComN 
for their recruitment to the septum and the cell poles (Ben-Yehuda et al., 2003; Bramkamp et 
al., 2008; dos Santos et al., 2012). With MinJBs, a transmembrane protein, which acts as a 
molecular bridge between DivIVABs and the FtsZ-inhibiting MinCDBs complex, DivIVABs 
interacts to recruit itself and MinCDBs complex at the division site and the cell poles for correct 
cell division (Bramkamp et al., 2008; Patrick and Kearns, 2008). DivIVABs is necessary for 
sporulation where it associates with the DNA binding protein RacABs, acting as a bridge 
between the oriC region and the cell poles, anchoring chromosomes at the poles (Ben-Yehuda 
et al., 2003). Subsequently, DivIVABs and RacABs attract Spo0J and Soj to the chromosome, 
participating in chromosome segregation (Ben-Yehuda et al., 2003; Wu and Errington, 2003). 
The spo0J-soj system determines the orientation and positioning of the chromosome early in 
sporulation (Wu and Errington, 2003). The correct localization of DivIVABs ensures the 
RacABs mediated securing of the chromosome to the distal side of the prespore during 
sporulation (Errington and Wu, 2017). ComNBs, a small protein from B. subtilis has been 
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described as a polarly localized, posttranscriptional regulator of competence gene expression 
(Ogura and Tanaka, 2009). Such a unique localization by ComNBs is achieved by a direct 
interaction with DivIVABs which leads to the accumulation of comEBs (ComN’s target mRNA) 
to septal and polar sites (dos Santos et al., 2012). Although ComNBs is non-essential for the 
polar assembly of the core competency DNA uptake machinery, its delocalization resulted in 
a significant reduction in the efficiency of competencies (dos Santos et al., 2012). DivIVABs 
also binds to MafBs, a protein involved in cell division arrest in competent cells of B. subtilis 
(Briley et al., 2011). This highly conserved protein is synthesized in competent cells under the 
direct control of ComKBs, a transcriptional factor (Briley et al., 2011). A point mutation in 
mafBs inhibits its interaction with DivIVABs and also cell division (Briley et al., 2011). The 
interaction between DivIVABs and SecABs, the secretion ATPase, is important for correct 
localization of DivIVABs during cell division (Halbedel et al., 2014). Mutation in SecABs leads 
to inhibition of sporulation and DivIVABs delocalization (Halbedel et al., 2014). 
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Figure 1.4. DivIVA interacting partners in Bacillus subtilis (Halbedel et al., 2019). 
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1.8.3. DivIVA interacting partners in other bacteria 
The range of DivIVA interacting partners changes from one Gram-positive bacterial 
species to another (Table 1.1). For example, in Listeria monocytogenes, another Gram-positive 
human pathogen, DivIVALm performs three functions that include precise positioning of the 
septum at midcell, assistance in the secretion of autolysins, and enabling swarming motility of 
L. monocytogenes (Kaval et al., 2014); each of these functions are governed by different 
domains of DivIVA (Kaval et al., 2017). In L. monocytogenes, MinC and MinD localizes at 
the cell poles in a DivIVALm-dependent fashion unlike MinJ (Kaval et al., 2014). Other than 
these interacting partners, DivIVALm also interacts with SecA2, the accessory secretion 
ATPase, to assist the secretion of two autolysins p60 (CwhA) and MurA (NamA) (Lenz and 
Portnoy, 2002) through the SecA2-dependent secretion pathway (Kaval et al., 2014). divIVA 
mutants had impaired autolysin secretion levels (Kaval et al., 2014) which lead to cell chaining 
and defective division site selection (Lenz and Portnoy, 2002; Machata et al., 2005).  
The S. pneumoniae homologue of DivIVA is crucial for normal growth by ensuring 
proper septum placement, and chromosome segregation (Fadda et al., 2003; Nováková et al., 
2010). DivIVASp interacts with several divisome proteins from the dcw cluster including 
FtsZSp, FtsASp, ZapASp, FtsKSp, FtsISp, FtsBSp, FtsQSp and FtsWSp (Fadda et al., 2007). A point 
mutation at the N-terminal coiled-coil of DivIVASp (A78T) significantly reduced DivIVA 
interaction with the “late” divisome proteins FtsLSp, FtsQSp, FtsBSp and FtsWSp (Fadda et al., 
2007; Vicente and García-Ovalle, 2007). Other than these cell division proteins, DivIVASp also 
interacted with ParB (Fadda et al., 2007) through ParA that helps in chromosome segregation. 
In Streptococcus suis serotype 2, an important swine pathogen, Ser/Thr kinases (STK) encoded 
by stk, directly phosphorylates DivIVASp (Thr-199) and affects cell growth and division ( 
Nováková et al., 2010a; Ni et al., 2018). DivIVASs is one of the target substrates for STK, which 
when mutated exhibits abnormal growth and asymmetrical division, including lower viability, 
enlarged cell mass (Nováková et al., 2010a; Ni et al., 2018). STK regulates the cell growth and 
virulence of S. suis by phosphorylating targeted substrates that are involved in different 
biological processes (Ni et al., 2018). Similarly in S. pneumoniae, StkP also phosphorylates 
DivIVASp affecting cell division and morphogenesis (Giefing et al., 2008; Nováková et al., 
2010). DivIVA of Corynebacterium glutamicum and Streptomyces coelicolor interacts with 
ParB/Spo0J (Donovan et al., 2012, 2013; Sieger et al., 2013), which binds to chromosomal 
origins of replication via ParA for chromosomal segregation (Mierzejewska and Jagura-
Burdzy, 2012). Additionally in Streptomyces coelicolor, another rod-shaped Gram-positive 
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bacterium, DivIVA is involved in apical growth and control of cell polarity by establishing 
sites for hyphal branching and for cell wall growth (Flärdh, 2010). 
S. aureus also encodes a homologue of DivIVASa, that associates with various divisome 
proteins to ensure cell division and chromosome segregation (Bottomley et al., 2017). A highly 
conserved molecular chaperone, DnaKSa, interacts with and stabilizes DivIVASa in S. aureus 
(Bukau and Walker, 1989; Bottomley et al., 2017). Bottomley et al., 2017 also reported an 
indirect function of DivIVASa in chromosomal segregation by its interaction with the 
chromosome segregation protein, SMC, where these two act collectively to maintain accurate 
chromosome segregation (Bottomley et al., 2017). 
In the rod-shaped bacteria, Mycobacterium smegmatis and M. tuberculosis, DivIVA, 
also called as Wag31, controls cell growth, morphology and cell wall synthesis (Nguyen et al., 
2007; Kang et al., 2008; Meniche et al., 2014). M. tuberculosis Wag31 interacts with the 
penicillin-binding protein, PBP3 (Mukherjee et al., 2009) and ParB (Donovan et al., 2012), and 
wag31 in M. tuberculosis is essential for cell viability (Donovan et al., 2012). Wag31Ms 
interacts with ParA, a member of the mycobacterial chromosome segregation machinery for 
cell separation (Donovan et al., 2012; Ginda et al., 2013).  
In conclusion, DivIVA plays a pivotal function in Gram-positive bacteria by interacting 
with a variety of interacting partners in different genera. A variety of interacting partners confer 
a variety of functions to DivIVA in cellular processes ranging from the synthesis of the cell 
wall (Nguyen et al., 2007; Kang et al., 2008), cell growth (Flärdh, 2010), chromosome 
segregation (Perry and Edwards, 2006; Fadda et al., 2007; Donovan et al., 2012; Bottomley et 
al., 2017), cell division (Bramkamp et al., 2008; Giefing et al., 2008; Patrick and Kearns, 2008; 
Mukherjee et al., 2009; Nováková et al., 2010; Ni et al., 2018), competence development 
(Briley et al., 2011; dos Santos et al., 2012), sporulation (Perry and Edwards, 2006; Lenarcic 
et al., 2009) and protein secretion (Nováková et al., 2010; Halbedel et al., 2012, 2014; Kaval 
et al., 2014; Ni et al., 2018).  
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Table 1.1. DivIVA interacting partners from different Gram-positive bacteria. 
DivIVA homologue from: Interacting partners 
Bacillus subtilis MinJBs (Bramkamp et al., 2008; Patrick and 
Kearns, 2008) 
RacABs (Ben-Yehuda et al., 2003) 
ComNBs (dos Santos et al., 2012) 
MafBs (Briley et al., 2011) 
SecABs (Halbedel et al., 2014) 
Spo0JBs (Perry and Edwards, 2006) 
SpoIIEBs (Eswaramoorthy et al., 2014) 
Streptococcus pneumoniae FtsZSp, FtsASp, ZapASp, FtsKSp and FtsISp, FtsBSp, 
FtsQSp and FtsWSp (Fadda et al., 2007) 
STKSp (Ser/Thr kinases) (Giefing et al., 2008) 
Streptococcus suis STKSs (Ser/Thr kinases) (Nováková et al., 2010) 
Corynebacterium glutamicum ParBCg (Donovan et al., 2013) 
RodACg (Sieger et al., 2013) 
Listeria monocytogenes MinCD (Kaval et al., 2014) 
SecA2 (Kaval et al., 2014) 
Streptomyces coelicolor ParBSc (Donczew et al., 2016) 
S. aureus DnaKSa, FtsZSSa, FtsASa, EzrASa, DivICSa, 
DivIBSa, PBP1Sa and PBP2Sa (Bottomley et al., 
2017) 
Chromosome segregation protein (SMC) 
(Bottomley et al., 2017) 
Mycobacterium smegmatis 
(Wag31) 
ParA (Donovan et al., 2012; Ginda et al., 2013) 
Mycobacterium tuberculosis 
(Wag31) 
PBP3 (Mukherjee et al., 2009)  
ParB (Donovan et al., 2012) 
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1.9. Cell division interactome 
While the gene arrangement in the dcw cluster varies in different bacteria species, key 
cell division proteins are relatively conserved (Pucci et al., 1997). For examples, proteins like 
FtsZ, FtsA, ZipA, FtsQ/DivIB, FtsL, FtsW, FtsB/DivIC, FtsI and FtsK are highly conserved in 
almost all cell-walled Eubacteria (Margolin, 2000; Harry et al., 2006). But additional proteins 
like Min proteins, ZipA, ZapA, EzrA, FtsN or SepF, may or may not be present depending on 
the bacterial species (Margolin, 2000). All these proteins interact with one another to form one 
large multicomponent complex spanning the cytoplasmic membrane. Using in vivo and in vitro 
biochemical techniques such as bacterial two-hybrid (B2H) assay, GST-pull down assay, Co-
immunoprecipitation (Co-IP) and Surface Plasmon Resonance (SPR) cell division protein-
protein interaction networks have been established for only four bacterial species i.e. E. coli 
(Di Lallo et al., 2003; Karimova et al., 2005), N. gonorrhoeae (Zou et al., 2017), S. aureus 
(Steele et al., 2011) and S. pneumoniae (Fadda et al., 2007; Maggi et al., 2008).  
1.9.1. Cell division interactome in Gram-positive bacteria 
Maggi et al. (2008) tested 11 streptococcal cell division proteins for interactions using 
a B2H assay and co-immunoprecipitation from S. pneumoniae. A total of 37 homo- and/or 
hetero-dimeric interactions were observed where each protein interacted with at least two or 
more interacting partners except for PBP1A which had only one interacting partner (Maggi et 
al., 2008). There were 7 unique interactions i.e. FtsASp–FtsKSp, FtsASp–FtsLSp, FtsZSp–FtsWSp, 
FtsZSp–FtsQSp/DivIBSp, FtsZSp–FtsLSp, FtsKSp–FtsWSp, FtsLSp–FtsISp/PBP2XSp, when 
compared with the E. coli interactome (Maggi et al., 2008). Using co-immunoprecipitation, 
seventeen confirmed interactions (i.e. FtsZSp with FtsASp, FtsKSp, FtsQSp, FtsBSp, FtsLSp, and 
FtsWSp; FtsASp with FtsKSp, FtsLSp, and FtsLSp; FtsKSp with FtsQSp, FtsISp, and FtsWSp; FtsQSp 
with FtsLSp, and FtsWSp; FtsBSp-FtsWSp; and FtsLSp with FtsISp, and FtsWSp) were observed 
among nine cell division proteins that included FtsZSp, FtsASp, FtsKSp, DivlBSp, DivlCSp, 
FtsLSp, FtsWSp, and PBP2xSp (Maggi et al., 2008).  
 In S. aureus, the potential interactions between thirteen divisome proteins (i.e. FtsZSa, 
FtsASa, EzrASa, GpsBSa, SepFSa, Pbp1Sa, Pbp2Sa, Pbp3Sa, DivIBSa, DivICSa, FtsLSa, FtsWSa and 
RodASa) were mapped using a B2H assay by Steele et al. (2011). Around 49 homo-and/or 
hetero-dimeric protein interactions were identified and almost all proteins were found to 
interact with multiple interacting partners except for SepFSa and GpsBSa which interacted with 
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only EzrASa (Steele et al., 2011). SepFSa interaction with FtsZSa has been well-studied in B. 
subtilis (Hamoen et al., 2006) but was not observed in S. aureus (Steele et al., 2011). When 
compared with the interactome of S. pneumoniae, following interactions were observed to be 
conserved: FtsASa with FtsZSa, all division-specific PBPs, FtsWSa, DivICSa and FtsLSa; FtsWSa 
with FtsLSa and all division-specific PBPs; DivICSa, DivIBSa and FtsLSa with all division-
specific PBPs; and FtsLSa with DivICSa. EzrASa interacted with all thirteen cell division proteins 
(Fig. 1.5.) (Steele et al., 2011).  
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Figure 1.5. Characterized cell division interactomes from A) S. pneumoniae (Maggi et al., 
2008), and B) S. aureus (Steele et al., 2011).  
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1.9.2. Cell division interactome in Gram-negative bacteria 
Di Lallo et al. (2003) were first to use B2H assay to deduce the cell division interactome 
network in E. coli using 9 divisome proteins (i.e. FtsZEc, FtsAEc, ZipAEc, FtsKEc, FtsQEc, FtsLEc, 
FtsIEc, FtsWEc, and FtsNEc). Karimova et al. (2005) later expanded on this knowledge using 
their own version of a B2H assay i.e. the bacterial adenylate cyclase two-hybrid (BACTH) 
system, which relies on the reconstruction of a cyclic AMP (cAMP) signalling cascade upon 
interaction (Karimova et al., 1998). They reconfirmed all the interactions showed by Di Lallo 
et al. (2003) and included FtsB for testing possible interactions with other cell division proteins. 
Collectively in E. coli, 16 interactions (i.e. FtsZEc with FtsAEc, ZipAEc, FtsKEc; FtsAEc with 
FtsIEc, FtsNEc, FtsQEc; FtsKEc with FtsIEc, FtsQEc; FtsQEc with FtsBEc, FtsLEc, FtsIEc, FtsNEc, 
FtsWEc; FtsBEc with FtsLEc, FtsIEc; FtsLEc with FtsIEc, FtsWEc; FtsIEc with FtsWEc, FtsNEc; and 
FtsWEc with FtsNEc) between ten cell division proteins (i.e. including FtsZEc, FtsAEc, ZipAEc, 
FtsKEc, FtsQEc, FtsBEc, FtsLEc, FtsIEc, FtsWEc, and FtsNEc) were identified (Di Lallo et al., 2003; 
Karimova et al., 2005). Maggi et al. (2008) compared S. pneumoniae interactome with E. coli 
and observed 8 unique interactions that were absent in E. coli interactome which was a 
reflection of distinct cell division mechanisms in these two organisms (Di Lallo et al., 2003; 
Karimova et al., 2005; Maggi et al., 2008). 
Zou et al. (2017) characterized cell division interactome from Neisseria gonorrhoeae, 
another Gram-negative coccal bacterium, using B2H and GST-pull down assays. Nine positive 
interactions (i.e. FtsZNg-FtsANg, FtsZNg-FtsKNg, FtsZNg-FtsWNg, FtsANg-FtsKNg, FtsANg-
FtsQNg, FtsANg-FtsWNg, FtsANg-FtsNNg, FtsINg-FtsWNg, and FtsKNg-FtsNNg) were observed 
among 8 cell division proteins i.e. FtsZNg, FtsANg, ZipANg, FtsKNg, FtsQNg, FtsINg, FtsWNg, and 
FtsNNg, that defined the cell division interactome. FtsANg did not homodimerize or interact with 
FtsZEc but interacted with FtsNNg which is unlike E. coli interactome (Fig. 1.6) (Di Lallo et al., 
2003; Karimova et al., 2005; Zou et al., 2017).  
1.9.3. Conserved cell divisome interactions 
When cell division interactomes from E. coli (Di Lallo et al., 2003; Karimova et al., 
2005), N. gonorrhoeae (Zou et al., 2017), S. aureus (Steele et al., 2011) and  
S. pneumoniae (Fadda et al., 2007; Maggi et al., 2008) were compared, the interaction between 
FtsZ and FtsA was found to be conserved in all four interactomes. The interaction between 
FtsZ and FtsK was positive in E. coli, N. gonorrhoeae, and S. pneumoniae but  
S. aureus was not tested.  
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Figure 1.6. Characterized cell division interactomes from Gram-positive organisms: A) 
Neisseria gonorrhoeae (Zou et al., 2017); B) E. coli (Karimova et al., 2005; Di Lallo et al., 
2003 ).  
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1.10. Cell division in E. faecalis 
1.10.1. E. faecalis Division Cell Wall (dcw) cluster 
Enterococcus faecalis dcw gene cluster was identified first by Pucci et al. (1997) and 
Massidda et al. (1998) reported its resemblance with E. hirae. Ramirez et al. (2005) extended 
the information on the E. faecalis dcw cluster and reported the presence of 16 genes organized 
in four operons (Fig. 1.1). The first operon contains promoter region located upstream of 
mraZEf followed by mraWEf, ftsLEf, ftsIEf, mraYEf, murGEf and ftsQEf, followed by a terminator 
sequence located immediately downstream of ftsQEf (Ramirez-Arcos, 2005). The second 
operon in the dcw cluster contains ftsAEf, ftsZEf, ylmEEf, ylmFEf, ylmGEf, and ylmHEf with the 
promoter sequence located upstream of ftsAEf  (Ramirez-Arcos, 2005).  The third and fourth 
operons contain divIVAEf and ileSEf respectively (Ramirez-Arcos, 2005). All the genes within 
the enterococcal dcw cluster are transcribed in the same direction using four σ70 promoter 
sequence and three predicted ρ-independent transcriptional terminators (Ramirez-Arcos, 
2005). Among all enterococcal dcw cluster genes, only divIVAEf has been studied so far 
(Ramirez-Arcos, 2005; Rigden et al., 2008). Ramirez et al. 2005 also postulated that divIVAEf 
might be co-transcribed with other upstream cell division protein encoding genes. 
1.10.2. DivIVA from E. faecalis 
Unlike the dcw clusters from other Gram-positive bacteria, such as B. subtilis,  
S. pyogenes, S. pneumoniae and S. aureus, divIVEf, is located within the dcw cluster of E. 
faecalis (Ramirez-Arcos, 2005). E. faecalis divIVEf encodes DivIVAEf which comprises 
predominantly of coiled-coil domains, one at the N-terminus, one at the C-terminus, and two 
in the central region of the protein that is responsible for the self-interacting properties of 
DivIVAEf (Rigden et al., 2008). Both, the N-terminal and central coiled-coil regions were 
indispensable for DivIVAEf function (Rigden et al., 2008). An N-terminal point mutation in 
DivIVAEf resulted in aberrant phenotypes, such as irregular shape, aggregation, and 
enlargement, indicating disruption of normal cell division (Rigden et al., 2008). DivIVAEf is 
essential for cell viability and is involved in cell division and chromosome segregation 
(Ramirez-Arcos, 2005), similar to its counterpart in S. pneumoniae (Fadda et al., 2003, 2007). 
divIVA inhibits proper cell division when absent (Ramirez-Arcos, 2005). Its absence leads to 
abnormal cell clusters possessing rounded enlarged cells instead of the characteristic 
ovodiplococcal cells (Ramirez-Arcos, 2005). Overexpression of DivIVAEf in E. coli KJB24 
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resulted in enlarged cells with disrupted cell division (Ramirez-Arcos, 2005). E. faecalis 
DivIVA failed to complement the cell division defects of either  
S. pneumoniae or B. subtilis divIVA mutants, reflecting the variety of DivIVA functions in 
different microorganisms and indicating that DivIVA could be playing a species-specific 
function (Ramirez-Arcos, 2005).  
1.10.3. Discovery of a novel DivIVAEf interacting partner 
To identify novel DivIVAEf interacting proteins in E. faecalis, a Y2H system was used 
to screen an E. faecalis genomic DNA library using DivIVAEf as the bait protein. Fifteen 
positive clones were identified from ~3x104 transformed yeast colonies. Thirteen of the 
positive clones had inserts corresponding to full-length divIVAEf and the remaining two positive 
clones contained a 400bp DNA fragment from an unknown ORF (unpublished data). Upon 
bioinformatic analysis, this 400bp DNA fragment was found to encode a peptide corresponding 
to the C-terminus of the hypothetical protein EF1025 (GenBank accession # NP_814759) in E. 
faecalis. This thesis builds in part upon the characterization of this novel protein.  
27 
 
1.11. Hypothesis and objectives  
1.11.1. Background 
The diverse functionality of DivIVA in Gram-positive organisms across species, 
suggests that DivIVA associates with different proteins in different bacterial species 
performing a variety of functions. These DivIVA-associating proteins are not a part of 
divisome and indirectly assist DivIVA in cell growth and division. Although DivIVA 
interacting partners have been reported from many bacterial species, there is a lack of 
information regarding DivIVA-associating proteins in E. faecalis. We have identified a novel 
DivIVAEf interacting protein i.e. EF1025, but its characteristics and the biological function is 
unknown.  
The cell division interactome presents a network of assembly of divisome proteins. The 
cell division interactomes of only E. coli, N. gonorrhoeae, S. aureus and S. pneumoniae have 
been characterized (Di Lallo et al., 2003; Maggi et al., 2008; Steele et al., 2011; Zou et al., 
2017). These interactomes show the existence of multiple unique interactions within the 
divisome proteins that might help in stabilizing the macromolecular complex, divisome (Maggi 
et al., 2008, 2008). The dcw cluster of E. faecalis contains homologues of divisome proteins 
FtsZ, FtsA, FtsK, FtsQ (DivIB), FtsL, FtsI and probably FtsB (DivIC), EzrB and ZapA. The 
cell division interactome of E. faecalis, by contrast, is not presently known.  
1.11.2. Hypothesis  
The hypothesize of this thesis is that EF1025 is a cell division protein in E. faecalis, 
which interacts with DivIVAEf and affects cell division. I also hypothesize that homologues of 
EF1025 may interact with DivIVA from other species. Like other functionally characterized 
DivIVA interacting partners, EF1025 might not also be a part of divisome and will be assisting 
during the process of cell division. 
1.11.3. Objectives 
1. To biochemically, biologically, and functionally characterize EF1025 from E. faecalis by: 
a. Bioinformatically characterizing EF1025, its homologues and domains. 
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b. Researching the interaction of EF1025 and domains present in EF1025 with 
DivIVAEf using GST pull-down assay and re-analyze previous B2H and Co-
immunoprecipitation assay results for this interaction. 
c. Studying the oligomerization properties of EF1025 using size exclusion 
chromatography (SEC), Dynamic light scattering (DLS) and SEC- multi-angle light 
scattering (SEC-MALS) techniques. 
c. Creating an E. faecalis EF1025 deletion mutant and EF1025 overexpressing strain.  
d. Ascertaining the morphological changes in E. faecalis when EF1025 is deleted or 
overexpressed by electron microscopy and atomic force microscopy.  
2. To investigate CcpN, an EF1025 homologue from B. subtilis by: 
a. Ascertaining whether there is an interaction between CcpN and DivIVABs by B2H 
and GST pull-down assays. 
b. Ascertaining the heterologous interaction between EF1025 and DivIVABs by GST 
pull-down assay. 
c. Ascertaining the morphological changes by electron microscopy and atomic force 
microscopy in B. subtilis when ccpN is insertionally inactivated. 
3. To establish a preliminary cell division interactome of E. faecalis by: 
a. Testing E. faecalis cell division protein-protein interactions between FtsZEf, FtsAEf, 
FtsQEf, FtsLEf, FtsIEf, FtsWEf, DivIVAEf, and FtsBEf, using B2H assays and re-analyze 
previous B2H data using statistical methods. 
b. Identifying whether EF1025 interacts with E. faecalis cell division proteins i.e. 
FtsZEf, FtsAEf, FtsQEf, FtsLEf, FtsIEf, FtsWEf, DivIVAEf, and FtsBEf, using B2H assays 
and re-analyze previous B2H data using statistical methods. 
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2.1. Abstract 
DivIVA plays multifaceted roles in Gram-positive organisms through its association with 
various cell division and non-cell division proteins. We report a novel DivIVA interacting 
protein in Enterococcus faecalis, named EF1025 (encoded by EF1025), which is conserved in 
Gram-positive bacteria. The interaction of EF1025 with DivIVAEf was confirmed by Bacterial 
Two-Hybrid, Glutathione S-Transferase pull-down, and co-immunoprecipitation assays. 
EF1025, which contains a DNA binding domain and two Cystathionine β-Synthase (CBS) 
domains, forms a decamer mediated by the two CBS domains. Viable cells were recovered 
after insertional inactivation or deletion of EF1025 only through complementation of EF1025 
in trans. These cells were longer than the average length of E. faecalis cells and had distorted 
shapes. Overexpression of EF1025 also resulted in cell elongation. Immuno-staining revealed 
comparable localization patterns of EF1025 and DivIVAEf in the later stages of division in E. 
faecalis cells. In summary, EF1025 is a novel DivIVA interacting protein influencing cell 
length and morphology in E. faecalis.  
32 
 
2.2. Introduction 
A key protein in Gram-positive bacteria is DivIVA which is implicated in cell division 
and other functions (Cha and Stewart, 1997; Ben-Yehuda et al., 2003; Fadda et al., 2003; Pinho 
and Errington, 2004; Ramirez-Arcos, 2005; Briley et al., 2011; Halbedel and Lewis, 2019). 
DivIVA self-interacts, oligomerizes and associates with a functionally different array of 
proteins in different Gram-positive bacteria (Halbedel and Lewis, 2019). In Bacillus subtilis 
(Bs), DivIVABs functions as a mid-cell determinant by attracting the MinC/MinD protein 
complex to the cell poles, thereby preventing cell division at the polar region (Cha and Stewart, 
1997; Edwards and Errington, 1997; Marston and Errington, 1999; Edwards et al., 2000; 
Karoui and Errington, 2001; Harry and Lewis, 2003). DivIVABs also associates with the DNA 
binding protein RacA, which acts as a bridge between the oriC region and the cell poles, 
anchoring the chromosome at the poles during sporulation (Ben-Yehuda et al., 2003). In 
addition, DivIVABs interacts with Spo0J, participating in chromosome segregation during 
sporulation (Ben-Yehuda et al., 2003; Wu and Errington, 2003; Perry and Edwards, 2006); 
ComN which is involved in competence development (dos Santos et al., 2012); and, with Maf, 
a regulator of cell shape and division (Butler et al., 1993). The interaction between Maf and 
DivIVABs arrests cell division in competent cells (Briley et al., 2011). DivIVA of 
Corynebacterium glutamicum interacts with RodA and ParB, (Donovan et al., 2012; Sieger et 
al., 2013), which binds the origin of replication with ParA, resulting in chromosomal 
segregation (Mierzejewska and Jagura-Burdzy, 2012). DivIVA is involved in apical growth 
and control of cell polarity in Streptomyces coelicolor (Flärdh, 2010), by interacting with ParB 
to co-ordinate chromosomal segregation. (Donczew et al., 2016). DivIVA in S. pneumoniae 
interacts with several proteins implicated in divisome formation, including FtsZ, FtsA, ZapA, 
FtsK and FtsI, FtsB, FtsQ and FtsW (Fadda et al., 2007). These studies highlight the diverse 
functionality of DivIVA in Gram-positive organisms. There is no information regarding 
DivIVA-associating proteins in Enterococcus faecalis (Ef).   
 E. faecalis, an opportunistic, commensal, Gram-positive, ovococcal pathogen is 
recognized for its resistance to multiple antibiotics and for causing hospital-acquired infections 
(Murray, 1990; Cross and Jacobs, 1996; Hidron et al., 2008a, 2008b; Sievert et al., 2013). 
Enterococcal infections are potentially fatal, causing neonatal and wound infections, 
endocarditis, meningitis, and urinary tract infections (Hidron et al., 2008a, 2008b; Torelli et 
al., 2017). Due to its ability to form biofilms, catheter-related urinary tract infections with E. 
faecalis are difficult to treat (Mohamed and Huang, 2007). To formulate new therapeutic agents 
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and targets for resisting antibiotic resistant E. faecalis infections, a greater understanding of 
enterococcal biology, physiology and genetics is required.  
E. faecalis contains DivIVA (Ramirez-Arcos, 2005). This research describes a novel 
DivIVA-interacting protein, EF1025, which was annotated as a hypothetical protein in E. 
faecalis strain V583 (Paulsen et al., 2003). EF1025, which is conserved in most Gram-positive 
bacteria, contains a DNA binding domain at its N-terminus and two highly conserved 
Cystathionine β-Synthase (CBS) domains at the central and C-terminal regions. Bacterial Two-
Hybrid (B2H), Glutathione S-Transferase (GST) pull-down, and Co-Immunoprecipitation (Co-
IP) assays were used to demonstrate an interaction between EF1025 and DivIVAEf. EF1025 
self-interacts and forms a decamer. It was not possible to obtain viable cells after the deletion 
or insertional inactivation of EF1025 without in trans expression of the gene. These rescued 
cells grew more slowly than wild type E. faecalis.  Scanning electron microscopy (SEM) and 
atomic force microscopy (AFM) revealed cell elongation and aberrant cell shape in rescued 
cells. Cell elongation was also observed in SEM images when EF1025 was overexpressed in 
E. faecalis cells. Using an E. coli model, overexpression of EF1025 in E.coli PB103 resulted 
in filamentation. Immunofluorescence microscopy showed that EF1025 localized comparably 
to DivIVAEf localization during the later stages of cell division. 
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2.3. Materials and methods 
2.3.1. Strains, plasmids and growth conditions 
 Strains and plasmids used in this study are listed in Tables S1 and S2. E. coli XL1-Blue 
or DH5α were used as hosts for cloning. E. coli C41 (DE3) was used to overexpress cloned 
proteins, E. coli PB103 (de Boer et al., 1988) for heterologous overexpression of E. faecalis 
proteins, and E. coli R721 (Di Lallo et al., 2001, 2003) was used for the bacterial-two hybrid 
evaluations. E. coli strains were grown at 37°C in Luria-Bertani (LB) medium (Difco, Detroit, MI) 
and antibiotics were included in the following concentrations as required: ampicillin (Amp) 100 
μg/mL, kanamycin (Kan) 50 μg/mL and erythromycin (Ery) 125 μg/mL. E. faecalis JH2-2 (Jacob 
and Hobbs, 1974), the parental strain, was used for the preparation of genomic DNA. E. faecalis 
was cultured at 37°C without aeration in Brain Heart Infusion (BHI) broth (Difco, Detroit, MI) 
and supplemented with appropriate antibiotics if required (Ramirez-Arcos, 2005; Rigden et al., 
2008). Saccharomyces cerevisiae SFY526, used in yeast two-hybrid (Y2H) assays (Clontech 
Laboratories, Inc., CA), was grown at 30°C for 2-4 days on yeast extract-peptone-dextrose-adenine 
medium (YPDA) or appropriate synthetic dropout media (Yeast Protocols Handbook, Clontech). 
2.3.2. Bioinformatic analysis 
DNA sequences interacting with DivIVAEf,  identified after screening Y2H libraries of  
E. faecalis JH2-2 (Supplementary methods) were blasted against the E. faecalis V583 genome 
(Paulsen et al., 2003) using NCBI BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). A putative 
open reading frame, named EF1025 (GenBank accession number NC_004668), was identified 
from the E. faecalis V583 genome. The upstream sequence of EF1025 (~ 480bp) was analyzed for 
promoter prediction (http://www.fruitfly.org/cgi-bin/seq_tools/promoter.p1) and the deduced 
amino acid sequence of EF1025 was ascertained using ProtParam 
(http://us.expasy.org/tools/protparam.html). Homologues of EF1025 were identified using 
BLASTp (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) against the non-redundant 
protein sequences database. EF1025 was also analyzed by PROSITE (Sigrist et al., 2010) 
(http://ca.expasy.org/cgi-bin/prosite/mydomains) to identify functional domains. Transmembrane 
motifs in EF1025 were predicted using TMbase (http://www.ch.embnet.org/cgi-
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bin/TMPRED_form_parser) and potential coiled-coil structures were predicted using COILS  
(http://www.ch.embnet.org/software/COILS_form.html).  
2.3.3. EF1025-DivIVA interactions in the Bacterial Two-Hybrid (B2H) assays 
The B2H system of Di Lallo et al. (2001 and 2003) was used to investigate interactions 
between DivIVAEf and EF1025 and its various domains. This particular assay involves a hybrid 
repressor which recognizes a chimeric operator. Potential interacting proteins are cloned at the two 
chimeric regions at the C-terminus of this hybrid repressor. The dimerization of the heterologous 
proteins permits reconstitution of the hybrid repressor which recognizes the chimeric operator and 
downregulates the activity of the downstream reporter gene, lacZ (Di Lallo et al., 2001). Modified 
B2H vectors pcI434-L and pcIp22-L, containing a linker with multiple endonuclease restriction 
sites were used in B2H assays (Table S2A). EF1025, EF1025CBS12 (encoding AA80-209 of 
EF1025) and divIVAEf were PCR-amplified from the E. faecalis JH2-2 using primers EF1025-F/R, 
EF1025C-F/R and CBdivIVA-F/R, respectively (Supplementary Materials, Table S3A) and 
cloned into the modified B2H vectors, resulting in plasmids pdivIVA22, pdivIVA434, 
pEF1025434, p22CBS1CBS2 and p434CBS1CBS2, respectively (Table S2A). These plasmids 
were transformed into E. coli R721 alone or in combination (Di Lallo et al., 2001, 2003; Greco-
Stewart et al., 2007). Freshly transformed single colonies were grown overnight in 4 mL LB 
medium supplemented with Amp 50µg/mL and Kan 30 µg/mL. Cells were diluted 1:100 using 
fresh LB medium containing the same antibiotics and were incubated for ~1 hr (OD600 ~0.1) at 
37°C, followed by the addition of 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). Cells 
were further incubated to mid-log phase (i.e. OD600 ~0.5) at 37°C, harvested, and tested for β-
galactosidase activity, as previously described (Di Lallo et al., 2001). Each experiment was 
performed in triplicate and the average percentage β-galactosidase activity was calculated.   
2.3.4. GST pull-down assays 
To create a GST-DivIVAEf fusion, divIVAEf was PCR-amplified from genomic DNA from 
E. faecalis JH2-2 (see supplementary methods) using primers IVA-5/IVA-11 (Table S3B) 
(Ramirez-Arcos, 2005). The amplicon was cloned into pGEX-2T, generating plasmid pGST-Div 
(Supplementary Materials, Table S2B). EF1025 was PCR-amplified from  E. faecalis JH2-2 DNA 
using primers EF1025F-F/R (Table S3B) and cloned into pET30a(+), resulting in plasmid 
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pETEF1025 (Table S2B). The two CBS domains i.e. CBS1 and CBS2, of EF1025 were PCR-
amplified from E. faecalis JH2-2 DNA using primers EF1025-CF/R and cloned into pET30a(+), 
resulting in plasmid pETEF1025CBS12 (Table S2B and 3B). 
GST-DivIVAEf, 6×His-EF1025, or 6×His-EF1025CBS12 fusions were overexpressed in 
E. coli C41 (DE3)(Ramirez-Arcos, 2005). The GST-DivIVAEf fusion protein was purified using 
GST affinity beads (GST-Bind Kit, Novagen, USA). 6×His-EF1025 or 6×His-EF1025CBS12 
were purified from 200 mL log-phase growth of E. coli C41 by sonication in 5 mL Interaction 
Buffer (IB, 20 mM Tris/HCl pH 7.5, 10% glycerol, 50 mM KCl, 0.5 mM EDTA, 1% Triton X100, 
1 mM DTT). The cell lysate was centrifuged and the supernatant (50 µL) was incubated with 20 
µL GST-DivIVAEf bound beads, pre-equilibrated with IB buffer, at 4°C for 2 hrs. Beads were 
washed with cold IB buffer 3× and the retained protein was eluted using a 40 µL 1×SDS loading 
buffer and heating at 95 C for 10 min. Eluted protein was separated by SDS-PAGE, followed by 
Western blot analysis using anti-6×His monoclonal antibody (Biorad, USA). The same protocol 
was used to study DivIVAEf and EF1025CBS12 interaction. Purified GST protein was used as a 
control and was produced in E. coli C41 (DE3) from plasmid pGEX2T.  
2.3.5. Production of anti-EF1025 polyclonal antibody 
6×His-EF1025 was overexpressed in E. coli C41DE3 from plasmid pETEF1025 (Table 
S2B) and was purified as described previously (Ramirez-Arcos, 2005). Female New Zealand 
White rabbits were injected with ~30 µg/mL purified 6×His-EF1025 in Freund’s adjuvant (Sigma; 
v/v=1:1) at the Animal Core Facility of the Vaccine and Infectious Diseases Organization 
(University of Saskatchewan) with a booster dose on day 21 after the initial injection. Polyclonal 
IgG antibody was purified by affinity purification of antiserum using Protein-A sepharose beads 
(Pharmacia Bioscience; (Ramirez-Arcos, 2005). Antibody specificity was tested by western 
blotting assay using an E. faecalis JH2-2 whole cell protein extract which was prepared by 
sonicating 50 mL of cell culture and resuspending the cells in 2.5 mL of Tris buffer (Fig. S1). 
Previously prepared anti-DivIVAEf (Ramirez-Arcos, 2005) was used as a positive control. 
2.3.6. Co-immunoprecipitation (Co-IP) 
An overnight culture of E. faecalis JH2-2 was diluted 1:100 in BHI broth and incubated 
for 16-20 hrs at 37°C without aeration. 200 mL were centrifuged at 10,000 rpm for 10 minutes and 
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the pellet was re-suspended in 5 mL Co-IP buffer (25 mM HEPES pH7.9, 100 mM NaCl, 5% 
glycerol, 0.5 mM EDTA, 0.1% Triton X100, 1 mM DTT and 0.5 mM PMSF). The suspension was 
sonicated, on ice, 3×, for 30 seconds each, with an interval of 20 seconds. The cell lysate was 
centrifuged under the same conditions (above) and the supernatant was collected for Co-IP assays.  
Protein-A Sepharose beads (Pharmacia Inc., Canada) were cross-linked with 20 µg of 
either anti-DivIVAEf or anti-EF1025 polyclonal antibody in 200 µL PBS as follows: antibody was 
incubated with 50 µL Protein-A Sepharose beads at room temperature (RT) for 1 h. Beads were 
washed with PBS once and then washed twice with 0.2 M sodium borate (pH 9.0). 
Dimethylpimelimdate (Sigma) was added to the beads to a final concentration of 20 mM and 
incubated for 30 min at RT to allow cross-linking. The reaction was stopped by adding 0.2 M 
ethanolamine (final concentration 20 mM) pH8.0 (Sigma) and incubating at RT for 2 hrs. Beads 
were then washed with PBS and stored at 4°C for later use. Prior to Co-IP, 20 µL antibody-bound 
beads were incubated with 10 mg/mL BSA overnight at 4°C to block non-specific binding sites. 
Beads were then equilibrated with Co-IP buffer and subsequently incubated with 200 µL of  
E. faecalis JH2-2 cell extract for 2 hrs at 4°C. After removing the supernatant, beads were washed 
with Co-IP buffer 3× for 10 min each. Proteins retained on the beads were eluted in 80 µL 1×SDS 
loading buffer, separated on 12% SDS-PAGE, and transferred onto a nitrocellulose membrane for 
Western blot assay. Blots were probed with either anti-DivIVAEf or anti-EF1025 polyclonal 
antibody. Beads alone or beads cross-linked with anti-MinCNg polyclonal antibody (Ramirez-
Arcos et al., 2001) were used as negative controls.   
2.3.7. EF1025 self-interaction 
To determine whether EF1025 self-interacts, and to map the sites responsible for  
self-interaction, the predicted functional domains of EF1025 were constructed, in different 
combinations, in Y2H vectors as follows: EF1025CBS12 (AA80-204) carrying CBS1 and CBS2 
domains, NCBS1-EF1025 (AA6-204) containing the N-terminus HTH domain and CBS1 domain, 
CBS2-EF1025 (AA144-204) containing the CBS2 domain, and N-EF1025 (AA6-50) containing 
the N-terminus HTH domain. E. faecalis JH2-2 DNA was used as a template for PCR amplification 
of these fragments. Primers for the amplification of various fragments are described in 
Supplementary Table S3C. These amplicons were cloned into the vectors pGAD424 and pGBT9 
resulting in plasmids pGADEF1025CBS12, pGBDEF1025CBS12, pGADEF1025NCBS1, 
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pGBDEF1025NCBS1, pGADEF1025CBS2, pGBDEF1025CBS2, pGADEF1025-N and 
pGBDEF1025-N, respectively (Table S2C). Each plasmid construct was co-transformed with a 
plasmid expressing full-length EF1025 (e.g. pGADEF1025 or pGBDEF1025) into S. cerevisiae 
SFY526. Transformation efficiencies were calculated by plating 50 µL of diluted transformants 
on separate plates followed by counting the number of colonies produced. Transformants were 
selected on complete synthetic medium lacking leucine and tryptophan (SD-leu-trp) (Clontech). 
Transformation efficiencies were calculated by plating 50 µL of diluted transformants on separate 
plates followed by counting the number of colonies produced. After 3-4 days of incubation at 
30°C, using a colony lift assay (Clontech, CA), cells were screened for blue color development in 
the presence of 5-Bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal, Sigma-Aldrich; St. 
Louis, MS) to study the self-interaction ability of EF1025. Positive clones were further subcultured 
in SD-leu-trp broth and a spectrophotometric assay for β-galactosidase activity, using the substrate 
o-nitrophenyl-β-D-galactopyranoside (Ramirez-Arcos, 2005).  
SEC-MALS, the combination of Size Exclusion Chromatography with Multi-Angle Light 
Scattering analysis (Wyatt Technology, USA), was used to determine the oligomerization state of 
EF1025. Using His-bind resin (Novagen, Canada), 1mg of purified 6×His-EF1025 was loaded 
onto a Superdex 200 column (Biorad) equilibrated with a buffer comprising 50 mM Tris base, 400 
mM NaCl, pH 7.4. A single peak, corresponding to EF1025 eluted by SEC, was detected by the 
MALS detector to estimate molar mass.  
2.3.8. Overexpression of EF1025 in E. faecalis JH2-2 
To overexpress EF1025 in E. faecalis JH2-2, EF1025 was cloned into pMSP3545 
(Supplementary Materials, Table S2). pMSP3545 was first modified by introducing an Amp-
encoding gene that was PCR amplified from pcDNA3.1(+) using primer pairs AmpF/R (Table 
S3D), into pMSP3545 creating pMSP3545A (Table S2D). Linkers LinkA/B (Table S3D), which 
contained restriction sites BamHI and NcoI, were ligated to the  Amp gene amplicon prior to 
ligation in pMSP3545. pMSP3545A was electroporated into electrocompetent E. faecalis JH2-2 
cells using previously described methods (Ramirez-Arcos, 2005) and colonies were selected on 
BHI supplemented with Ery (125 µg/mL), creating E. faecalis MK0.   E. faecalis JH2-2 and  
E. faecalis MK0 served as controls for all electroporation experiments. EF1025 and 80 bp 
upstream which included the predicted promoter sequence was PCR amplified using primers 
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EF1025npF/R, and the amplicon was digested with NcoI and XbaI, purified and subcloned into 
pMSP3545A,  digested with the same enzymes, creating pMSPEF1025A (Table S2D). 
pMSPEF1025A was transformed into E. coli DH5α and transformants were selected for Amp 
resistance. Clones were confirmed for the presence of EF1025 using restriction digestion and PCR 
amplification with primers EF1025npF/R. pMSPEF1025A was electroporated into 
electrocompetent E. faecalis JH2-2 cells creating E. faecalis MK23 (Table S1) using previous 
methods (Ramirez-Arcos, 2005). To ascertain whether EF1025 was expressed from its native 
promoter in pMSPEF1025A, pMSPEF1025-flag was created by fusing a flag-tag encoding 
sequence which was PCR amplified from pcDNA3.1(+) using primers flagF/R (Table S3D). The 
amplicon was ligated in pMSPEF1025A downstream of EF1025 and electroporated into 
electrocompetent E. faecalis JH2-2 cells to create E. faecalis MK24 (Table S1). EF1025 
expression from pMSPEF1025-flag in E. faecalis MK24 was evaluated using an anti-flag 
monoclonal antibody (GenScript, USA) by Western blot analysis. Whole cell extracts of both  
E. faecalis JH2-2, E. faecalis MK23 and E. faecalis MK24 were prepared for these blots. In a 
separate Western blot, an anti-EF1025 antibody was used to compare EF1025 expression levels in 
the same strains.  
2.3.9. Complementation of  EF1025 deletions and insertional mutants in E. faecalis JH2-2 
Clones of insertionally inactivated or deleted EF1025 in E. faecalis JH2-2 could not be 
recovered unless EF1025 was expressed in trans. Therefore, E. faecalis JH2-2 was co-transformed 
both with plasmids expressing EF1025 (i.e. either pMSPEF1025-pro or pMSPEF1025A) and 
plasmid constructs designed to insertionally inactive (i.e. p3ERMEF1025::Kan) or delete (i.e. 
p3ERMΔEF1025::Cat) EF1025.  
To create p3ERMEF1025::Kan, first the N-terminal sequence of EF1025 (AA1-55) was 
PCR-amplified from E. faecalis JH2-2 using primers CBSDPF/CBS55R-Hind (Table S3D). The 
amplicon was digested and ligated to predigested pUC18 resulting in pUCEF1025-N (Table S2D). 
Then, a kanamycin cassette (KanR) was PCR-amplified from pTCV-lac (Table S2D; Poyart and 
Trieu-Cuot, 1997) with primers KanF/R (Table S3D), and the amplicon was inserted into 
pUCEF1025-N at its HindIII/SmaI sites, producing plasmid pUCEF1025-N-Kan (Supplementary 
Materials, Table S2D). The C-terminal sequence of EF1025 (AA56-209) was PCR-amplified from 
E. faecalis JH2-2 with primers CBS55F-SmaI/EF1025-R-BamHI (Table S3D) and the amplicon 
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was inserted into pUCEF1025-N-Kan creating the plasmid pUCEF1025::Kan (Supplementary 
Materials, Table S2D). Finally, pUCEF1025::Kan  was digested with EcoRI and BamHI, yielding 
a fragment containing EF1025-N, KanR and EF1025-C. This fragment was ligated into p3ERM-
H, creating the suicide vector p3ERMEF1025::Kan (Table S2D; Ramirez-Arcos, 2005). This 
plasmid was electroporated into E. faecalis JH2-2 (Ramirez-Arcos, 2005) with selection attempted 
using BHI agar containing Kan 500 µg/mL and incubation at 37°C for 2-3 days. Transformants 
were never obtained after multiple attempts, so p3ERMEF1025::Kan was co-electroporated with 
the shuttle plasmid pMSPEF1025-Pro that expresses wild type EF1025 in trans from its native 
promoter (Table S2D) into E. faecalis JH2-2 to create E. faecalis MJ26 (Table S3C; Ramirez-
Arcos, 2005). Transformants were selected on BHI supplemented with Ery (125 µg/mL) and Kan 
(500 µg/mL). For each electroporation experiment, we used E. faecalis JH2-2 and MK0 as controls 
for growth on BHI supplemented with erythromycin. E. faecalis JH2-2 failed to grow in the 
presence of erythromycin while E. faecalis MK0 grew well. To confirm that transformants 
contained both an insertionally inactivated chromosomal EF1025 as well as EF1025 expressed in 
trans from pMSPEF1025-pro in E. faecalis MJ26, primers mutF/Kan-R, KanF/KanR, EF1025-
Pro/KanR and KanF/CBSDPR were used to amplify chromosomal and plasmid fragments, 
followed by DNA sequencing of all amplified fragments for confirmation of the insertion (Table 
S3D).  
To ensure that phenotypes observed in E. faecalis MJ26 were not caused by polar effects 
of the insertional mutagenesis of EF1025 on the downstream gene, EF1026, qPCR was performed 
to study the expression of both genes (Supplementary Methods).  
A second strategy to inactivate EF1025 in E. faecalis JH2-2 involved the nonpolar deletion 
of chromosomal EF1025 (LeDeaux et al., 1997) by the introduction of the suicide plasmid 
pERMΔEF1025::Cat. Partial overlapping flanking primers ppdkF/R-BamHI (Table S3D) were 
used to amplify 500 bp upstream (includes the native promoter of EF1025) of the start codon of 
EF1025 and 500 bp downstream of the stop codon of EF1025 using primers 1026F/R-EcoRI 
(Table S3D) of E. faecalis JH2-2 DNA. A chloramphenicol cassette was amplified from pLemo 
(NEB) using primers CatF/R (Table S3D). The three fragments were combined by overlap PCR 
amplification (Hussain and Chong, 2016), creating a fragment that contained the chloramphenicol 
cassette flanked by the 500 bp upstream fragment and 500 bp downstream fragment. The resultant 
fragment was purified, digested and ligated into p3ERM-H, creating the suicide vector 
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p3ERMΔEF1025::Cat (Table S2D). As no transformants were recovered after electroporation of 
p3ERMΔEF1025::Cat into E. faecalis JH2-2, this plasmid along with pMSPEF1025A (Table S2D) 
were co-electroporated into E. faecalis JH2-2 (Shepard and Gilmore, 1995) creating E. faecalis 
MK12. Transformants were selected on BHI agar plates containing Chl 5 µg/mL and Ery 125 
µg/mL, incubated at 37°C for 2-3 days. The deletion of EF1025 in E. faecalis MK12 was 
confirmed by PCR-amplification using primers ppdkF/EF26b-R, mutF/EF26b-R, 
ppdkF/EF1025npR, EF1025npF/1026R, CatF/1026R and CatF/R (Table S3C and D) followed by 
DNA sequencing of these amplified fragments (data not shown). E. faecalis JH2-2 did not grow 
at this concentration of chloramphenicol.  As a positive control, p3ERMΔEF1025::Cat was 
electroporated into E.coli DH5α and transformants were selected on LB agar plates containing Chl 
33 µg/mL at after incubation for 24 hrs at 37°C.    
2.3.10. Microscopy 
SU8010 Cold Field Emission Ultra-High-Resolution scanning electron microscope 
(WCVM, University of Saskatchewan, Saskatoon, Saskatchewan) was used to image E. faecalis 
strains JH2-2, MK0, MK12, MJ26, MK23, MK24 (Table S1). Strains were cultured in BHI 
medium with or without appropriate antibiotics, without agitation, at 37°C, either overnight (~20 
hrs) or to stationary phase. Cells were fixed on poly-l-lysine coverslips, dehydrated in ethanol, 
critical point dried, sputter coated with gold and imaged (Ramirez-Arcos et al., 2001). Length 
measurements were performed across the poles of the diplococcal bacteria and the percentage of 
elongated cells was calculated by measuring the lengths of 110-250 cells.  
A Hitachi HT7700 High Contrast High-Resolution Digital Transmission Electron 
Microscope (WCVM, University of Saskatchewan, Saskatoon, Saskatchewan) was used to image 
E. faecalis strains JH2-2 and MJ26 prepared as previously described (Ramirez-Arcos, 2005). 
2.3.11. Immuno-fluorescence microscopy of E. faecalis JH2-2 
To visualize DivIVAEf and EF1025 localization, E. faecalis JH2-2 cells in exponential 
phase were collected and fixed using a procedure modified from Harry and Lewis (2003). One mL 
of cell culture was harvested and the resuspended pellet was fixed with 1 ml fixation buffer (2.5% 
paraformaldehyde, 0.03% glutaradehyde in 30 mM sodium phosphate buffer pH 7.5) for 30 min, 
at RT, then for 2 hrs at 4°C. Cells were washed 3× with 1PBS and resuspended in 200 µL GTE 
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(50 mM glucose, 20 mM Tris-HCl pH 7.5, 10 mM EDTA) to which a freshly prepared lysozyme 
solution (2 mg/mL) was added. This volume was transferred to and fixed on poly-L-lysine coated 
coverslips. Cells attached to the coverslips were blocked with BSA-PBST (3% bovine serum 
albumin [wt/vol] and 0.2% Triton X-100 [vol/vol] in PBS) for 2 hrs at RT. Cells were then 
incubated with either anti-DivIVAEf (1:200) or anti-EF1025 (1:100) in BSA-PBST for 3 hrs at RT. 
After washing with PBST, cells were incubated with a fluorescence-labeled secondary antibody 
(1:500 dilutions in BSA-PBST, goat anti-rabbit Alexa Fluor 488, Invitrogen) for 45 min. Images 
were acquired using U-M655 and U-M665 filters and processed using InVitro 3 and ImagePro 6.0 
software (Media Cybernetics). Each experiment was performed 4× using 2 independent cell 
cultures, and about 300 cells were counted for each immuno-staining. Cells were also stained with 
DAPI (Thermofischer, CA) and were mounted and observed under a 100X oil immersion objective 
using an Olympus BX61 microscope with standard filters. DAPI-stained cells were divided into 
five cell division stages. Stage 1 was defined as a single cell with a central condensed chromosome. 
Stage 2 cells contained segregating chromosome as the cell started to divide. Stage 3 and 4 were 
defined by the presence of two newly replicated cells with segregated chromosome. As the cell 
completed one round of cell division, Stage 5 comprised of two daughter cells with condensed 
DNA in the center. E. faecalis MWMR16 cells were used as a negative control which contains 
point mutations in the coiled-coil region of DivIVAEf (Rigden et al., 2008).   
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2.4. Results 
2.4.1. Identification and in silico analysis of a novel DivIVAEf interacting protein in E. faecalis  
To identify DivIVAEf interacting proteins from E. faecalis, a Y2H system was used to 
screen an E. faecalis genomic DNA library using DivIVAEf as the bait protein (data not shown). 
Positive clones were sequenced and bioinformatic analysis indicated a sequence corresponding to 
the C-terminus of the hypothetical protein EF1025 (GenBank accession # NP_814759) of the  
E. faecalis V583 genome; EF1025 spans nucleotide positions 983760-984389 (Fig. 2.1A). In silico 
analysis of EF1025 indicated that a ribosome binding site (GGAGG) is located at nucleotide 
position (nt) –6 to –10, and a putative promoter at position nt -36 to -87. EF1025 has a 
transcriptional orientation (Fig. 2.1B) similar to the downstream gene EF1026, a hypothetical 
protein with a kinase phosphoprotein phosphatase (PPPase) domain. A predicated terminator 
sequence is located downstream of EF1026. The upstream gene, EF1024, is transcribed in the 
opposite orientation of EF1025 and EF1026 and encodes a putative pyruvate phosphate dikinase 
(PPDK) domain (Fig. 2.1B).  
 EF1025 comprises 209 amino acids (AA), with a molecular weight of ~23kDa and a 
theoretical isoelectric point of 6.75. Domain prediction studies (Fig. 2.1B) showed that EF1025 
contains an N-terminal Helix-turn-Helix (HTH) DNA binding domain (AA 6-50), and two CBS 
domains (i.e. CBS1, AA 80-137 and CBS2, AA 144-204). The CBS1 domain is in the central 
region of EF1025 and CBS2 is located at the C-terminus. EF1025 does not contain any 
transmembrane motifs (suggesting that it is a cytosolic protein), nor does it contain coiled-coil 
regions. 
The EF1025 protein sequence was used as a query in BLASTp against 10000 targeted 
sequences in the non-redundant (nr) protein sequences database (last accessed May 2019). EF1025 
was identified as belonging to the CBS pair superfamily and is conserved predominantly in Gram-
positive bacteria, primarily in Firmicutes, As with EF1025, Gram-positive homologues contain an 
N-terminal HTH domain and two CBS domains located identically. In B. subtilis, the EF1025 
homologue is named CcpN and is involved in the gluconeogenic pathway (Servant et al., 2005).  
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Figure. 2.1. (A) EF1025 position in E. faecalis V583 genome. Transcriptional orientation of genes 
upstream (i.e. EF1024) and downstream (i.e. EF1026 and EF1027) to EF1025 (i.e. EF1025). The 
direction of an arrow within the rectangle indicates the transcriptional orientation of the gene. The 
bent arrow indicates promoter region upstream of EF1025 and vertical line indicates terminator 
region. (B) EF1025 domain prediction. N: N-terminus; C: C-terminus; HTH: Helix-turn-helix 
domain; CBS: Cystathionine-β-Synthase domain. Space in between domains constitutes hinge 
regions. 
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2.4.2. EF1025 oligomerizes and self-interacts 
To determine whether EF1025 self-interacts, fragments comprising different combinations 
of domains of EF1025 were cloned into Y2H vectors and initially tested for interactions using 
colony lift assay (data not shown), followed by a quantitative assay for increased β-galactosidase 
activity. The quantitative assay indicated that EF1025 strongly self-interacts (Fig. 2.2). 
Furthermore, the EF1025CBS12, containing the CBS1 and CBS2 domains, strongly interacted 
with EF1025. Fragments containing the N-terminus HTH domain and the central CBS1 domain 
(i.e. EF1025NCBS1) and fragments EF1025CBS2 (contains CBS2 domain) and EF1025-N (i.e.  
N-terminus HTH domain) showed no interaction with EF1025.  
6×His-EF1025 was found to be a decamer, with an estimated molecular mass of 222 kDa, 
using a combination of Size Exclusion Chromatography (SEC) with Multi-Angle Light Scattering 
(MALS) analysis (Fig. S2). Reduced disulfide linkages did not change the overall molecular 
weight of 6His-EF1025.  
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Figure 2.2. EF1025 self-interacts using CBS1 and CBS2 domains. EF1025 self-interacts in the 
Y2H assay. Bars represent full-length and truncations of EF1025. Amino acid positions are 
indicated on the top. Open bars—predicted domains; closed bars—hinge regions; HTH - helix-
turn-helix domain; CBS –cystathionine-β-synthase; Full-length EF1025 contains 209 amino acids 
(AA1-209); CBS12— EF1025 CBS1 and CBS2 domains together (AA80-204); NCBS1—N-
terminus and CBS1 domain of EF1025 (AA1-131); CBS2—CBS2 domain of EF1025 (AA131-
209); N—N-terminus of EF1025 (AA1-50). ND—Not detectable. The experiment was performed 
three times in triplicate. SD— standard deviation. Miller Units represent β-galactosidase activity. 
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2.4.3. EF1025 interacts with DivIVAEf in vitro and in vivo 
A B2H system was used to confirm preliminary Y2H results showing the interaction of 
EF1025 with DivIVAEf. In this assay, less than 50% residual β-galactosidase activity is indicative 
of positive interaction (Di Lallo et al., 2001; Zou et al., 2017). E. coli R721 cells showed a baseline 
residual β-galactosidase activity of 100%. E. coli R721 transformed, with one of pdivIVA22, 
pdivIVA434, pEF1025434, p434CBS1CBS2, or p22CBS1CBS2, showed residual β-galactosidase 
activities of 78%, 82%, 55%, 66% and 77%, respectively, and served as negative controls. The 
positive control (E. coli R721 cells containing plasmids pdivIVA22 and pdivIVA434), which 
demonstrated the self-interaction of DivIVAEf (Ramirez-Arcos, 2005), displayed 36% residual β-
galactosidase activity. Our results indicated an interaction between DivIVAEf and EF1025 (Fig. 
2.3; pdivIVA434 and p22EF1025 together) with the residual β-galactosidase activity of 21%. The 
two CBS domains together (i.e. p22CBS1CBS2 or p434CBS1CBS2) also interacted with 
DivIVAEf  (pdivIVA434 or pdivIVA22) with 14% residual β-galactosidase activity. 
  
48 
 
Figure 2.3. EF1025 interacts with DivIVAEf. in B2H assay. The β-galactosidase activity was 
expressed in percentage Miller Units (y-axis). The x-axis shows the combination of B2H plasmids 
used in the experiment. Average values were obtained from three independent assays that were 
performed in triplicate. Values of less than 50% indicate a positive interaction. The error bars 
represent 1 standard deviation.  
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The interaction between EF1025 and DivIVAEf was also ascertained using a GST-pull 
down assay. A Western blot using anti-EF1025 antibody revealed that GST-DivIVAEf was pulled 
down by 6His-EF1025 (Fig. 2.4A, Lane 3) or 6His-EF1025CBS12 (Fig. S3, Lane 3). GST did 
not interact with 6His-EF1025 (Fig. 2.4A, Lane 2) or 6His- EF1025-C (Fig. S3, Lane 2).  
The in vitro interaction between EF1025 and DivIVAEf was also determined using a Co-IP 
assay. EF1025 co-precipitated with DivIVAEf using an anti-DivIVAEf antibody (Fig. 2.4B, Lane 
2), and DivIVAEf co-precipitated with EF1025 with anti-EF1025 antibody (Fig. 2.4C, Lane 2). As 
a negative control, anti-MinCNg ( MinC from N. gonorrhoeae) antiserum failed to precipitate 
EF1025 or DivIVAEf (Fig. 4B and C Lane 4).  
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Figure 2.4. Interaction of EF1025 with DivIVAEf. (A) GST pull-down assay. Shown is the Western 
blot probed with anti-6×His (BioRad, CA) monoclonal antibody to check the presence of EF1025. 
Lane 1: supernatant containing overexpressed EF1025 representing 10% input of EF1025; Lane 
2: GST bound beads; Lane 3: GST-DivIVAEf bound beads; Lane 5: Protein ladder. (B)  
Co-immunoprecipitation assay of EF1025. EF1025 was co-precipitated with DivIVAEf using the 
anti-DivIVAEf antibody as bait. The blot was probed with the anti-EF1025 polyclonal antibody. 
Lane 1: E. faecalis extracts representing 10% input in Co-IP assays; Lane 2: anti-DivIVAEf 
antibody bound beads; Lane 3: beads alone; Lane 4: anti-MinCNg antibody bound beads. (C)  
Co-immunoprecipitation assay of DivIVAEf. DivIVAEf with EF1025 using anti-EF1025 antibody 
as bait. The blot was probed with an anti-DivIVAEf polyclonal antibody. Lane 1: E. faecalis 
extracts representing 10% input in Co-IP assays; Lane 2: anti-EF1025 antibody bound beads; Lane 
3: beads alone; Lane 4: anti-MinCNg antibody bound beads. --- indicates the empty lane. 
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2.4.4. In trans complementation of inactivated or deleted EF1025  
 Two strategies were used to inactivate or delete EF1025 in E. faecalis JH2-2. First, we 
attempted to insert a KanR cassette at position nt151 (AA50 and Fig. S4A) of EF1025 using 
p3ERMEF1025::Kan. No transformants were recovered after several attempts.  The second 
strategy, in which an EF1025 deletion mutant would be created by in frame replacement of EF1025 
(p3ERM EF1025::Cat) with a CatR cassette (Fig. S4B) in E. faecalis JH2-2  also failed to produce 
transformant colonies. Expression of EF1025 was rescued by co-transformation with plasmid 
combinations p3ERMEF1025::Kan and pMSPEF1025-pro, and p3ERMΔEF1025::Cat and 
pMSPEF1025A. These rescue strategies were successful, creating transformant strains E. faecalis 
MJ26 and MK12, respectively (Fig. S4C and D). Taken together, the data suggest that EF1025 
may be an essential gene. E. faecalis MJ26 and MK12 grew more slowly than E. faecalis JH2-2 
(Fig. S5). 
 The expression EF1026 in E. faecalis MJ26 was determined by RT-PCR to ascertain that 
the lethal effects of the KanR insertion in EF1025 was not due to polar effects on EF1026. 
Amplified DNA fragments corresponding to the various regions of EF1026 indicated that the gene 
was transcribed (Fig. S6). Expression levels (i.e. ∆CT values) for EF1026 in E. faecalis JH2-2 (i.e. 
16.88 ± 0.13) and E. faecalis MJ26 (i.e. 16.79 ± 0.04) were equal. 
 The phenotypes of E. faecalis MJ26 and MK12 differed from wild type E. faecalis JH2-2. 
SEM of E. faecalis JH2-2 showed cells with symmetrical division at the mid-cell with 
characteristic ovococcal cell morphology (Fig. 2.5A). E. faecalis MJ26 and E. faecalis MK12 cells 
formed elongated cells with distorted cell shapes (Fig. 2.5B and C) which were aggregated, failed 
to segregate (Fig. 2.5B) and had multiple division sites within a single elongated cell (Fig. 2.5C). 
Compared to the length of the wild type E. faecalis JH2-2 cells (1.16 ± 0.14 µm, n=141), 47% of 
E. faecalis MJ26 (1.63  0.29 µm, n=174) and 49% of E. faecalis MK12 (1.74  0.27 µm, n=127) 
cells were significantly (p<0.05) longer (Fig. 2.5D) when measured across the poles. The control 
E. faecalis MK0 (i.e. contains empty plasmid pMSP3545A) had a cell length (1.15  0.18 µm, 
n=165) identical (p<0.05) to E. faecalis JH2-2 (Fig. 2.5D). Transmission electron microscopy 
showed that 10% of E. faecalis MJ26 cells were aggregated (n=273) with abnormal septation, 
resulting in daughter cells of different sizes and shapes (Fig. 2.6B, C and D).  AFM images showed 
larger aggregated cell clusters for E. faecalis MK12 as compared to E. faecalis JH2-2 (Fig. S7).   
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Figure. 2.5. Rescued E. faecalis cells (i.e. E. faecalis MJ26 and MK12) showed compromised cell 
division phenotypes. Scanning electron micrographs showing (A) Normal E. faecalis JH2-2 lancet-
shaped cells; (B) aggregated E. faecalis MJ26 cells with impaired segregation; (C) E. faecalis 
MK12 cells showing impaired cell shape and multiple division sites. White arrow indicates 
aggregated cells that failed to segregate; red arrows indicate cells with distorted cell shape; yellow 
arrows indicate cells with formation of multiple division rings. Bar scale indicated at the bottom 
right corner of each image; (D) Comparison of cell lengths for E. faecalis strains: JH2-2 (n=141), 
MK0 (n=165, harboring pMSPEA), MK12 (n=127) and MJ26 (n=174). E. faecalis strains JH2-2 
and MK0 served as control strains. “n” represents the number of cells counted for each sample; * 
represents  two-tail p value from t-test for each group set (i.e. p <0.05); NS- non-significant. The 
error bars represent 1 standard deviation. 
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Figure 2.6. E. faecalis MJ26 cells showed impaired cell division. Transmission electron 
micrographs showing (A) wild-type E. faecalis JH2-2 lancet-shaped cells; (B, C and D) E. faecalis 
MJ26 cells with aggregated cells that failed to segregate and impaired septation leading to unequal 
daughter cells. Black arrows indicate aggregated cells that failed to segregate; red arrows indicate 
septa formation at random sites within the cells. Bar scale indicated at the bottom right corner of 
each image. 
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2.4.5. Overexpression of EF1025 in E. faecalis and E. coli induces cell elongation 
E. faecalis MK23 was created in which EF1025 is expressed from its native promoter both 
from the chromosome and from pMSPEF1025A. In order to ensure that EF1025 could be 
expressed from its native promoter in trans, E. faecalis MK24 was constructed (contains 
pMSPEF1025-flag) and the protein detected in whole cell extract by Western blot using a 
monoclonal anti-flag antibody (Fig. S8A. Lane 3). Expression of EF1025-flag was not detected in 
E. faecalis JH2-2 or MK23 cell extracts (Fig S8A, Lanes 1 and 2). This confirmed expression of 
an extra chromosomal copy of EF1025 in E. faecalis MK24 when electroporated with 
pMSPEF1025-flag. This shows that E. faecalis MK23 is overexpressing EF1025 due to the 
presence of an extra chromosomal copy of EF1025. When anti-EF1025 antibody was used to 
identify the expression levels of EF1025, the overexpression of EF1025 in E. faecalis MK23 and 
E. faecalis MK24 was observed as determined by densitometric quantification of band intensities, 
as compared to its expression in E. faecalis JH2-2 (Fig. S8B and C).  
SEM analysis showed a statistically significant (p<0.05) increase in cell length (1.37 ± 0.21 
µm, n=202; Fig. 2.7B and C) in E. faecalis MK23 as compared to wild type E. faecalis JH2-2 cells 
(1.16 ± 14 µm, n=141; Fig. 2.7A and C).  
Seventy per cent of cells (63/89) overexpressing EF1025 in E. coli PB103 (i.e. E. coli 
MK23) were filamentous (Fig. S9B) as compared none of the cells being filamentous in controls 
comprising E. coli cells with pUC18 and cells overexpressing prgXEf, a transcriptional regulator 
encoding gene (Christie and Dunny, 1986; Bae et al., 2000) in the same vector.  
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Figure. 2.7. EF1025 overexpression in E. faecalis JH2-2 cells causes cell elongation. Scanning 
electron micrographs showing (A) E. faecalis JH2-2 lancet-shaped cells; (B) E. faecalis MK23 
cells harbouring pMSPEF1025A, showing elongated cell morphology. 3µm bar scale at the bottom 
right corner of each image establishes the comparison in cell length for E. faecalis JH2-2 and 
MK23; and (C) Comparison of cell lengths of E. faecalis strains: JH2-2 (n=141), MK23 (n=202) 
and MK24 (n=226) where “n” represents a number of cells counted for each sample. * represents 
two-tail p value from t-test for each group set (i.e. p <0.05). The error bars represent 1 standard 
deviation. 
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2.4.6. EF1025 localizes at the septum and cell poles in E. faecalis  
Immunofluorescence studies of E. faecalis JH2-2 cells with anti-DivIVAEf or anti-EF1025 
polyclonal antibody were performed to determine their localization patterns during cell division. 
Cell division that entailed 5 stages (273 cells counted for DivIVAEf and 281 for EF1025 
localization). During Stage 1, as the cell started to divide and the chromosome started to segregate, 
DivIVAEf (20.5%, 56/273 cells) localized at the poles and along the length of the cell. In this stage, 
EF1025 (23.1%, 65/273 cells) was dispersed along the inner membrane (Fig. 2.8, Stage 1). In Stage 
2, EF1025 (14.9%, 42/281) localized along the length of the cell in contrast with DivIVAEf (36.7%, 
100/273) that remained localized at the poles and the midcell (Fig. 2.8, Stage 2). At Stage 3, 
EF1025 (36%, 104/281 cells) and DivIVAEf (16.1%, 44/273) localized similarly, i.e. to the cell 
poles and midcell. In Stage 4, as the cells progressed towards completion of cell division, EF1025 
(13.2%, 37/281) and DivIVAEf (16.8%, 46/273) localized as disks and bands along the cell length 
and septum. With one completed round of cell division (i.e. Stage 5), EF1025 (11.7%, 33/281 
cells) was redistributed along the inner membrane before another round of cell division, while 
DivIVAEf (9.9%, 27/73) once again localized as dots at the cell poles of the newly formed daughter 
cells (Fig. 2.8, Stage 5), like Stage 1 cells. The coiled-coil region of DivIVAEf facilitates 
oligomerization and is essential for its biological functioning (Rigden et al., 2008). E. faecalis 
MWMR16 which contains point mutations in the coiled-coil region of DivIVAEf (Rigden et al., 
2008) exhibited loss of DivIVAEf localization at the cell poles and midcell position (Fig. S10). The 
signal was observed to be dispersed all along the membrane. The different stages of cell division 
were missing for E. faecalis MWMR16. 
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Figure 2.8. DivIVAEf and EF1025 localizes similarly in the later stages of cell division in  
E. faecalis JH2-2 cells.  Averaged images and fluorescence intensity traces of E. faecalis JH2-2 
cells grown to mid-exponential phase in BHI broth and dual-stained with DAPI and Alexa-Fluor 
488 as described in the methodology section. Cells were segregated into five division Stages, and 
images from the indicated number of cells (n) were acquired using the InVitro 3 and ImagePro 6.0 
softwares (Media Cybernetics) as described in Methodology. EF1025 localized at the cell poles 
and the septa in E. faecalis JH2-2 cells similar to DivIVAEf localization. Column 1 and 4, nucleoid 
localization from DAPI labelling; Column 2 and 5, DivIVA and EF1025 localization, respectively, 
in immunofluorescence microscopy; Column 3 and 6, merged image of DAPI stained nucleoid 
and fluorescent DivIVA and EF1025, respectively. 
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2.5. Discussion 
In the present study, we investigated a novel DivIVAEf interacting protein, EF1025, from 
E. faecalis. EF1025 belongs to the CBS pair superfamily and is conserved in Firmicutes including 
Bacillus, Streptococcus, Clostridium, Paenibacillus, Staphylococcus, Lactobacillus, Streptomyces 
and Listeria. Surprisingly, EF1025 homologues in the Firmicutes S. pneumoniae, S. pyogenes and 
L. lactis did not belong to the CBS pair superfamily as they contained an N-terminal HTH domain, 
but no CBS domains and their sequence similarities ranged from 40-44%. We also determined 
bioinformatically that EF1025 homologues, with uncharacterized functions and different 
combinations of CBS and HTH domains, may be present in species of the Proteobacteria and 
Euryarcheota such as Vibrio, Campylobacter, Burkholderia, Acinetobacter, Fusobacterium, 
Methanosarcina and Methanoculleus. Proteins containing CBS domains are present in organisms 
ranging from archaea to humans and were originally identified in Methanococcus jannaschii as 
sequence motifs of approximately 60 amino acids (Bateman, 1997). Although several 
crystallographic studies have been carried out on CBS domains from bacteria, their precise 
function remains unexplained (Baykov et al., 2011). It has been postulated that CBS domains may 
act as allosteric “internal inhibitors” of the functional domains of proteins (Aravind and Koonin, 
1999; Biemans-Oldehinkel et al., 2006). Proteins with CBS domains can form dimers through the 
interaction of these domains. For example, TM0935 of Thermotoga maritima self-interacts 
through its two CBS domains forming a dimer (Miller et al., 2004). An Mg2+ transporter from E. 
faecalis, MgtE, also contains two CBS domains but the precise function of these CBS domains 
remains unelucidated (Ragumani et al., 2010). Our experiments show the importance of the two 
CBS domains in EF1025 self-interaction. The absence of one CBS domain resulted in the loss of 
EF1025 self-interaction.  
DivIVA, a topological factor in Gram-positive bacteria, interacts with a variety of proteins 
in various bacteria (Muchová et al., 2002; Halbedel and Lewis, 2019). The range of DivIVA 
interacting partners changes from one genus to another (Kaval and Halbedel, 2012). In Listeria 
monocytogenes (Lm), DivIVALm, performs a variety of functions through its interaction with 
different proteins (i.e. MinCD and SecA2), including precise positioning of the septum at midcell, 
assistance in the secretion of autolysins, enabling swarming motility (Kaval et al., 2014, 2017). In 
Streptococcus suis (Ss) serotype 2, Ser/Thr kinases (STK) directly phosphorylate DivIVASs 
thereby affecting cell growth and division (Nováková et al., 2010). DivIVA from S. aureus (Sa) 
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associates with various divisome proteins (FtsZSa, FtsASa, EzrASa, DivICSa, DivIBSa, PBP1Sa and 
PBP2Sa) to ensure cell division and chromosome segregation (Bottomley et al., 2017). The 
molecular chaperone, DnaK, interacts and stabilizes DivIVASa in S. aureus (Bukau and Walker, 
1989; Bottomley et al., 2017). Bottomley et al., 2017 also reported an indirect function of 
DivIVASa in chromosomal segregation by its interaction with the chromosome segregation protein, 
SMC (Bottomley et al., 2017). In Mycobacterium smegmatis (Ms) and M. tuberculosis (Mt), the 
DivIVA homologue is Wag31 (Nguyen et al., 2007; Kang et al., 2008; Meniche et al., 2014). 
Wag31Mt interacts with the penicillin-binding protein, PBP3 (Mukherjee et al., 2009) as well as 
and ParB (Donovan et al., 2012) and Wag31Ms interacts with ParA (Donovan et al., 2012; Ginda 
et al., 2013). DivIVA from E. faecalis is essential for cell viability and growth, proper cell division 
and chromosome segregation (Ramirez-Arcos, 2005). Rigden et al. (2008) showed that the 
oligomerization of DivIVAEf is mediated by two centrally located coiled coils that are important 
for its proper biological functioning (Rigden et al., 2008). E. faecalis DivIVAEf mutant, E. faecalis 
MWMR16, contained a disrupted coiled coil region, failed to interact with EF1025 in a B2H assay 
due to the loss of a functional coiled-coil region in DivIVAEf (Rigden et al., 2008; Hedlin, 2009). 
Our research addressed the essentiality, localization and function of EF1025 during cell division.  
Immunostaining showed that EF1025 localized in a pattern comparable to DivIVAEf in  
E. faecalis. Previously, Fadda et al 2007 showed DivIVA localization to the mid-cell septa and 
poles in S. pneumoniae using similar methods (Fadda et al., 2007). EF1025 localized laterally 
along the cell length in Stages 1 and 2 and a pattern comparable to DivIVAEf in Stages 3, 4 and 5 
of cell division. This localization progression may assist proper cell segregation required for cell 
division during the later stages of cell division when these two proteins interact. GpsB, an essential 
protein which determines the ellipsoidal shape in S. pneumoniae, localized in a similar but not 
identical manner to FtsZ and is implicated in determining cell shape by septal ring closure (Land 
et al., 2013). There is a possibility that the localization of EF1025 (a cytosolic protein) to the lateral 
cell regions could be facilitated by DivIVAEf association. Different domains of DivIVABs have 
been reported to interact with different partners that are membrane proteins as well as cytosolic 
proteins (Perry and Edwards, 2006; Bramkamp et al., 2008; Patrick and Kearns, 2008; Briley et 
al., 2011; dos Santos et al., 2012; Baarle et al., 2013; Halbedel et al., 2014; Schumacher, 2017; 
Halbedel and Lewis, 2019).  Membrane localization of cytosolic proteins enhances the interaction 
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abilities of interacting partners during processes such as cell division which involves multi-protein 
complex formation (Yogurtcu and Johnson, 2018).  
We postulate that EF1025 may be an essential gene since, during our attempts to delete or 
insertionally inactivate the gene, we were never able to recover viable cells. When these strains 
were complemented with EF1025 (i.e. E. faecalis MJ26 and MK12) they grew more slowly with 
a longer log phase as compared to the E. faecalis JH2-2. This most likely occurred because the 
rescue plasmids (i.e. pMSPEF1025-pro and pMSPEF1025A) failed to provide full 
complementation. This failure also led to altered cell shape and length. In S. pneumoniae, depletion 
of GpsB, caused cessation of growth and substantial cell elongation (Chastanet and Carballido-
Lopez, 2012; Land et al., 2013). Based on the localization pattern of EF1025 and the elongated 
and aberrant phenotypes exhibited by E. faecalis MK12 cells, and the similarity of their 
localization patterns, we postulate that EF1025 could be one of the members of the septal 
machinery in E. faecalis, which has an unstudied GpsB homologue.  
An interesting EF1025 homologue (41% identity) in B. subtilis, named CcpN (control 
catabolite protein of gluconeogenic genes), has two CBS domains and an HTH domain (Servant 
et al., 2005). CcpN plays a negative regulatory role in the transcription of the gluconeogenic genes 
gapB (one of the GAPDH-encoding genes) and pckA (encodes PEP carboxykinase), which are 
required in carbon catabolite repression pathways (Licht et al., 2005; Servant et al., 2005; Tännler 
et al., 2008; Licht and Brantl, 2009). Transcription regulation by CcpN has been attributed to its 
HTH domain which binds to the conserved upstream promoter regions of gapB and pckA (Licht et 
al., 2005; Servant et al., 2005; Tännler et al., 2008; Licht and Brantl, 2009). We detected strong 
interactions between CcpN and DivIVABs by B2H and GST-pull down assay (paper in 
preparation). We observed that gapB from B. subtilis shared 48% homology with type I gap from 
E. faecalis while pckA from  B. subtilis and E. faecalis showed 20% homology. E. faecalis was 
observed to have type I and type II gap as two homologues of gapB. Our preliminary sequence 
searches indicate that the conserved upstream promoter sequences from B. subtilis are absent in E. 
faecalis for type I gapB and pckA (unpublished data). This suggests that even though CcpN and 
EF1025 belong to the same superfamily, they possibly regulate the expression of different genes. 
CcpN is not an essential gene in contrast to EF1025 (Servant et al., 2005; Tännler et al., 2008); 
this may be because each protein may regulate different genes.  
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In conclusion, this research presents the first evidence of a DivIVAEf interacting protein, 
EF1025, in E. faecalis that affects cell viability, cell length and shape. Using immunofluorescence, 
we showed that the localization patterns of EF1025 and DivIVAEf during the later stages of cell 
division in E. faecalis were similar. Our inability to insertionally inactivate or delete EF1025 
without in trans complementation of the gene indicates that gene is important for viability. 
Different microscopy methods showed cell elongation, aggregation and impaired cell division in 
complemented cells with a deleted or inactivated chromosomal gene.  
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2.6. Supplemental information 
2.6.1. Strains, plasmids and growth conditions 
Plasmid DNA was purified using Plasmid Mini-prep or Plasmid Midi-prep Kits (Qiagen 
Inc., CA). Reading frame conservation and gene integrity of all plasmids was confirmed by DNA 
sequencing [Core DNA Synthesis and Sequencing Facility, Centre for Research in 
Biopharmaceuticals and Biotechnology, University of Ottawa, (UOCDSSF), the Plant 
Biotechnology Institute (PBI), National Research Council of Canada, Saskatoon, Saskatchewan] 
or Eurofins Canada. Primers (Table S3) were synthesized at the UOCDSSF and Invitrogen 
(Thermo Scientific; Waltham, MA), and were used for PCR and DNA sequencing reactions. PCR 
reactions were carried out using Q5 DNA polymerase (New England BioLabs Ltd., ON, Canada) 
in a Perkin Elmer GenAmp PCR System 9600 Thermocycler (Perkin Elmer, Inc., Woodbridge, 
ON, USA). 
2.6.2. Cloning and screening an E. faecalis genomic DNA library by Y2H assay 
An E. faecalis JH2-2 genomic DNA library was created in the Y2H system (Clontech) 
using the vector pGAD424 of the Clontech Matchmaker GAL4 Two-Hybrid System (Clontech) 
(Table S2C). E. faecalis JH2-2 genomic DNA was prepared using the Wizard Genomic DNA 
Purification Kit according to the manufacturer’s instructions (Promega, Madison, WI USA). 
Approximately 10 µg genomic DNA was partially digested with Sau3AI and size-fractionated by 
agarose gel electrophoresis. DNA fragments ranging between 0.2- to 1.5-kb were excised from the 
gel and purified using PCR Purification Kit (Qiagen). Purified DNA fragments were then ligated 
to pre-cleaved BamHI-pGAD424. The ligation mixture was transformed into E. coli DH5α 
competent cells and transformants were selected on LB plates supplemented with Amp 100 µg/ml 
(LB-Amp). Colonies were harvested by washing the plates with LB-Amp broth. Approximately 
1×105 colonies were collected in 50 ml LB-Amp broth which was incubated at 37°C for 2 hrs, 
followed by centrifugation to collect pelleted cells. Plasmid DNA was purified using Midi-prep 
Kit (Qiagen) and was named pGAD424-Lib (Table S2C). Colony counts were estimated by 
serially diluting an aliquot of the cell suspension in LB-Amp broth.  
To determine the ratio of colonies harbouring a plasmid with an inserted DNA fragment 
and sizes of the inserts, 30 individual colonies were randomly selected from the original library 
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and were sub-cultured on LB-Amp broth. Plasmid DNA was purified and double digested with 
EcoRI/BglII followed by electrophoresis on 1% agarose gels. 77% (23/30) of the recombinant 
clones carried inserts of sizes ranging between ~350 bp to ~2 kb. To determine the quality of the 
library, an aliquot of the purified library plasmid DNA (pGAD424-Lib) or the parental vector 
pGAD424 DNA was digested with SnaBI/PstI. The digested library DNA (pGAD424-Lib) 
exhibited DNA fragments of various sizes that were bigger than 1.5 kb, indicating that the majority 
of the library plasmid DNA carried inserts (data not shown).  
To screen the library, the previously constructed plasmid pSRBD-Div was used to express 
the bait protein, DivIVAEf (Table S2C; (Ramirez-Arcos 2005)). Plasmids pSRBD-Div and 
pGAD424-Lib were co-transformed into S. cerevisiae SFY526 according to the manufacturer’s 
instructions (Clontech). Transformants were selected on complete synthetic medium lacking 
leucine and tryptophan (SD-leu-trp) (Clontech). After 3-4 days of incubation at 30°C, blue-
coloured clones were screened in the presence of 5-Bromo4-chloro-3-indolyl-β-D-
galactopyranoside (X-Gal, Sigma-Aldrich; St. Louis, MS) by a colony–lift filter assay (Clontech). 
Positive clones were streaked on SD-leu-trp medium plates (Clontech). A spectrophotometric 
assay for β-galactosidase activity, using the substrate o-nitrophenyl β-D-galactopyranoside (ONPG 
liquid assays), was performed to confirm the results of the colony-lift assay (Ramirez-Arcos, 
2005). Transformation efficiency was monitored by plating 50 µL of diluted transformants on  
SD-leu-trp medium plates followed by counting the number of colonies produced.  
In a positive clone, pGAD424-Lib plasmid was separated from a pSRBD-Div by sub-
culturing the yeast cells of the positive clone in SD-leu-trp broth for 2-4 days at 30°C. Cells were 
harvested by centrifugation and the cell pellet was re-suspended in 250 μL of Qiagen buffer P1 
(Qiagen plasmid mini-prep kit) with 10 μL glass beads (Sigma), followed by vigorous vortexing 
for 3 min. P2 buffer (250 µL, Qiagen) was added to the lysate, and plasmid DNA was purified. To 
isolate plasmid pGAD424-Lib, the aforementioned purified plasmid DNA was transformed into 
E. coli DH5α cells and the resulting E. coli colonies were examined for plasmid content in a 
cracking assay (Ramirez-Arcos, 2005). The size of released supercoiled plasmid DNA was 
determined by electrophoresis on 1 % agarose gels. The difference in the size of pSRBD-Div  
(6.2 kb) and pGAD424-Lib (≥6.6 kb) allowed easier separation from each other. The plasmid of 
interest (i.e. pGAD424-Lib) was then purified from E. coli transformants and analyzed by 
restriction endonuclease digestion with EcoRI/PstI. Purified plasmid DNA was sequenced at the 
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UOCDSSF using primers AD424F and AD424R (Supplementary Materials, Table S3C) to 
generate DNA sequences of the inserts in pGAD424-Lib for bioinformatic identification of the 
discovered genes.  
2.6.3. Reverse transcriptase PCR (RT-PCR)/qPCR 
Total RNA from E. faecalis JH2-2 and MJ26 was isolated using the Qiagen RNeasy Total 
RNA kit (Qiagen) for RT-PCR assay which was performed as previously described (Fadda et al., 
2003). cDNA was created from total isolated RNA by incubating ~0.1 µg RNA, 0.5 unit reverse 
transcriptase (Promega) and 2 µl random primer mix at 42°C for 30 min. This cDNA was used to 
amplify EF1026 from JH2-2 and MJ26 using primers EF26aF/R, EF26bF/R (Table S3E). The 
housekeeping gene, gdh (encoding glucose dehydrogenase) was used as a positive control and was 
PCR amplified using primers HKaF/R, HKbF/R (Table S3E). PCR amplification of genomic DNA 
using primers EF26aF/R served as a positive control whereas PCR amplification of total RNA 
using primers EF26aF/R served as a negative control. PCR products were separated by 
electrophoresis on 1.5% agarose gel for further analysis. For qPCR, cDNA from E. faecalis JH2-
2 was used to create standards using primers EF26aF/R (Table S3E) and was used to identify 
EF1026 levels in E. faecalis MJ26. Each reaction was performed in triplicate and contained 2X 
SYBR-Green master mix (Cat # 4472912, Life Technologies Inc.), 0.25 µL of each primer  
(10 µM), 1 µL of DNA (50 ng/µL), and 3.5 µL PCR-grade water in a total 10 µL reaction volume.  
2.6.4. Expression of EF1025 in E. coli PB103 
To express EF1025 in E. coli PB103, EF1025 was PCR-amplified from E. faecalis JH2-2 
and cloned into pUC18 (Amersham), resulting in plasmid pUCHisEF1025 (Table S2F). For 
controls, prgX, a transcriptional regulator of itself and PrgB (cell wall aggregation substance)  
(Bhatty et al., 2015; Bae et al., 2000), was PCR-amplified from pSR-X (Table S2F; Bae et al., 
2000; Rigden et al., 2008) and cloned into pUC18, resulting in plasmid pUCHisPrgx, which 
encodes 6×His tagged PrgX (Table S2F). Each plasmid was individually transformed into E. coli 
PB103 and transformants were selected on LB medium supplemented with Amp100 creating 
strains E. coli PB MK23 and E. coli PB MK25, respectively (Table S1). Expression of  
6×His-EF1025 or 6×His-PrgX was determined by Western blot assays using anti-6×His 
monoclonal antibodies (Biorad).  
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2.6.5. Atomic force microscopy 
For atomic force microscopy, cell suspensions from overnight grown cultures of E. faecalis 
were deposited onto Cell-Tak (LifeTechnologies) coated coverslips for 30 min, fixed with 
formalin, and air-dried prior to AFM imaging (Bhat et al., 2015). Samples were imaged with 
silicon nitride cantilevers (HYDRA6R-200NG; Nanosensors, Neuchatel, Switzerland) with 
calibrated spring constants ranging from 0.03 to 0.062 N/m. QI™ images and force curves (JPK 
software) at each pixel of a 128×128 raster scan were collected using a Z-length of 0.926 um and 
a scan rate of 95 um/s. Surface roughness was calculated according to Bhat et al. (2015) from 
multiple 200 x 200 nm squares along the centre of the cell from QI™ height images for at least 10 
cells each from three biological replicates. 
The morphology of E. coli PB103 harboring pUCHisEF1025 was ascertained using an 
Olympus BX61 microscope (Olympus Canada Inc.), as described previously (Ramirez-Arcos et 
al., 2001). At least 30 fields were examined each containing a minimum of 40 cells. 
2.6.6. Statistical analysis 
All studies were conducted in triplicates and GraphPad Prism was used for statistical 
analysis unless otherwise indicated. The results were reported as mean ± standard deviation (SD), 
differences assessed using a two-tailed unpaired t-test and ANOVA for which p < 0.05 was 
considered statistically significant. 
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Table S1. Bacterial strains used in the study. 
 
Strains Relevant characteristics Resources or references 
E. coli XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB lacIqZ_M15Tn10 
(Tetr)] 
Strategene 
E. coli DH5α endA1 hsdr17 (rk-mk+) supE44 thi-1 recA1 gyrA96 relA1 (argF-lacZYA) U169 
deoR [ø80d lac (lacZ) M15) 
Gibco-BRL 
E. coli C41 (DE3) FˉompT hsdSB (rB-mB-) gal dcm Δ(srl-recA) 306::Tn10 (tetR) (DE3) Miroux et al., 1996 
E. coli PB103 dadR1 trpE61 trpA62 tna-5 purB+ de Boer et al., 1988 
E. coli R721 71/18 glpT::O-P434/P22lacZ Di Lallo et al., 2001, 
2003 
E. faecalis JH2-2 RifR, FusR; plasmid free Jacob & Hobbs, 1974  
S. cerevisiae SFY526 MATa ura3-52 his3-200 ade2-101 lys2-801 trp1-901 leu2-3 112 canr gal4-542 
gal80-538 URA3::GAL1UAS- GAL1TATA –lacZ 
Clontech Laboratories, 
CA 
E. faecalis MK0 E. faecalis JH2-2 carrying pMSP3545A This study 
E. faecalis MK23 E. faecalis JH2-2 carrying pMSPEF1025A (PEF1025-EF1025) for expressing 
EF1025 in trans under its native promoter. EryR (125 µg/mL) 
This study 
E. faecalis MK24 E. faecalis JH2-2 carrying pMSPEF1025-flag (PEF1025-EF1025-flag) for 
expressing EF1025-flag in trans under its native promoter. EryR (125 µg/mL) 
This study 
E. faecalis MJ26 Derived from E. faecalis JH2-2 with insertionally inactivated EF1025 
(EF1025::kanR). E. faecalis MJ26 carried pMSPEF1025-Pro (PEF1025-EF1025) for 
expressing EF1025 in trans under its native promoter. KanR (500 µg/mL) and EryR 
(125 µg/mL) 
This study 
E. faecalis MK12 Derived from E. faecalis JH2-2 with deletion of EF1025 (ΔEF1025::catR). E. 
faecalis MK12 carried pMSPEF1025A (PEF1025-EF1025) for expressing EF1025 
in trans under its native promoter. CatR (5 µg/mL) and EryR (125 µg/mL). 
This study 
E. coli PB MK23 
 
Derived from E. coli PB103 for overexpressing EF1025 using pUCHisEF1025. 
AmpR (100 µg/mL) 
This Study  
E. coli PB MK25 Derived from E. coli PB103 for overexpressing prgX using pUCHisPrgx. AmpR 
(100 µg/mL). 
This Study 
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Table S2. Plasmids used in this study 
Plasmid Relevant characteristics Sources or references 
(A) Plasmids for bacterial two-hybrid assays  
pcI434 KanR, bacterial two-hybrid vector Di Lallo  et al., 2001 
pcIp22 AmpR, bacterial two-hybrid vector  Di Lallo  et al., 2001 
pcIp22-L pcIP22 derivative carrying a linker with multiple cloning sites  This study 
pcI434-L pcI434 derivative carrying a linker with multiple cloning sites This study 
pdivIVA22 pcIP22 derivative carrying E. faecalis divIVA This study 
pdivIVA434 pcI434 derivative carrying E. faecalis divIVA This study 
pEF1025434 pcIP434L derivative carrying EF1025   This study 
p22CBS1CBS2 pcIP22L derivative carrying EF1025 fragment coding AA80-204 This study 
p434CBS1CBS2 pcI434L derivative carrying EF1025 fragment coding AA80-204 This study 
(B) Plasmids for GST pull-down assays and 6×His tagged protein expression  
pGEX-2T AmpR Plac::gst Amersham Bioscience 
pGST-Div AmpR Plac::gst, GST-DivIVAEf  This study 
pET30a(+) KanR PT7::6xhis Novagen 
pETEF1025 KanR PT7, 6xHis-EF1025 This study 
pETEF1025CBS12 KanR PT7, 6xHis-EF1025 with CBS1 and CBS2 domains This study 
(C) Plasmids for EF1025 self-interaction studies  
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pGAD424 AmpR PADH1::gal4 (AD) Clonetech, CA 
pGBT9 AmpR PADH1::gal4 (DBD) Clonetech, CA 
pGADEF1025CBS12 AmpR PADH1::gal4 (AD), AD-EF1025 with CBS1 and CBS2 domains (AA80-204) This study 
pGBDEF1025CBS12 AmpR PADH1::gal4 (DBD), DBD- EF1025 with CBS1 and CBS2 domains (AA80-
204) 
This study 
pGADEF1025NCBS1 AmpR PADH1::gal4 (AD), AD-EF1025 with N-terminal and CBS1 domains (AA1-
137) 
This study 
pGBDEF1025NCBS1 AmpR PADH1::gal4 (DBD), DBD-EF1025 with N-terminal and CBS1 domains 
(AA1-137) 
This study 
pGADEF1025CBS2 AmpR PADH1::gal4 (AD), AD-EF1025 with CBS2 domain (AA137-204) This study  
pGBDEF1025CBS2 AmpR PADH1::gal4 (DBD), DBD- EF1025 with CBS2 domain (AA137-204) This study 
pGADEF1025-N AmpR PADH1::gal4 (AD), AD-EF1025 with N-terminal domain (AA1-50) This study 
pGBDEF1025-N AmpR PADH1::gal4 (DBD), DBD- EF1025 with N-terminal domain (AA1-50) This study 
pGADEF1025 AmpR PADH1::gal4 (AD), AD-EF1025 (AA1-209) This study 
pGBDEF1025 AmpR PADH1::gal4 (DBD), DBD-EF1025 (AA1-209) This study 
pSRBD-Div AmpR PADH1::gal4 (DBD), DBD-DivIVAEf (Ramirez-Arcos, 2005) 
pGAD424-Lib E.faecalis genomic DNA library constructed in pGAD424 vector This study 
(D) Plasmids for construction of an EF1025 insertion or deletion strain and plasmids to overexpress EF1025 in E. faecalis JH2-2 
pMSP3545  EryR PnisA::nisA Callegan  et al., 1999 
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pcDNA3.1(+) AmpR NeoR,  Plac, PSV40 and PT7::flag Invitrogen 
pMSP3545A  EryR, AmpR, PnisA::nisA This study 
pMSPEF1025A EryR,  AmpR PEF1025::EF1025 for  EF1025expression under its native promoter This study 
pMSPEF1025-flag EryR,  AmpR PEF1025::EF1025 for EF1025 expression under its native promoter with 
flag tag on C-terminus 
This study 
pMSPEF1025-pro EryR Pmljd::mljd1 for EF1025 expression under its native promoter This study 
p3ERMEF1025::Kan p3ERM ΔHindIII, EF1025::Kan This study 
p3ERMΔEF1025::Cat p3ERM ΔHindIII, ΔEF1025::Cat This study 
pUC18 AmpR Plac::lacZ Amersham Biosciences 
pUCEF1025-N N-terminus of EF1025 ligated in pUC18 This study 
pTCV-lac KanR::lacZ Poyart & Trieu-Cuot, 1997 
pUCEF1025-N-Kan N-EF1025 (5’)-kanR This study 
pUCEF1025::Kan EF1025::kanR  This study 
pLEMO CatR, PT7, pACYC184 derivative carrying lysY New England Biolabs 
(E) Plasmids for heterologous expression of EF1025 in E. coli  
pUCHisEF1025 AmpR Plac, 6xHis-EF1025 This study 
pSR-X AmpR Plac, PrgX This study 
pUCHisPrgx AmpR Plac, 6xHis-Prgx This study 
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Table S3. Primers used in this study 
Primer Sequence (5’ to 3’) 
(A) Primers for B2H experiments 
EF1025-F GCGTCGAC TTATCTGTTTTGTGCG   
EF1025-R GCGGATCCCTACGTAATATAGGTTAAAATTTTCGT 
EF1025C-F GCGTCGACGGAGATCATGAGTCCACCA                         
EF1025C-R GCGGATCCCTACGTAATATAGGTTAAAATTTTCGT    
CBdivIVA-F GCGTCGACTATGGCATTAAC                                             
CBdivIVA-R GCGGATCCCTATTTTGATTC        
(B) Primers for GST pull-down assays 
IVA-5 GCGCGGATCCATGGCATTAACTCCATTAGA   
IVA-11 GCGCGAATTCTTACTATTTTGATTCTTCTTCAA 
EF1025F-F           CGCTTAAGTTATCTGTTTTGTGCG                                    
EF1025F-R   CGGGATCCATGAAATTAAGTAAACG                            
EF1025-CF          CGCGGATCCCCACCATTGATGGTTGCCCAAGAC      
EF1025-CR          GCCCTCGAGCCCTTATCTGTTTTGTGCGGCTTC            
(C) Primers for EF1025 self-interaction studies and other Y2H assays 
AD424F ACCACTACAATGGATGAT                                                 
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(D) Primers for construction of an EF1025 knockout strain and plasmids to overexpress EF1025 in E. faecalis JH2-2 
AmpF GGAGTCTAGAGCTACCATGGATCCGTGCGCGGAACCCCTATTTG 
AmpR GAACGAGATCTGTCTGACGCTCAGTGGAACG 
LinkA GGTGTCAACGATATCCTCC 
LinkB AATTGGAGGATATCGTTGACACCTTC 
EF1025npF GAGCCCATGGCGTGACCTCCGTTTAATATGTG 
EF1025npR GGGTCTAGATTAAGCTCCCTTATCTGTTTTGTG 
CBSDPF GCCGGAATTCATGAAATTAAGTAAACG AC                  
CBS55-R-Hind CCCAAGCTTAACTTTCGGACTTGC                                
AD424R ACAGTTGAAGTGAACTTG C                                        
CBSDPF GCCGGAATTCATGAAATTAAGTAAACG AC                  
CBSDPR2 AAACTGCAGTTATCTGTTTTGCGGC                                
CBSAA80F CGGGATCCATGAGTCCACCAT TG                                   
CBSAA137R AAACTGCAGTTAATTTAAAGAGGC                                 
CBSAA137F CGGAATTCAATACAAATATTGATGGC                            
DEORR AAACTGCAGTTAAACTTTCGGACTTGC                          
AD424F ACCACTACAATGGATGAT                                                 
AD424R ACAGTTGAAGTGAACTTG C                                        
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KanF CCCAAGCTTGTGGTTTCAAAATCG       
KanR TCCCCCGGGTTAGGTACTAAAACA          
CBS55-F-Sma TCCCCCGGGGCAAGTCCGAAAGTTG    
EF1025-R-BamHI CGGGATCCTTATCTGTTTTGTGCGGC    
Mut-F CTCTTTACCTTCATTGTGTG                                            
ProF AACTGCAGCAAAATTTCTGATTGTAAGTG 
CBSDPR AAACTGCAGTTATCTGTTTTGCGGC                                
ppdKF GAGGGATCCAGCACCGCTGCGAACGGAAACTAAG                             
ppdKR CCAGTGATTTTTTTCTCCATCATTTCCTCCTCAATTCCTC 
1026F GAGTGGCAGGGCGGGGCGTAAGGGAGCTTAATTATGAAAAAAGAG                             
1026R GAGGAATTCTACATACTGACTGGCGTCTTTGAGG 
CatF GAGGAATTGAGGAGGAAATGATGGAGAAAAAAATCACTGGATATAC                               
CatR CTTTTTTCATAATTAAGCTCCCTTACGCCCCGCCCTGCCACTC                                                                                                                                                                                                             
FlagF GATCTTTATAATCACCGTCATGGTCTTTGTAGTCG 
FlagR GAGATCTAGACTACTTGTCATCGTCATCCTTG 
(E) Primers used for RT-PCR 
    EF25aF CGCATTTCGGACATACTAGC 
    EF25aR TTGGGCAACCATCAATGGTG 
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    EF26aF TCAAGCGAAAGCCGGAGTAG 
    EF26aR ACTGACTGGCGTCTTTGAGG   
    EF26bF CAGTCGGTTGGCTTCCTTAG 
    EF26bR CACTGGGATGCCATACTTCG 
    HKaF TGGTGCAGCTACGGGTTTAG   
    HKaR CTTTAGGCAGCTCACCGACA 
    HKbF CTGGTGCAGCTACGGGTTTA 
    HKbR GCTCACCGACATAGTCAGCA 
(F) Primers used for the construction of plasmids to express EF1025 in E. coli PB103 
  HisEF1025F3 CGGAATTCGCACCATCATCATCATCATATGAA             
  EF1025-R-BH CGGGATCCTTATCTGTTTTGTGCGGC                               
  HisPrgxF2 CGGAATTCGCACCATCATCATCATCATATGAC             
  PrgxR2 GCTCTAGATTAGTTTAAGATAGGTTC 
74 
 
Figure S1. Western blot exhibiting specificity of anti-DivIVAEf and anti-EF1025 antibody for 
DivIVAEf and EF1025. An E. faecalis whole cell lysate was probed with anti-DivIVAEf (Lanes  
1-4), and anti-EF1025 (Lanes 5-8). A protein ladder confirmed the presence of protein bands of 
sizes corresponding to DivIVAEf (40 kDa) or EF1025 (27 kDa).  
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Figure S2. Light scattering (LS) data and measured molar mass for EF1025 by SEC-MALS. 
Separated by SEC and detected using the μDAWN and UT-rEX (red) detected with the Wyatt 
TREOS and Optilab T-rEX (blue). The plot shows the chromatograms as a function of elution 
time. The average molecular weight calculated was 222 kDa for the complex. Black line shows 
the aggregation profile of the protein. 
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Figure S3. EF1025CBS12 interacts with DivIVAEf in GST pull-down assay. Shown is a Western 
blot probed with an anti-6xHis EF1025 monoclonal antibody. Lane 1: Protein Ladder; Lane 2: 
GST bound beads; Lane 3: GST-DivIVAEf bound beads; Lane 5: E. faecalis extracts representing 
10% input of EF1025CBS12.  
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Figure S4. PCR Confirmation for creation of E faecalis MJ26 and E faecalis MK12. (A) Schematic 
presentation of genomic insertional inactivation of EF1025 in E. faecalis. A kanR cassette was 
inserted at the nt151 position of mljd1. Arrows indicated primers used for PCR amplification to 
confirm KanR insertion in the E. faecalis genomic DNA; (B) Schematic presentation of deletion 
of EF1025 in E. faecalis. (C) PCR confirmation of insertional mutation. PCR was performed on 
E. faecalis MJ26 genomic DNA using primer pairs Mut-F/Kan-R (Lane 1- 1300 bp),  
Kan-F/Kan-R (Lane 2- 930 bp), Pro-F/Kan-R (Lane 3- 1500 bp), Kan-F/CBSDPR (Lane 4- 1409 
bp) and CBSDPF/CBSDPR (Lane 5- 1560 bp and 630 bp). M: 1kb plus DNA ladder. Presence of 
wild type EF1025 was due to the presence of co-transformed plasmid pMSPEF1025-Pro (Lane 5). 
Lane 6: cropped lane from same gel with amplified wild type EF1025; (D) PCR confirmation of 
EF1025 deletion using primer pairs ppdKF/EF26b-R (Lane 2- 1780 bp), mutF/EF26b-R  
(Lane 3- 1480 bp), catF/1026R (Lane 4- 1280 bp).   
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Figure S5. E. faecalis MJ26 and MK12 grew slower than E. faecalis JH2-2 cells. Viability curve 
of E. faecalis MJ26 cells. Growth was measured by OD at 600nm and normalised for each sample. 
E. faecalis MJ26 cells were subcultured on BHI containing appropriate antibiotics. Samples were 
withdrawn for plating every 2 hours. X- axis: Viable counts (CFU/ml), Y- axis- time (hours). X 
marked line- E. faecalis MK12; Open triangle line- E. faecalis JH2-2; Closed triangle line- E. 
faecalis MJ26. The error bars represent 1 standard deviation.  
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Figure S6. Figure S6. RT-PCR of EF1026 in E. faecalis JH-2-2 and MJ26 showing absence of 
polar effect. PCR amplified products corresponding to EF1026 from JH-2-2 and MJ26. Lanes 1 
and 2: EF_1026 from E. faecalis JH-2-2, Lanes 3 and 4: gdh from E. faecalis JH-2-2, Lane 5: 
negative control E. faecalis JH-2-2 with no reverse transcriptase; Lanes 6 and 7: EF_1026 from  
E. faecalis MJ26, Lanes 8 and 9: gdh from E. faecalis MJ26, Lane 10: negative control from  
E. faecalis MJ26 with no reverse transcriptase. gdh- glucose dehydrogenase (housekeeping gene).  
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Figure S7. E. faecalis MK12 cells exhibit larger aggregates than JH2-2. Representative AFM error 
images of E. faecalis JH2-2 (A) and E. faecalis MK12 (B) collected in QI mode with a resolution 
of 128128 pixels per image. Both JH2-2 and MK12 form relatively frequent cell aggregates that 
are larger for MK12. Since these clusters had irregular shapes and cell numbers, sizes could not 
be accurately estimated. Bar scale (5 µm) indicated at the bottom right corner of each image. 
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Figure S8. Shown are (A) Western blot probed with anti-Flag antibody to detect the presence of 
EF1025-flag in E. faecalis MK24. (B) Representative Western blot probed with anti-EF1025 to 
detect the presence of EF1025. Whole cell extract from: Lane 1: E. faecalis JH2-2; Lane 2:  
E. faecalis MK23; and Lane 3: E. faecalis MK24. (C) Densitometric quantification of band 
intensities corresponding to EF1025 from strains E. faecalis JH2-2, E. faecalis MK23, and  
E. faecalis MK24. 
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Figure S9. Overexpression of EF1025 in E. coli PB103 leads to severe cell elongation. Phase 
contrast microscopy of E. coli PB103 cells. (A) E. coli PB103 cells; (B) filamentous E. coli PB 
MK23 (>15 µm) cells transformed with pUCHisEF1025, and (C) E. coli PB MK25 overexpressing 
prgXEf. Scale bars represent 25 μm; n=89.   
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Figure S10. DivIVAEf exhibited loss of localization at the cell poles and midcell position in  
E. faecalis MWMR16 cells.  Averaged images and fluorescence intensity traces of E. faecalis 
MWMR16 cells grown to mid-exponential phase in BHI broth and dual-stained with DAPI and 
Alexa-Fluor 488 as described in the methodology section and images were acquired using the 
InVitro 3 and ImagePro 6.0 softwares (Media Cybernetics) as described in Methodology. 
DivIVAEf with coiled-coil disrupted region localized along the cell membrane.  
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3.1. Abstract 
CcpN is a transcriptional repressor in Bacillus subtilis that binds to the promoter region of 
gapB and pckA, downregulating their expression in the presence of glucose. CcpN also represses 
sr1, which encodes a small non-coding regulatory RNA that suppresses the arginine biosynthesis 
gene cluster. CcpN has homologues in other Gram-positive bacteria including Enterococcus 
faecalis. We report the interaction of CcpN with DivIVA of B. subtilis as determined using 
Bacterial two-hybrid and GST pull-down assays. Insertional inactivation of CcpN leads to cell 
elongation and formation of straight chains of cells. These findings suggest that CcpN is a 
moonlighting protein involved in both gluconeogenesis and cell elongation.   
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3.2. Introduction 
DivIVA is a highly conserved cell division protein in Gram-positive bacteria which interacts 
with a variety of different proteins in various species (Cha and Stewart, 1997; Fadda et al., 2003; 
Pinho and Errington, 2004; Ramirez-Arcos, 2005). In Bacillus subtilis (Bs), DivIVA (DivIVABs) 
acts as a temporal regulator for FtsZ-inhibiting MinCD proteins, restricting their activity to the 
cell's polar and septal areas and prevents cell division in the chromosome-free areas near the poles 
as well as in the vicinity of the active Z-ring (Cha and Stewart, 1997; Edwards and Errington, 
1997; Marston et al., 1998; Marston and Errington, 1999; Edwards et al., 2000; Karoui and 
Errington, 2001; Harry and Lewis, 2003). DivIVABs is also involved in the segregation of 
chromosomes during sporulation by positioning the oriC region of the chromosome to the cell 
poles through its association with RacA, which acts as a bridge between the oriC region and the 
cell poles (Thomaides et al., 2001; Ben-Yehuda et al., 2003). DivIVABs also binds to Maf, a protein 
involved in cell division arrest in competent cells (Briley et al., 2011). As well, DivIVA is involved 
in apical growth and cell polarity control by establishing hyphal branching sites and cell wall 
growth both in  B. subtilis (Flärdh, 2010) as well as Streptomyces coelicolor (Flärdh, 2003). In  
S. pneumoniae, DivIVA interacts with several divisome proteins including FtsZ, FtsA, ZapA, 
FtsK, FtsI, FtsB, FtsQ and FtsW (Fadda et al., 2007). We recently reported that DivIVA from  
E. faecalis interacts with a newly reported protein, EF1025, and affects cell length (Sharma et al., 
2020). 
The EF1025 homologue in B. subtilis is CcpN, a transcriptional regulator of gluconeogenic 
genes (Servant et al., 2005). While the majority of genes involved in carbon catabolite repression 
are regulated by CcpA-dependent catabolite control, three genes, gapB, pckA and sr1, are 
downregulated by CcpN in the presence of glucose (Licht et al., 2005; Servant et al., 2005). During 
glycolysis, gapB and pckA, enzymes which are involved in gluconeogenesis (i.e. NADPH-
dependent glyceraldehyde-3-P dehydrogenase, and PEP carboxykinase) are repressed (Servant et 
al., 2005). The other gene repressed by CcpN is sr1, which encodes a small non-coding regulatory 
RNA that inhibits the translation of ahrC (Licht et al., 2005).  ahrC encodes a transcriptional 
regulator that activates arginine catabolism in rocABC and rocDEF operon and suppresses the 
arginine biosynthesis gene cluster (Heidrich et al., 2006, 2007). CcpN in B. subtilis controls central 
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carbon fluxes; and disruption of CcpN led to mutant growth phenotype caused by ATP dissipation 
via extensive futile cycling (Tännler et al., 2008).  
The DivIVAEf interacting protein, EF1025, from Enterococcus faecalis, shares 41% 
homology with CcpN from B. subtilis (Sharma et al., 2020). EF1025 is essential for cell viability 
and affects the cell length and shape of E. faecalis. Because the EF1025/CcpN protein is highly 
conserved in Gram-positive bacteria, we hypothesized that CcpN would also interact with 
DivIVABs. We report a unique interaction between CcpN and DivIVA from B. subtilis, using 
bacterial-two hybrid and GST-pull down assays. A heterologous interaction was also determined 
between EF1025 and DivIVABs in a GST-pull down assay. Insertional inactivation of ccpN leads 
to cell elongation and changes in cell surface roughness in B. subtilis, suggesting a possible 
function for CcpN during the cell elongation process. Our research expands the knowledge of 
DivIVABs interacting partners and highlights a dual function for CcpN in B. subtilis.  
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3.3. Materials and methods: 
3.3.1. Strains and growth conditions 
Bacterial strains and plasmids used in this study are shown in Table 3.1. E. coli XL1-Blue 
or DH5α were used for cloning, E. coli C41 (DE3) was used to overexpress cloned proteins and 
E. coli R721 was the host (Di Lallo et al., 2001, 2003) for bacterial-two hybrid assays. B. subtilis 
168 genomic DNA was used to amplify ccpN and divIVA to create constructs for B2H and GST 
pull-down assays. E. coli and B. subtilis strains were grown in Luria-Bertani (LB) broth (Difco, 
Franklin Lakes, NJ, USA) at 37°C and the following antibiotics (Sigma, CA) were added to the 
medium as required: ampicillin, kanamycin, erythromycin and chloramphenicol. 
3.3.2. Bioinformatic analysis 
The EF1025 homologue in B. subtilis, CcpN, was identified using BLASTp 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) against the non-redundant protein 
sequences database for which the EF1025 protein sequence was used as a query. The deduced 
amino acid sequence was analyzed using the ProtParam tool 
(http://us.expasy.org/tools/protparam.html).  The CcpN sequence was also analyzed by PROSITE 
(Sigrist et al., 2010) (https://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) to identify 
functional domains. Transmembrane motifs were predicted using the TMbase program 
(https://embnet.vital-it.ch/software/TMPRED_form.html) and potential coiled-coil structures in 
CcpN were predicted using the COILS program 
(http://www.ch.embnet.org/software/COILS_form.html).  
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Table 3.1. Bacterial strains used in the study. 
Strains Relevant characteristics Resources or 
References 
Escherichia coli XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F´ proAB lacIqZ_M15Tn10 
(Tetr)] 
Strategene 
E. coli DH5α endA1 hsdr17 (rk-mk+) supE44 thi-1 recA1 
gyrA96 relA1 (argF-lacZYA) U169 
deoR [ø80d lac (lacZ) M15) 
Gibco-BRL 
E. coli C41 (DE3) FˉompT hsdSB (rB-mB-) gal dcm Δ(srl-
recA) 306::Tn10 (tetR) (DE3) 
Miroux et al., 1996 
E. coli R721 71/18 glpT::O-P434/P22lacZ Di Lallo et al., 
2001, 2003 
E. coli pETEF1025 E. coli C41 (DE3) with pETEF1025 for 
6×His-EF1025 overexpression  
 Sharma et al., 
(2020) 
B. subtilis 168 trpC2; plasmid free B. subtilis Genetic 
Stock Center 
(BGSC) 
B. subtilis KS1685 trpC2 ccpN’:: pMUTIN4 This study 
B. subtilis GM1620 trpC2 ccpN’:: pMUTIN2 Servant et al., 2005 
B. subtilis PS1622 trpC2amyE’::PgapB::lacZ-cat 
ccpN’::pEC23 
Servant et al., 2005 
B. subtilis PS1649 trpC2 amyE’::PpckA::lacZ-cat Servant et al., 2005 
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3.3.3. CcpN-DivIVA interactions in the Bacterial Two-Hybrid assays (B2H) 
The B2H system of Di Lallo et al. (2001) was employed to investigate interactions between 
CcpN and DivIVABs. To facilitate cloning, B2H vectors pcI434 and pcIp22 (Di Lallo et al., 2001) 
were modified by inserting a linker containing multiple endonuclease restriction sites, resulting in 
plasmids pcI434-L and pcIp22-L (Table 3.2). ccpN and divIVABs were PCR-amplified from  
B. subtilis 168 using primers CcpNF/CcpNR and DivIVABsF/DivIVABsR, respectively (Table 3.3). 
Amplicons were cloned into the B2H vectors pcI434-L and pcIp22-L, resulting in plasmids 
pcIp22CcpN, pcI434CcpN, pcIp22divIVA and pcI434divIVA (Table 3.2). B2H plasmids were 
transformed into E. coli R721 either singly or in combination. B2H assays were modified (Di Lallo 
et al. 2001, 2003) as follows: freshly transformed single colonies of E. coli R721 cells, harbouring 
different combinations of plasmids pcIp22CcpN, pcI434CcpN, pcIp22divIVA and pcI434divIVA, 
were grown overnight in 4 mL LB medium supplemented with Chl 30 µg/ml, Amp 50 µg/ml and 
Kan 25 µg/ml. Cells were diluted 1:100 in fresh LB medium containing the same antibiotics for 
~1 hour (OD600 ~0.1) at 34°C, followed by the addition of 0.1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG). Cells were further cultured to mid-log phase (OD600=~0.5) at 
34°C, harvested, and tested for β-galactosidase activity as previously described (Di Lallo et al., 
2001). E. coli R721 cells were used as the baseline control for the calculation of the percentage 
residual β-galactosidase activity (Table 3.1). A value of less than 50% residual β-galactosidase 
activity as compared to the E. coli R721 cells, was defined as positive for protein interactions. 
Each experiment was performed in triplicate, and an average of the percentage residual β-
galactosidase activity and the standard deviation was determined.  
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Table 3.2. Plasmids used in the study. 
Plasmids Relevant Characteristics Resources/References 
pcI434 KanR, bacterial two-hybrid vector Di Lallo et al., 2001 
pcIp22 AmpR, bacterial two-hybrid vector Di Lallo et al., 2001 
pcIp22-L pcIP22 derivative carrying a linker with 
multiple cloning sites 
Sharma et al., (2020) 
pcI434-L pcI434 derivative carrying a linker with 
multiple cloning sites 
Sharma et al., (2020) 
pcIp22CcpN pcIP22 derivative carrying the B. subtilis 
ccpN gene 
This study 
pcIp434CcpN pcI434 derivative carrying the B. subtilis 
ccpN gene 
This study 
pcI22divIVA pcIP22 derivative carrying the B. subtilis 
divIVA gene 
This study 
pcI434divIVA pcI434 derivative carrying the B. subtilis 
divIVA gene 
This study 
pGEX-2T AmpR Plac::gst Amersham Bioscience 
pGST-Div AmpR Plac::gst, GST-DivIVABs This study 
pET30a(+) KanR PT7::6xhis Novagen 
pETCcpN KanR PT7, 6×His-CcpN This study 
pMUTIN4 Integration vector EmR, AmpR, LacZ B. subtilis Genetic 
Stock Center (BGSC) 
pMUTccpN Integration vector EmR, AmpR, 
LacZ::ccpN 
This study 
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Table 3.3. Primers used in the study. 
Primer name Sequence 5’ to 3’ 
CcpNF GCGGTCGACT GTGAGTACGATCGAACTAAA 
CcpNR GCCCGGATCCA TTATAGGATTTCATTTTCAG 
DivIVBsF GAGGGATCCTATGCCATTAACGCCAAATGATATTC 
DivIVBsR GCGAGATCTTTTATTCCTTTTCCTCAAATACAGCGTC 
BsDivIVF GAGGGATCCATGCCATTAACGCCAAATGATATTC 
BsDivIVR GCGCTCGAGTTATTCCTTTTCCTCAAATACAGCGTC 
BsCcpNF GCGCCATATGAGTACGATCGAACTAAATAAAC 
BsCcpNR GCGCGGATCCTAGGATTTCATTTTCAGATAAACTGAC 
KOCcpN-F GCGCGAATTCGTGAGTACGATCGAACTAAATAAAC 
KOCcpN120 GCGCGAATTCGCGCCCGGATTTAGCCATAC 
KOCcpN-R GCGCGGATCCTTATAGGATTTCATTTTCAGATAAACTGAC 
KOCcpN318 GCGCGGATCCTTATTCTAAAAACATGGTGCAAATCGCATC  
EryF CGGGTCAGCACTTTACTATTG 
EryR GGACCTACCTCATAGACAAG 
LacZR TTATTTTTGACACCAGACC 
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3.3.4. GST pull-down assays 
To create a GST-DivIVABs fusion, divIVABs was PCR-amplified from B. subtilis 168 using 
primers BsDivIVF/BsDivIVR (Table 3.3). The amplicon was cloned into the GST vector pGEX-
2T, generating plasmid pGST-Div (Table 3.2). ccpN was PCR-amplified using primers 
BsCcpNF/BsCcpNR (Table 3.3B) and cloned into the 6His tag vector pET30a(+), resulting in 
plasmid pETCcpN (Table 3.2). GST-DivIVABs or 6His-CcpN fusions were overexpressed in  
E. coli C41 (DE3) as described in Rigden et al. (2008). GST-DivIVBs was purified and bound to 
GST affinity beads according to the manufacturer’s instructions (GST-Bind Kit, Novagen, USA). 
Soluble 6His-CcpN was extracted from 200 mL log-phase growth cells of E. coli C41 by 
sonication in 5 ml Interaction Buffer (IB, 20 mM Tris/HCl pH 7.5, 10% glycerol, 50 mM KCl,  
0.5 mM EDTA, 1% Triton X100, 1 mM DTT). The cell lysate was centrifuged and the supernatant 
(50µl) was incubated with 20 µL GST-DivIVABs bound beads pre-equilibrated with IB buffer, at 
4°C for 2 hours. Beads were washed with cold IB buffer three times. Protein retained on the beads 
was eluted using 40 µL 1SDS loading buffer and heating at 95°C for 10 min. Eluted protein was 
separated by SDS-PAGE, followed by Western blot analysis using anti-6His and anti-GST 
monoclonal antibody (Genscript, USA) at a concentration of 0.3 µg/mL. Purified GST protein was 
used as a control and was produced in E. coli C41 (DE3) from plasmid pGEX2T, as previously 
described (Zou et al., 2017).  
To study the heterologous interaction between EF1025 and DivIVABs, pGST-Div was 
overexpressed in E. coli C41 (DE3)(Ramirez-Arcos, 2005) (Table 3.1 and 3.2B). The GST-
DivIVABs fusion protein was purified using GST affinity beads (GST-Bind Kit, Novagen, USA) 
and was used to study its interaction with 6His-EF1025, which was purified from E. coli 
pETEF1025, as previously described (Sharma et al., 2020). SDS-PAGE and Western blot were 
developed formed as described previously (Ramirez-Arcos, 2005; Rigden et al., 2008). 
Monoclonal anti-GST antibody was used for detecting GST-DivIVAEf (Genscript, USA) at 0.3 
µg/mL. The 6His tagged proteins were probed with anti-6His monoclonal antibodies (0.25 
µg/mL) according to the manufacturer’s instructions (Genscript, USA). 
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3.3.5. Insertional inactivation of ccpN  
B. subtilis ccpN was disrupted by insertional mutagenesis by constructing an integration 
plasmid as follows: a 120 bp fragment of the N-terminal coding sequence of ccpN was PCR-
amplified from B. subtilis 168 using primers KOCcpN-F/KOCcpN120 (Table 3.3). A fragment 
from the C-terminal was amplified using primers KOCcpN-R/KOCcpN318 (Table 3.3). These 
amplicons were digested with BamHI and EcoRI and ligated to predigested pMUTIN4 resulting 
in pMUTccpN (Table 3.2). pMUTccpN carried the N-terminal and C-terminal fragments of ccpN 
flanking either end of the LacZ and PSpec of pMUTIN4. pMUTccpN was transformed into 
competent E. coli DH5α and selected for ampicillin resistance. pMUTccpN was electroporated 
into electrocompetent B. subtilis 168 cells creating B. subtilis KS1685 and cells were selected for 
erythromycin resistance (Bron and Venema, 1972), creating B. subtilis KS1685. Correct clones 
were confirmed using PCR amplification of the upstream and downstream regions of pMUTIN4  
using primer sets LacZR/KOCcpN-R, KOCcpN-F/EryF, KOCcpN-F/LacZR, and EryF/KOCcpN-
R to ensure the integration of pMUTIN4 into B. subtilis 168 genome (Table 3.3).  
3.3.6. Microscopy 
A SU8010 Cold Field Emission Ultra-High-Resolution scanning electron microscope 
(SEM) (WCVM, University of Saskatchewan, Saskatoon, Saskatchewan) was used to image  
B. subtilis strains 168, KS1685 (this study), GM1620, PS1622 and PS1649 (Dr. Stephane 
Aymerich, Director, Micalis Institute, Paris, kindly provided B. subtilis strains GM1620, PS1622 
and PS1649, Table 3.1). Cells were cultured in LB medium with or without appropriate antibiotics, 
without agitation at 37°C either overnight (~20 h) or to stationary phase. Cells were fixed on  
poly-L-lysine coverslips, sequentially dehydrated in ethanol, critical point dried, sputter coated 
with gold and imaged (Ramirez-Arcos et al., 2001). The percentage of elongated cells were 
calculated measuring the length of 90-105 cells.  
For atomic force microscopy (AFM), coverslips were coated with Cell-Tak 
(LifeTechnologies) to which cell suspensions from overnight cultures were deposited. Cells were 
fixed with formalin, air dried (Bhat et al., 2015) and imaged with silicon nitride cantilevers 
(HYDRA6R-200NG; Nanosensors, Neuchatel, Switzerland) with calibrated spring constants 
ranging from 0.03 to 0.062 N/m. QI™ images were collected (Z-length = 0.926 um; scan rate = 
96 
95 um/s; 128  128 pixel raster scan) and generated force curves (JPK software) at each pixel 
(Sharma et al., 2020). Height, length and surface roughness were calculated from QI™ height 
images according to Bhat et al. (2015), the latter from multiple squares (200 × 200 nm) along the 
centre of at least 10 cells each from 3 biological replicates. 
3.3.7. Statistical analysis 
AFM and SEM studies were conducted in triplicate and analyzed using Microsoft Excel or 
Graph Pad Prism respectively unless otherwise indicated. The results were reported as mean ± 
standard deviation (SD), differences assessed using a two-tailed unpaired t-test and ANOVA for 
which p < 0.05 was considered statistically significant.   
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3.4. Results 
3.4.1. Bioinformatics analysis 
CcpN, a protein comprising 212 amino acids (AA) with an estimated molecular weight of 
~24 kDa and a theoretical isoelectric point of 6.97, contains no transmembrane motifs or coiled-
coil regions. CcpN contains an N-terminal helix-turn-helix (HTH) DNA binding domain (AA 11-
60), and two Cystathionine β-Synthase (CBS) domains (i.e. CBS1, AA 82-148 and CBS2, AA 
155-206). The CBS1 domain is centrally located whereas the CBS2 domain is located at the  
C-terminus of CcpN. 
3.4.2. CcpN interacts with DivIVA in vitro and in vivo 
CcpN shares 41 % homology with EF1025 from E. faecalis. Since EF1025 interacts with 
DivIVAEf, and because many firmicutes have homologues of this protein, we investigated whether 
such an interaction is unique to E. faecalis. In the B2H system used to assess the interaction 
between CcpN and DivIVABs, less than 50% residual β-galactosidase activity is considered as a 
positive interaction (Di Lallo et al., 2001, 2003). A positive interaction was observed between 
DivIVA and CcpN (Fig. 3.1, 32%) when E.coli R721 cells harbouring plasmids pdivIVA22 and 
pCcpN434 together (Table 3.2) were measured for residual β-galactosidase activity. The reverse 
combination of these plasmids i.e.  pCcpN22 and pdivIVA434 together also resulted in a positive 
interaction (24%). As a positive control, FtsA and FtsZ proteins from Neisseria gonorrheae were 
measured for residual β-galactosidase activity (28%). E. coli R721 cells (Table 3.1) served as a 
control baseline β-galactosidase activity control.  
The in vitro interaction between CcpN and DivIVABs was ascertained by GST-pull down 
assay, in which 6His-CcpN was pulled down by GST-DivIVABs (45 kDa). GST alone acted as a 
negative control and did not interact with 6His-CcpN (Fig. 3.2A, Lane 3). A Western blot using 
monoclonal anti-His antibody revealed the presence of a 25 kDa band corresponding to  
6His-CcpN (Fig. 3.2A, Lane 5).  
In a heterologous interaction, the in vitro interaction between EF1025 and DivIVABs was 
ascertained by GST-pull down assay in which 6×His-EF1025 was pulled down by GST-DivIVABs 
(45 kDa). GST alone acted as a negative control and did not interact with 6His-EF1025 (Fig. 
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3.2B, Lane 3). A Western blot using an anti-EF1025 antibody (Sharma et al., 2020) revealed the 
presence of a 25 kDa band corresponding to 6His-EF1025 (Fig. 3.2B, Lane 5).  
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Figure 3.1. CcpN interacts with DivIVABs in B2H assay. The β-galactosidase activity was 
expressed in Miller Units (y-axis). The x-axis shows the combination of B2H plasmids used and 
the percentage Miller Units. Average values were obtained from three independent assays in 
triplicate. Values of less than 50% indicate a positive interaction. The error bars represent 1 
standard deviation.  
100 
 
Figure 3.2. DivIVABs interacts with CcpN and EF1025 in GST pull-down assay. (A) Western blot 
probed with anti-6His and anti-GST monoclonal antibody. Lane 1: overexpressed and purified 
CcpN (25 kDa); Lane 2 and 4: empty; Lane 3: GST (25 kDa); Lane 5: pulled down GST-DivIVABs 
(45 kDa)  along with CcpN (25 kDa); Lane 6: Protein ladder. (B) Western blot probed with anti-
6HisEF1025 polyclonal antibody and anti-GST monoclonal antibody. Lane 1: overexpressed 
6His-EF1025 (25 kDa) containing supernatant representing 10% input; Lane 2 and 4: empty; 
Lane 3: GST (25 kDa); Lane 5: pulled down GST-DivIVABs (45 kDa) bound beads along with 
6His-EF1025 (25 kDa); Lane 6: Protein ladder. 
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3.4.3. ccpN insertional inactivation leads to cell elongation 
Insertional inactivation of EF1025 in E. faecalis affects cell length and cell septation, 
phenotypes (Levin et al., 1992; Varley and Stewart, 1992; Abhayawardhane and Stewart, 1995; 
Chung et al., 2004). We proposed that disruption of ccpN could also produce a similar phenotype 
in B. subtilis. ccpN was insertionally inactivated by introducing an erythromycin cassette using the 
plasmid pMUTIN4 in B. subtilis KS1685 (Tables 3.1 and 3.2). Using scanning electron 
microscopy (SEM), B. subtilis KS1685 cells were compared with wild type B. subtilis 168 cells. 
B. subtilis 168 cells showed rod-shaped cells with normal division (Fig. 3.3A). B. subtilis KS1685 
cells were elongated and grew in straight chains of connected cells (Fig. 3.3C). These cells failed 
to segregate and detach distinctively from one another (Fig. 3.3D). We compared the morphology 
of B. subtilis KS1685 cells with B. subtilis GM1620 and PS1622 strains developed by Servant et 
al., 2005 (Fig. 3.3E and 3.3F) which contain ccpN disrupted by pMUTIN2 through single/multiple 
integration events (Table 3.1). B. subtilis GM1620 and PS1622 cells were also elongated and failed 
to segregate. Another control strain i.e. B. subtilis PS1649 (Table 3.1), developed by Servant et 
al., 2005, containing disrupted pckA, exhibited rod-shaped cells with a normal division like  
B. subtilis 168 (Fig. 3.3B). 
The lengths of wild type B. subtilis 168 cells (2.6 ± 0.94 µm, n= 102), B. subtilis KS1685 
(6.16  1.2 µm, n= 92), B. subtilis GM1620 (6.67  2.13 µm, n= 92) and PS1622 (6.88  2.51 µm, 
n= 97) cells were compared. B. subtilis KS1685 (6.161.2 µm, n=92), B. subtilis GM1620 
(6.672.13 µm, n=92) and PS1622 (6.882.51 µm, n=97) strains with ccpN disruption were 
significantly (p < 0.05) longer (Fig. 3.4) as determined by SEM. Control strain, B. subtilis PS1649 
(Table 3.1), had a cell length (2.51  0.54 µm, n= 97) similar (p > 0.05) to wild type B. subtilis 
168 cells (2.6 ± 0.94 µm, n= 102) (Fig. 3.3B and 3.4).  
Analysis of the cells by AFM showed that wthe cell length of B. subtilis 168 (3.08 ± 0.56 
µm) was similar (p= 0.36) to that of PS 1649 (3.24 ± 0.74 µm). These lengths were statistically 
different (p < 0.05) from B. subtilis KS 1685 (4.71 ± 0.58 µm), PS 1622 (4.05 ± 0.39 µm) and GM 
1620 (5.33 ± 0.86 µm) cells which were longer (Fig. 3.5).  The cell heights measured by AFM for 
B. subtilis 168 (0.36 ± 0.044 µm), PS 1649 (0.36 ± 0.01 µm) and GM 1620 (0.038 ± 0.048 µm) 
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were statistically identical but were statistically different (p < 0.05) from both B. subtilis KS 1685 
(0.31 ± 0.01 µm) and B subtilis PS 1622 (0.32 ± 0.01 µm).  
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Figure 3.3. Insertional inactivation of ccpN leads to cell elongation and failed segregation in  
B. subtilis KS 1685 (this study), PS 1622 and GM1620. Scanning electron micrographs showing 
(A) Normal B. subtilis 168 cells; (B) B. subtilis PS 1649 cell exhibiting normal cell length and 
morphology; (C and D) B. subtilis KS 1685 cells; (E and F) B. subtilis PS 1622 and GM 1620 
cells, respectively, showing elongated cells with impaired segregation. White arrow indicates 
failed segregation in rod-shaped cells. Bar scale indicated at the bottom right corner of each image.  
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Figure 3.4. Comparison of cell lengths for B. subtilis strains: 168 (n= 102), PS 1649 (n= 97), KS 
1685 (n= 92), PS 1622 (n= 97) and GM 1620 (n= 92). B. subtilis strains 168 and PS 1649 served 
as control strains. “n” represents the number of cells counted for each sample; * represents two-
tail p value from t-test for each group set (p < 0.05); NS- non-significant. The error bars represent 
1 standard deviation. 
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Figure 3.5. B. subtilis KS1685 cells exhibited cell elongation. Representative AFM images of (A) 
B. subtilis 168; (B) B. subtilis PS1649; (C) B. subtilis KS1685; (D) B. subtilis GM1620; (E)  
B. subtilis PS1622 collected in QI mode with a resolution of 128×128 pixels per image. Bar scale 
(1 µm) indicated at the bottom right corner of each image; and (F) Comparison of cell lengths for 
B. subtilis strains: 168 (n= 43), PS 1649 (n= 43), KS 1685 (n= 32), PS 1622 (n= 34) and GM 1620 
(n= 37). All data was analyzed by t-test where * indicates p < 0.05; NS- non-significant. The error 
bars represent 1 standard deviation. 
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3.5. Discussion 
Studies of protein-protein interactions between various proteins have been mostly studied 
using two-hybrid systems or other biochemical methods like GST-pull down and Co-
immunoprecipitation (Ishikawa et al., 2006). The in vivo Bacterial two-hybrid assay shows a novel 
interaction between CcpN and DivIVA in B. subtilis. This interaction was confirmed using an in 
vitro GST pull-down assay. We also observed a positive heterologous interaction between EF1025, 
a CcpN homologue in E. faecalis, and DivIVABs. These data suggest that the interaction between 
DivIVA and CcpN homologues is probably conserved among Gram-positive microorganisms. 
EF1025 interacts with DivIVAEf and affects cell length and shape
 (Sharma et al., 2020). The two 
CBS domains of EF1025 independently interacted with EF1025 in B2H and GST pull-down 
assays. While the function of the HTH domain of CcpN in gluconeogenesis has been previously 
discussed by Servant et al. (2005), the function of the two CBS domains in CcpN remains to be 
answered.  
We investigated whether CcpN in B. subtilis might play a similar role as its homologue, 
EF1025 in E. faecalis (Sharma et al., 2020). CcpN affects the cell length in B. subtilis (Servant, Le 
Coq and Aymerich 2005; Sharma et al., 2020). B. subtilis 1685 cells containing disrupted ccpN 
were significantly longer than the wild-type B. subtilis 168 cells. We observed the same degree of 
elongation in B. subtilis GM1620 and PS1622. B. subtilis PS1649, with disrupted pckA (one of the 
genes regulated by CcpN), showed no change in cell length and behaved like the wild-type  
B. subtilis 168 cells. This shows that the cell elongation phenotype is exclusive to the strains 
containing a disruption of ccpN expression, and that ccpN is involved in determining cell length 
in B. subtilis. Interestingly, unlike EF1025, disruption of ccpN proved to be non-essential.  
B. subtilis cells have a distinctive elongated cylindrical tube morphology with 
hemispherical poles. Growth occurs through elongation along the cell's long axis with division 
occurring when a cell doubles in length (Errington and Wu, 2017). In B. subtilis, cell shape is 
determined and maintained by the action of “cytoskeletal” proteins of the MreB family such as 
MreB, Mbl, MreBH and RodA that are structurally and biochemically related to eukaryotic actins 
(Henriques et al., 1998; Carballido-Lopez, 2006). A degree of remodelling or active movement of 
the filaments occurs during cell elongation (Carballido-López and Errington, 2003; Defeu Soufo 
and Graumann, 2004). B. subtilis cells with mutations in mreB exhibited enhanced diameter and 
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grew in “straight rows” (Carballido-Lopez, 2006). MreB associates with elongation-specific 
peptidoglycan-synthesizing complexes that include MreC, MreD, RodA, Penicillin Binding 
Proteins (PBPs), and peptidoglycan hydrolases (Carballido-López and Formstone, 2007; White et 
al., 2010). CcpN may be another member of the category of proteins that determine cell length in 
B. subtilis. The cells were longer and failed to segregate in the ccpN mutants B. subtilis 1685, 
GM1620 and PS1622, in which cells remained closely attached to one another and grew in straight 
rows. Taken together, these results suggest that CcpN affects cell length and enables timely cell 
segregation in B. subtilis. This also suggests that CcpN has two different functions in the cell i.e. 
controlling cell length and expression of gapB and pckA in the presence or absence of glucose 
(Servant et al., 2005). 
Many proteins, called “moonlighting proteins” perform multiple, apparently unrelated, 
functions that have not resulted from gene fusions, RNA splicing, or pleiotropic impacts, and they 
are found throughout the evolutionary tree (Jeffery, 1999). By using only one polypeptide chain, 
moonlighting proteins govern different functions and interacting partners possibly due to the minor 
differences in amino acid sequence (Jeffery, 2016). For example, CbtA (formerly known as YeeV) 
of E. coli alters cell shape by inhibiting both cell division and cell elongation. CbtA is the toxin 
component of the CbtA/CbeA chromosomal toxin-antitoxin system in E. coli that targets both FtsZ 
and MreB. CbtA interacts independently with FtsZ and MreB affecting cell shape (Heller et al., 
2017) by a simultaneously blocking cell division and cell elongation pathways. Both of these 
interactions are functionally important, independently contributing both to toxicity and cell-shape 
disturbances (Heller et al., 2017). 
Very often two protein species with a high degree of amino acid sequence identity share 
the same function.  However, there have been many cases reported in which two proteins have 
different functions resulting from subtle differences in amino acid sequence (Jeffery, 2016). 
EF1025 and CcpN share 41% homology at the protein level, and both contain one N-terminal 
helix-turn-helix domain and two CBS domains, one located centrally and the other at the  
C-terminus. Since CBS domains in EF1025 are responsible for interaction with DivIVAEf, we 
propose that different domains of CcpN may govern different cellular functions. The disparate 
cellular functions, namely gluconeogenesis and determination of cell shape, could be attributable 
to different domains of CcpN (Servant et al. 2005). Here we report another novel function of CcpN 
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from B. subtilis. CcpN interacts with DivIVABs like its homologue, EF1025 from E. faecalis. ccpN 
is a non-essential gene for cell viability but it regulates cell length and the ability to segregate after 
successful division.   
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4.1. Abstract 
Bacterial cell division, an essential process, is orchestrated by the coordinated interaction 
of key cell division proteins forming a macromolecular complex called the divisome, spanning the 
cytoplasmic membrane during cell division. Key cell division proteins like FtsZ, FtsA, 
FtsQ/DivIB, FtsL, FtsW, FtsB/DivIC, FtsI and FtsK are relatively conserved. Using in vivo and in 
vitro, biochemical techniques cell division protein-protein interaction networks have been 
established for only four bacterial species i.e. E. coli, N. gonorrhoeae, S. aureus and S. 
pneumoniae. E. faecalis contains homologues of divisome proteins FtsZ, FtsA, FtsK, FtsQ, FtsL, 
FtsI and FtsB, however, the cell division interactome of E. faecalis, by contrast, is not presently 
known. In this research article, we are reporting the unique interactome of E. faecalis divisome 
proteins (i.e. FtsZEf, FtsAEf, FtsQEf, FtsLEf, FtsIEf, FtsWEf, DivIVAEf, and FtsBEf), established using 
Bacterial-two hybrid system. We also used EF1025, a DivIVAEf interacting protein, to test for 
potential interactions with E. faecalis divisome proteins. EF1025 did not interact with any 
divisome protein except DivIVAEf. 
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4.2. Introduction 
Bacterial cells are critically dependent for growth, development, and reproduction on their 
ability to divide. Cell division is a complex mechanism orchestrated at the division site by a multi-
protein macromolecular complex called the divisome (Margolin, 2000; Gamba et al., 2009). The 
genes encoding these proteins are located in a highly conserved cluster known as “division cell 
wall (dcw)” cluster (Ayala et al., 1994; Tamames et al., 2001). The proteins encoded by the dcw 
genes are involved in cell division and peptidoglycan synthesis and are mostly essential for cell 
division (Boyle and Donachie, 1998; Kobayashi et al., 2003). Although the organization of various 
genes within the dcw cluster varies in different bacterial species as found in E. coli, B. subtilis, 
Staphylococcus aureus, Streptococcus pyogenes, Enterococcus faecalis, and S. pneumoniae (Fig. 
1.1; Massidda et al., 1998; Francis et al., 2000; Snyder et al., 2001; Fadda et al., 2003; Ramirez-
Arcos, 2005; Real and Henriques, 2006), the proteins involved in the process of cell division are 
comparatively conserved (Lutkenhaus et al., 2012; Haeusser and Margolin, 2016). 
The context of the divisome varies in different bacteria. For example, in B. subtilis, 
divisome assembly follows a concerted or cooperative mode, because most divisome proteins are 
interdependent for septal localization (Gamba et al., 2004). Over 13 proteins form the core 
divisome (i.e. FtsZBs, FtsABs, SepFBs, ZapABs, EzrABs, GpsBBs, FtsLBs, FtsBBs, FtsQBs, FtsWBs, 
PBP1Bs, PBP2BBs and DivIVABs) in B. subtilis (Gamba et al., 2009; Halbedel and Lewis, 2019). 
FtsZBs assembles forming single-stranded protofilaments at the mid-cell where it is tethered to the 
membrane by the “early” divisome proteins FtsABs or SepFBs (Jensen et al., 2005; Hamoen et al., 
2006; Peters et al., 2007; Gamba et al., 2009). Sequentially, ZapABs and EzrABs then interact with 
the Z-ring facilitating FtZBs polymerization (Levin et al., 1999; Gueiros-Filho and Losick, 2002; 
Singh et al., 2007; Cleverley et al., 2014). The complex comprised of FtsZBs-FtsABs-SepFBs-
ZapABs-EzrABs then recruits the ‘late’ cell division proteins i.e. FtsWBs, PBP1Bs, PBP2BBs, 
DivIBBs, DivICBs and FtsLBs, DivIVABs and GpsBBs (Perry and Edwards, 2004; Tavares et al., 
2008; Gamba et al., 2009; Lenarcic et al., 2009; den Blaauwen, 2018; Taguchi et al., 2019). These 
proteins do not directly interact with FtsZBs and are mainly cytosolic proteins or membrane 
proteins (Ishikawa et al., 2006). In E. coli, over 10 proteins (FtsZEc, FtsAEc, FtsLEc, FtsWEc, FtsBEc, 
ZipAEc, FtsIEc, FtsKEc, FtsQEc, and FtsNEc) constitute the core divisome because of their 
essentiality during the process of cell division (Haeusser and Margolin, 2016). In E. coli, “early” 
divisome proteins (FtsZEc, FtsAEc and ZipAEc) locate to the septum forming a dynamic ring 
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structure, called as the proto-ring, at an early stage in cell division which acts as an assembly stage 
for the remaining proteins (Erickson et al., 2010; Rico et al., 2013; Ortiz et al., 2016). This is 
followed by the recruitment of the “late” proteins (FtsKEc, FtsQEc, FtsLEc, FtsBEc, FtsWEc, FtsIEc 
and FtsNEc) that are involved in remodelling of the peptidoglycan layer and chromosome 
segregation (Aarsman et al., 2005).  
Using in vivo and in vitro, biochemical techniques such as bacterial two-hybrid (B2H) 
assay, GST-pull down assay, Co-immunoprecipitation (Co-IP) and Surface Plasmon Resonance 
(SPR), cell division protein-protein interaction networks have been established for four bacterial 
species i.e. E. coli (Di Lallo et al., 2003; Karimova et al., 2005), N. gonorrhoeae (Zou et al., 2017), 
S. aureus (Steele et al., 2011) and S. pneumoniae (Fadda et al., 2007; Maggi et al., 2008). In Gram-
negative E. coli, sixteen interactions between ten cell division proteins (i.e. including FtsZEc, 
FtsAEc, ZipAEc, FtsKEc, FtsQEc, FtsBEc, FtsLEc, FtsIEc, FtsWEc, and FtsNEc) were identified (Di 
Lallo et al., 2003; Karimova et al., 2005). Zou et al. (2017) characterized nine interactions among 
eight cell division proteins i.e. FtsZNg, FtsANg, ZipANg, FtsKNg, FtsQNg, FtsINg, FtsWNg, and FtsNNg, 
from Neisseria gonorrhoeae that defined the cell division interactome.  
Using two different approaches i.e. bacterial two-hybrid (B2H) system and  
co-immunoprecipitation (Co-IP), a total of 37 homo and/or hetero-dimeric interactions were 
observed among nine S. pneumoniae cell division proteins that included FtsZSp, FtsASp, FtsKSp, 
DivlBSp, DivlCSp, FtsLSp, FtsWSp, and PBP2xSp (Maggi et al., 2008).  In a B2H assay, Fadda et al. 
(2007) showed that DivIVASp interacts with several divisome proteins, including FtsZSp, FtsASp, 
ZapASp, FtsKSp, FtsISp, FtsBSp, FtsQSp and FtsWSp in S. pneumoniae (Fadda et al., 2007). Using 
the same method, Steele et al. (2011) reported around 49 homo-and/or hetero-dimeric protein 
interactions between thirteen divisome proteins (i.e. FtsZSa, FtsASa, EzrASa, GpsBSa, SepFSa, 
Pbp1Sa, Pbp2Sa, Pbp3Sa, DivIBSa, DivICSa, FtsLSa, FtsWSa and RodASa) in S. aureus.   
The E. faecalis dcw cluster contains homologues of divisome proteins FtsZ, FtsA, FtsK, 
FtsQ (DivIB), FtsL, FtsI and probably FtsB (DivIC), EzrA and ZapA (Pucci et al., 1997; Duez et 
al., 1998; Massidda et al., 1998) but the interaction network for these cell division proteins in  
E. faecalis, by contrast, is not presently known. To investigate the network of cell divisome 
proteins that forms a divisome in E. faecalis, protein-protein interactions between eight E. faecalis 
divisome proteins were studied using a B2H assay. Sixteen homo/hetero-dimer interactions were 
113 
identified among E. faecalis divisome proteins that included FtsZEf, FtsAEf, FtsQEf, FtsLEf, FtsIEf, 
FtsWEf, DivIVAEf, and FtsBEf. EF1025, a DivIVAEf interacting protein, failed to interact with any 
divisome protein members, therefore, is not a part of E. faecalis divisome. B2H assay results reflect 
the existence of unique interactome for E. faecalis when compared with interactomes from E. coli, 
N. gonorrhoeae, S. aureus, and S. pneumoniae.  
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4.3. Materials and methods 
4.3.1. Strains, plasmids and growth conditions 
Bacterial strains and plasmids used in this study are listed in Table 4.1. E. coli DH5α was 
used for cloning and E. coli R721 for B2H assays (Di Lallo et al., 2001). E. coli DH5α and E. coli 
R721 were grown at 37 °C in Luria-Bertani (LB) medium (BD Difco™, Sparks, MD) with 
appropriate antibiotics in the following concentrations as required: ampicillin (Amp) 50 μg/mL, 
kanamycin (Kan) 30 μg/mL and chloramphenicol (Chl) 33 μg/mL, for 6-8 hours. During B2H 
assays, E. coli R721 was grown in LB medium for the duration required and incubated at 34°C, as 
previously described (Di Lallo et al., 2001). E. faecalis JH2-2 (Jacob and Hobbs, 1974), was used 
for the preparation of genomic DNA and was cultured at 37°C without aeration in Brain Heart 
Infusion (BHI) broth (Difco, Detroit, MI). Genomic DNA was prepared from E. faecalis JH2-2 
using QIAamp DNA Mini Kit as per manufacturer instructions (Qiagen, CA). 
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Table 4.1. Bacterial strains used in the study.  
Strain Relevant Genotype Source 
Escherichia coli XL1 Blue hsdR17, supE44, recA1, endA1, gyrA46, thi 
relA1, lac/F’ [proAB+, lacIq, 
lacZDM15::Tn10(Tetr)] 
Stratagene 
Escherichia coli R721 71/18 glpT :: O-P434/P22 lacZ 
 
Di Lallo et. al. 
2001 
Enterococcus faecalis JH2-2 wild type, RifR, FusR 
 
Jacob & Hobbs, 
1974 
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4.3.2. Divisome protein interactions in the Bacterial Two-Hybrid assays (B2H) 
The B2H system (Di Lallo et al., 2001) was employed to investigate potential interactions 
between eight different E. faecalis divisome proteins i.e. FtsZEf, FtsAEf, FtsQEf, FtsLEf, FtsBEf, 
FtsIEf, DivIVAEf, and FtsWEf. EF1025, a DivIVAEf -interacting protein, was also tested for its 
potential interactions with E. faecalis divisome proteins. The B2H and a quantitative  
β-galactosidase activity assay were performed as previously described (Miller and Lee, 1984; Di 
Lallo et al., 2003). To facilitate cloning, modified B2H vectors pcI434-L and pcIp22-L (Di Lallo 
et al., 2001; Zou et al., 2017) that contained linkers were used. ftsA, ftsZ, ftsQ, ftsI, ftsW, ftsB, 
divIVA, EF1025 and ftsL were PCR amplified from E. faecalis JH2-2 genomic DNA using primer 
pairs A1/2, Z1/2, Q1/2, I1/2, W1/2, B1/2, D1/2, EF10251/2, and L1/2 (Table 4.3). Amplicons were 
cloned into the B2H vectors pcI434-L and pcIp22-L, respectively, resulting in plasmids  
pcIp22-A, pcIp22-Z, pcIp22-Q, pcIp22-I, pcIp22-W, pcIp22-B, pcIp22-D, pcIp22-E1025,  
pcIp22-L, pcI434-A, pcI434-Z, pcI434-Q, pcI434-I, pcI434-W, pcI434-B, pcI434-D,  
pcI434-E1025 and pcI434-L (Table 4.2). These plasmids were transformed into E. coli R721 either 
singly or in combination for B2H assays (Di Lallo et al., 2001, 2003; Greco-Stewart et al., 2007). 
Freshly transformed single colonies of E. coli R721 cells, harbouring different combinations of 
plasmids, were grown overnight in 4 mL of LB medium containing appropriate antibiotics. Cells 
were then diluted at 1:50 in fresh LB medium supplemented with the same antibiotics and 
incubated for ~1 hr at 34°C, followed by the addition of 0.1 mM isopropyl  
β-D-1-thiogalactopyranoside (IPTG). At mid-log phase (OD600= 0.6), cells were centrifuged and 
tested for β-galactosidase activity as previously described (Di Lallo et al., 2001).  
  
117 
Table 4.2. Plasmids used in the study. 
Plasmid Genotype Source 
pCIp22L pCIp22 derivative carrying a linker (Di Lallo et al., 2001; Zou et al., 2017)  
pCI434L pCI434 derivative carrying a linker (Di Lallo et al., 2001; Zou et al., 2017)  
pcIp22-Z pCIp22L derivative carrying ftsZ This study 
pcI434-Z pCI434L derivative carrying ftsZ This study 
pcIp22-W pCIp22L derivative carrying ftsW This study 
pcI434-W pCI434L derivative carrying ftsW This study 
pcIp22-Q pCIp22L derivative carrying ftsQ This study 
pcI434-Q pCI434L derivative carrying ftsQ This study 
pcIp22-L pCIp22L derivative carrying ftsL This study 
pcI434-L pCI434L derivative carrying ftsL This study 
pcIp22-I pCIp22L derivative carrying ftsI This study 
pcI434-I pCI434L derivative carrying ftsI This study 
pcIp22-A pCIp22L derivative carrying ftsA This study 
pcI434-A pCI434L derivative carrying ftsA This study 
pcIp22-D pCIp22L derivative carrying divIVA This study 
pcI434-D pCI434L derivative carrying divIVA This study 
pcI434-B pCI434L derivative carrying ftsB This study 
pcIp22-B pCIp22L derivative carrying ftsB This study 
pcIp22-EF1025 pCIp22L derivative carrying EF1025 This study 
pcI434-EF1025 pCI434L derivative carrying EF1025 This study 
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Table 4.3. Primers used in the study. 
Primer Sequence (5’-3’)1 Restriction 
Endonuclease site 
A1 GGCAGATCTCATGGCAAAAACAGGAATG BglII 
A2 CCGGATCCTTAGTCGAAAATGTTCGAGA BamHI 
L1 GCGGGTCGACGATGGCTGAATTGAAGAAAGT SalI 
L2 GCGGGATCCTTATTTAAACAGTCCTAACATT BamHI 
Q1 GCCGTCGACAGTGTGGAAGATTAGTAACGA SalI 
Q2 CGGGATCCTTATTCTGCTTGTTGCACTTC BamHI 
I1 GCCCGTCGACCATGATGAAAAGACATAAAT SalI 
I2 CCCAGATCTTTATTCTGTGCCTTCTAAAG BglII 
Z1 GCGCGTCGACCATGGAATTTTCATTAGAC SalI 
Z2 CGGGATCCTTATCGTTTTCTGCGGAAAA BamHI 
W1 GCCCGTCGACCTTGCCAAACAAAGTAAAGAAAC SalI 
W2 GCGGGATCCTTATTGGTTCTGTTCTAAAGATA BamHI 
B1 GCCGTCGACCATGGGAAAGAATGAAAAAAACTC SalI 
B2 GCGGGATCCTTATTCAGCTGAAGACTTAGTTGTT BamHI 
D1 GCGTCGACTATGGCATTAAC SalI 
D2 GCGGATCCCTATTTTGATTC BamHI 
EF10251 GCGTCGAC TTATCTGTTTTGTGCG   SalI 
EF10252 GCGGATCCCTACGTAATATAGGTTAAAATTTTCG BamHI 
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E. coli R721 cells with no plasmid were used as the baseline control for β-galactosidase 
production while E. coli R721 with single plasmid transformants served as a negative control for 
the calculation of the percentage residual β-galactosidase activity (Table 4.1). A percentage 
decrease in residual β-galactosidase activity was compared to the E. coli R721 cells, where a value 
of less than 50% was defined as positive for protein interactions. B2H studies were conducted in 
triplicate and analyzed using Graph Pad Prism respectively and an average of the percentage 
residual β-galactosidase activity and the standard deviation was determined.   
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4.4. Results  
4.4.1. E. faecalis divisome protein interactions 
The B2H assay (Di Lallo et al., 2001), was used to detect pairwise interactions between the 
proteins (FtsZEf, FtsAEf, FtsQEf, FtsLEf, FtsIEf, FtsWEf, DivIVAEf, and FtsBEf) from E. faecalis 
whose homologues have been reported to be implicated in divisome formation in S. pneumoniae, 
B. subtilis and S. aureus (Fadda et al., 2007; Maggi et al., 2008; Gamba et al., 2009; Steele et al., 
2011; Halbedel and Lewis, 2019). EF1025, a DivIVAEf interacting protein from E. faecalis, was 
also tested for potential interactions with E. faecalis divisome proteins.  
We identified twelve homo/hetero-dimer interactions among seven divisome proteins 
including FtsZEf, FtsAEf, FtsQEf, FtsLEf, FtsIEf, FtsWEf, and FtsBEf. Proteins like FtsZEf, FtsQEf, 
FtsWEf, and FtsBEf were identified to homo-dimerize by displaying lower than 50% residual  
β-galactosidase activity which indicated a positive interaction (Table 4.4). The self-interaction of 
FtsZEf served as a positive control in all B2H assays. Strong interaction was observed between 
FtsZEf -FtsAEf (30%), FtsZEf -FtsLEf (37%), FtsZEf-FtsIEf (41.6%), FtsWEf-FtsAEf (35.5%), FtsWEf-
FtsIEf (42.1%), FtsBEf-FtsQEf (43.9%), and FtsBEf-FtsLEf (42%) while FtsIEf-FtsAEf displayed 
relatively weaker interaction i.e. 47.2% residual β-galactosidase activity. The interaction between 
FtsBEf and FtsWEf showed borderline (i.e. 50.9%) residual β-galactosidase activity.  
  
121 
 
Table 4.4. Interactions between seven cell division proteins from E. faecalis as determined by B2H 
assay. The β-galactosidase activity was expressed in percentage Miller Units. Average values were 
obtained from three independent assays in triplicates. Values of less than 50% indicate a positive 
interaction (indicated in a closed box). FtsZEf self-interaction was used as a positive control. The 
data are the mean values of averages of percentage β-galactosidase activity.  
  
122 
4.4.2. DivIVAEf interaction with E. faecalis divisome proteins  
DivIVAEf was interpreted to interact with FtsZEf (47%), FtsQEf (47%), and FtsWEf (39%) 
by displaying less than 50% residual β-galactosidase activity (Table 4.5). No interaction was 
observed between DivIVAEf-FtsAEf, DivIVAEf-FtsLEf, DivIVAEf-FtsIEf, and DivIVAEf-FtsBEf as 
the residual β-galactosidase activity was observed to be higher than 50%. DivIVAEf also interacted 
with EF1025, as is shown previously (Chapter 2).  
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Table 4.5. DivIVAEf interaction with other divisome proteins from E. faecalis as determined by 
B2H assays. The data are the averages of at least three independent assays in triplicates. Average 
values of less than 50% indicate a positive interaction- indicated in closed boxes. 
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4.4.3. EF1025 interaction with E. faecalis divisome proteins 
 EF1025 is a previously reported DivIVAEf associating protein (Chapter 2) that affects cell 
length and shape in E. faecalis. To characterise whether EF1025 was a part of the divisome in  
E. faecalis or not, potential divisome interacting partners were identified in a B2H assay. EF1025 
failed to interact with FtsZEf, FtsQEf, FtsAEf, FtsLEf, FtsWEf, FtsIEf, or FtsBEf. However, EF1025 
showed positive interaction with DivIVAEf (44%) in the B2H assay, consistent with previous 
reports (Table 4.6; Chapter 2). 
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Table 4.6. Interaction of EF1025 with divisome proteins from E. faecalis as determined by B2H 
assay. The data are the averages of at least three independent assays in triplicates. Average values 
of less than 50% indicate a positive interaction- indicated in a box. 
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4.5. Discussion 
Studying protein-protein interactions (PPIs) is important since identifying interaction 
partners for a protein can help in identifying its function (Rao et al., 2014). This has led to the 
development of interactomes for various cellular processes such as cell division. Techniques like 
Yeast-two hybrid (Y2H), GST (Glutathione S-transferase)-pull down, Co-immunoprecipitation 
(Co-IP), B2H, immunofluorescence microscopy (IFM), Surface Plasmon Resonance (SPR), and 
green fluorescent protein (GFP) fluorescence microscopy have been widely used to study binary 
PPIs and deduce cell division protein interactions (Harry et al., 1995; Ma et al., 1996; Karimova 
et al., 1998; Di Lallo et al., 2001; Fadda et al., 2007; Maggi et al., 2008; Rigden et al., 2008; Zou 
et al., 2017). Results from this study show for the first time, using B2H analysis, the presence of 
various interactions in the E. faecalis divisome proteins.  
In total, 16 homo/hetero-dimer interactions were observed in proteins including FtsZEf, 
FtsAEf, FtsQEf, FtsLEf, FtsIEf, FtsWEf, DivIVAEf, and FtsBEf where many divisome members like 
FtsZEf, FtsAEf, FtsLEf, and DivIVAEf had multiple interacting partners (Fig. 4.1). This indicates 
that multiple interactions tend to stabilize the multi-protein divisome complex during cell division. 
The interactions between FtsA and FtsZ, and FtsA and FtsI, are conserved not only in Gram-
positive organisms like S. pneumoniae and S. aureus but in E. coli, a Gram-negative organism, as 
well (Karimova et al., 1998; Di Lallo et al., 2003; Maggi et al., 2008; Steele et al., 2011). This 
reflects the presence of a generic basic bacterial division multi-protein complex that is formed at 
the midcell. The homodimerization property of FtsZ, FtsB, FtsQ, and DivIVA has been reported 
in S. pneumoniae, and S. aureus also (Fadda et al., 2007; Maggi et al., 2008; Steele et al., 2011). 
Besides these, FtsA, FtsK, FtsL, and FtsL have been reported to homodimerize in S. pneumoniae, 
and S. aureus also (Fadda et al., 2007; Maggi et al., 2008; Steele et al., 2011). E. coli cell division 
interactome studies revealed homodimerization properties of FtsZEc, FtsAEc, FtsBEc, FtsQEc, 
FtsKEc, and FtsLEc (Karimova et al., 1998; Di Lallo et al., 2003). Surprisingly, FtsAEf was not found 
to self-interact in this study. DivIVA is a highly conserved, “late” cell division protein that is 
crucial for septum determination. Homologues of  B. subtilis DivIVA are present in most Gram-
positive bacteria,  interacting with different partners and performing a variety of functions (Fadda 
et al., 2003; Kang et al., 2008; Rigden et al., 2008; Donovan et al., 2012; Massidda et al., 2013; 
Kaval et al., 2014; Bottomley et al., 2017; Ni et al., 2018; Halbedel and Lewis, 2019). Of all the 
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functionally characterized DivIVA interacting proteins, none is a divisome member. We observed 
similar findings since EF1025 failed to interact with any other E. faecalis divisome proteins except 
DivIVAEf.  
When compared with cell division interactomes from Gram-negative bacteria, E. faecalis 
interactome shared four interactions i.e. FtsA-FtsI, FtsA-FtsZ, FtsB-FtsL and FtsB-FtsQ with  
E. coli divisome interactome (Karimova et al., 1998; Di Lallo et al., 2003), whereas Neisseria 
gonorrhoeae shared only one interaction between FtsA and FtsW (Zou et al., 2017). E. faecalis 
divisome interactome shared more number of key interactions with S. pneumoniae, and S. aureus, 
such as FtsZ-FtsA, FtsA-FtsL and FtsA-FtsI (Figure 4.1; Maggi et al., 2008; Steele et al., 2014). 
In comparison to S. pneumoniae interactome, the interaction of FtsZ with DivIVA and FtsL, and 
DivIVA interaction with FtsW and FtsQ are conserved (Fadda et al., 2007; Maggi et al., 2008). 
However, interactions like FtsA-FtsW, FtsL-FtsB, and FtsB-FtsQ were absent in S. pneumoniae 
but existed in S. aureus and E. faecalis (Maggi et al., 2008; Steele et al., 2011). Only one unique 
interaction i.e. FtsZEf-FtsIEf was identified in E. faecalis cell division interactome. This shows that 
although E. faecalis is a Gram-positive organism like S. pneumoniae and S. aureus, its interactome 
is unique.  
B2H is a powerful genetic technique that studies a more integrated network of overlapping 
interactions in contrast to the genetic experiments that explain sequential recruitment of proteins 
during divisome assembly (Rowlett and Margolin, 2015). Nonetheless, like any two-hybrid assay, 
B2H is also prone to false positives and negatives. Therefore, B2H is often paired with other 
rigorous methods like Co-IP and GST-pull down assay (Maggi et al., 2008; Zou et al., 2017). Di 
Lallo et al. (2003) were the first to use B2H assay to deduce the cell division interactome network 
in E. coli using nine divisome proteins (i.e. FtsZEc, FtsAEc, ZipAEc, FtsKEc, FtsQEc, FtsLEc, FtsIEc, 
FtsWEc, and FtsNEc). Karimova et al. (2005) later on expanded on this knowledge using their own 
version of a B2H assay i.e. the bacterial adenylate cyclase two-hybrid (BACTH) system, which 
relies on the reconstruction of a cyclic AMP (cAMP) signalling cascade upon interaction 
(Karimova et al., 1998). They reconfirmed all the interactions showed by Di Lallo et al. (2003) 
and included FtsB for testing possible interactions with other cell division proteins. Collectively 
in E. coli, sixteen interactions between ten cell division proteins (i.e. including FtsZEc, FtsAEc, 
ZipAEc, FtsKEc, FtsQEc, FtsBEc, FtsLEc, FtsIEc, FtsWEc, and FtsNEc) were identified (Di Lallo et al., 
2003; Karimova et al., 2005). Maggi et al. (2008) used B2H assay to test interactions between 
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eleven S. pneumoniae division proteins and reconfirmed nine interactions i.e. FtsA–FtsK, FtsA–
FtsL, FtsZ–FtsW, FtsZ–FtsQ/DivIB, FtsZ–FtsL, FtsK–FtsW, FtsL–PBP2x, FtsZ–FtsB/DivIC and 
FtsW–FtsB/DivIC using Co-IP assay.  
Co-IP is an excellent technique to study multi-protein complexes formed during cell 
division (Mackay et al., 2007). When coupled with mass spectrometry (MS), accurate detection of 
the complex components can be determined. However, producing an antibody against each protein 
in question with no cross-reactivity can be very expensive and time-consuming. Another robust 
technique to study co-complexes is tandem affinity purification-mass spectrometry (TAP-MS) 
which allows specific tagging and subsequent purification of the protein of interest along with its 
interacting partners (Berggård et al., 2007). TAP-MS can not only identify direct interaction but 
also indirect interactions between various proteins under the native conditions of the cell (Kaiser 
et al., 2008). Real-time imaging can also be performed to study the interaction of two cell division 
proteins using bimolecular fluorescence complementation (BIFC) (Pazos et al., 2013). BIFC relies 
on expressing the N-terminal and C-terminal fragments of a fluorescent protein which is non-
fluorescent but fluoresces when brought together through PPI (Hu et al., 2002). Such imaging can 
also be performed using Forster resonance energy transfer (FRET) which depends on the transfer 
of energy from a donor fluorophore to receptor fluorophore when they are in proximity (between 
1 and 8 nm), measured increase or decrease in donor emission reflects an interaction between two 
proteins (Sourjik and Berg, 2002). 
In conclusion, the first cell division interactome of E. faecalis using B2H assay has been 
produced. In comparison with the published interactomes from E. coli (Karimova et al., 1998; Di 
Lallo et al., 2003), S. aureus (Steele et al., 2011), and S. pneumoniae (Fadda et al., 2007; Maggi et 
al., 2008), the interaction pair FtsA-FtsZ and FtsA-FtsI, was conserved. We observed only one 
unique interaction pair i.e. FtsZ-FtsI, which indicates that E. faecalis divisome requires different 
stabilizing members during the process of cell division. Future work needs to focus on confirming 
these interactions using a GST-pull down or Co-IP assay. 
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Figure 4.1. Cell division interactome of (A) E. faecalis, (B) S. pneumoniae (Fadda et al., 2007; 
Maggi et al., 2008), (C) S. aureus (Steele et al., 2011), (D) N. gonorrhoeae (Zou et al., 2017), (E) 
E. coli (Di Lallo et al., 2003; Karimova et al., 2005). Red lines- conserved interaction; Dotted 
black lines- conserved interaction between E. faecalis and S. pneumoniae interactomes; Yellow 
solid line- conserved interaction between E. faecalis and S. aureus; Green dotted line- unique 
interaction; Curved arrows show self-interaction of proteins in E. faecalis. Presented interactome 
for S. pneumoniae is a compilation of original interactomes reported by Fadda et al. (2007) and 
Maggi et al. (2008). 
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Chapter 5. General conclusion and future considerations 
E. faecalis, well known for its multiple antibiotic resistance, is responsible for 70% of the 
hospital-acquired enterococcal infections worldwide (Cross and Jacobs, 1996; Hidron et al., 
2008a). Due to its additional ability to form a biofilm, catheter-related urinary tract infections are 
difficult to treat with conventional antibiotics (Mohamed and Huang, 2007). All these added 
characteristics render Enterococci as an increasingly difficult problem for society with available 
therapeutic agents in the market today. New therapeutic targets and strategies are needed to combat 
enterococcal infections that ask for an in-depth understanding of enterococcal physiology and 
genetics.  
B. subtilis served as a model organism for studying and understanding the process of cell 
division in Gram-positive bacteria for decades, and E. coli served the same role to Gram-negative 
bacteria. Researchers kept studying model organisms frequently for their convenience and made 
advancement in acquiring knowledge rapidly which resulted in the development of genetic tools, 
techniques and resources specifically for these organisms (Russell et al., 2017). As a result, 
studying model organisms surpassed studying non-model systems with time. Although major 
model organisms come with their convenience to study, aren’t necessarily the best systems for all 
possible questions.  
I present the first information about a DivIVAEf interacting protein, EF1025, in E. faecalis, 
which is predominantly conserved in Gram-positive bacteria and affects cell length and shape. The 
interaction between DivIVAEf and EF1025 was ascertained using in vivo and in vitro techniques. 
It was not possible to obtain viable cells after the deletion or insertional inactivation of EF1025 
without in trans expression of the gene. SEM and TEM images of the rescued cells displayed cell 
elongation and aberrant cell shape. My second study expanded the knowledge of the EF1025 
homologue, CcpN, in B. subtilis. This research suggests that the interaction between DivIVA and 
CcpN homologues could be highly conserved among Gram-positive microorganisms. CcpN 
interacted with DivIVABs in B2H and GST-pull down assays and insertional inactivation of ccpN 
resulted in cell elongation.  Finally, my third study reported the existence of a unique cell division 
interactome in E. faecalis. It also showed that EF1025 does not belong to E. faecalis divisome. 
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These findings collectively enhance knowledge of EF1025, a DivIVAEf interacting protein, in  
E. faecalis, thereby contributing to the overall understanding of this pathogen. 
5.1. EF1025 is a DivIVAEf interacting protein from E. faecalis 
Initially, DivIVA was proposed as the topological marker in B. subtilis where it was 
described as the replacement for MinE, a protein which provides the localization cues for targeting 
the MinCD complex to the cell poles (Cha and Stewart, 1997; Rowlett and Margolin, 2013). 
DivIVABs functions as a mid-cell determinant by attracting the MinC/MinD complex to the cell 
poles, therefore preventing cell division at the polar region (Cha and Stewart, 1997; Edwards et 
al., 2000; Edwards and Errington, 1997; Harry and Lewis, 2003; Karoui and Errington, 2001; 
Marston and Errington, 1999). DivIVABs was reported also to interact with sporulation proteins 
like RacA, Spo0J, and Soj (Ben-Yehuda et al., 2003; Wu and Errington, 2003). DivIVA interacts 
with different proteins in different Gram-positive bacterial species performing a wide variety of 
functions including synthesis of the cell wall (Nguyen et al., 2007; Kang et al., 2008), cell growth 
(Flärdh, 2010), chromosome segregation (Perry and Edwards, 2006; Fadda et al., 2007; Donovan 
et al., 2012; Bottomley et al., 2017), cell division (Bramkamp et al., 2008; Giefing et al., 2008; 
Patrick and Kearns, 2008; Mukherjee et al., 2009; Nováková et al., 2010; Ni et al., 2018), 
competence development (Briley et al., 2011; dos Santos et al., 2012), sporulation (Perry and 
Edwards, 2006; Lenarcic et al., 2009) and protein secretion (Nováková et al., 2010; Halbedel et 
al., 2012, 2014; Kaval et al., 2014; Ni et al., 2018). While there is a great deal of information about 
DivIVA interacting proteins in B. subtilis, S. pneumoniae, S. suis, S. aureus, L. monocytogenes, C. 
glutamicum, M. tuberculosis, M. smegmatis and S. coelicolor, there is no information available 
regarding DivIVA-associating proteins in E. faecalis.   
EF1025 was found to affect cell length and shape of E. faecalis cells. The rod-shape of  
B. subtilis is determined and maintained by the action of “cytoskeletal” proteins of the MreB family 
i.e. MreB, MreC and MreD, that are also involved in cell elongation (Wachi et al. 1987; Levin et 
al. 1992; Varley and Stewart 1992; Abhayawardhane and Stewart 1995). Mutations in mreB 
exhibit enhanced diameter and grew in a straight row (Carballido-Lopez, 2006). MreC and MreD 
play important functions in lateral wall growth in B. subtilis and its depletion leads to slower 
growth (Leaver and Errington, 2005). MreB associates with elongation-specific peptidoglycan 
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(PG)-synthesizing complexes that include the morphogenetic determinants, MreC and MreD, 
flippase RodA, Penicillin Binding Proteins (PBPs), and peptidoglycan hydrolases (Carballido-
López and Formstone, 2007; White et al., 2010). The other interacting partners included GpsB, a 
major PG synthesis regulator, and translation initiation factor EF-Tu (Soufo et al., 2010; Cleverley 
et al., 2019). Ovococcal species like S. pneumoniae, L. lactis, and E. faecalis do not produce MreB 
homologue but encodes MreC and MreD (Land and Winkler, 2011). MreC and MreD localized at 
the equator and septa of the dividing S. pneumoniae and their depletion results in cell rounding 
and lysis (Land and Winkler, 2011). The association of MreC and MreD with other possible 
members of the elongation machinery in S. pneumoniae is yet to be studied. E. faecalis also 
contains homologues of MreC and MreD, GpsB, RodA and various PBPs (unpublished work). 
Future work needs to focus on testing the interaction of EF1025 with these members of elongation-
specific machinery in E. faecalis to achieve a better understanding of how cell elongation happens 
in this organism. 
5.2. EF1025 homologue in B. subtilis, CcpN, also interacts with DivIVABs 
 EF1025 is predominantly conserved in Gram-positive bacterial species. The EF1025 
homologue in B. subtilis, CcpN, is a transcriptional regulator of gluconeogenic genes (Servant et 
al., 2005). EF1025 and CcpN share 41% homology and belongs to the CBS superfamily by 
possessing an HTH domain at N-terminal and two CBS domains at the central and C-terminal. 
CcpN has been extensively studied for its function in the downregulation of gapB, pckA and sr1 
in the presence of glucose (Licht et al., 2005; Servant et al., 2005). I report another interacting 
partner of DivIVABs and an additional novel function of CcpN in B. subtilis. 
 B2H and GST-pull down assays showed that CcpN interacted with DivIVABs. Surprisingly, 
EF1025 also interacted with DivIVABs in a heterologous interaction. Such an observation shows 
that the interaction between DivIVA and EF1025 homologues might be highly conserved among 
Gram-positive microorganisms and are not species-specific. It would be interesting to study if such 
conserved interaction is due to the presence of the HTH and CBS domains among all EF1025 
homologues or just the two CBS domains at the central and C-terminus. CcpN has been reported 
to utilize its HTH domain to bind to the conserved upstream promoter regions of gapB and pckA 
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for transcriptional regulation (Licht et al., 2005; Servant et al., 2005; Tännler et al., 2008; Licht 
and Brantl, 2009), but no research has focused on CBS domains in CcpN. 
Insertional inactivation of ccpN was not lethal to B. subtilis (i.e. Bs 1685) in contrast to 
EF1025 insertional inactivation of deletion in E. faecalis. B. subtilis 1685 cells were longer when 
observed using SEM or AFM. The strains developed by Servant et al. (2005) to study the effects 
of ccpN disruption in the transcription of gapB and pckA also reflected similar cell elongation. No 
elongation was observed in the control strain B. subtilis PS1649 with a disrupted pckA. This 
showed that the cell elongation phenotype was exclusive to the strains containing a disruption of 
ccpN expression. These strains also showed failed segregation and were observed to form long 
chains with closely attached cells. The failure to segregate was also observed in E. faecalis rescued 
cells (i.e. E. faecalis MJ26) with a complemented copy of EF1025. This shows that these 
phenotypes are specific to a function that might be played by CcpN in B. subtilis, and EF1025 in 
E. faecalis.  
5.3. E. faecalis cell division interactome is unique 
 Bacterial divisomes are dynamic hyperstructures whose assembly is mediated by multiple 
protein interactions that exist between various cell division proteins (de Boer, 2010; Lutkenhaus 
et al., 2012; Egan and Vollmer, 2013). Using techniques like Y2H, GST-pull down, Co-IP, B2H, 
immunofluorescence microscopy (IFM), Surface Plasmon Resonance (SPR), and green 
fluorescent protein (GFP) fluorescence microscopy, binary protein-protein interactions among 
various cell division proteins have been studied (Harry et al., 1995; Ma et al., 1996; Karimova et 
al., 1998; Di Lallo et al., 2001; Fadda et al., 2007; Maggi et al., 2008; Rigden et al., 2008; Zou et 
al., 2017). This has lead to the development of cell division networks/interactomes for E. coli 
(Karimova et al., 1998; Di Lallo et al., 2003), N. gonorrhoeae (Zou et al., 2017), S. aureus (Steele 
et al., 2011), and S. pneumoniae (Fadda et al., 2007; Maggi et al., 2008).  
 Using B2H assay, protein-protein interactions among eight essential divisome proteins i.e. 
FtsZEf, FtsAEf, FtsQEf, FtsLEf, FtsIEf, FtsWEf, DivIVAEf, and FtsBEf, were tested to establish the 
very first cell division interactome of E. faecalis. The interaction between FtsZ and FtsA, and FtsA 
and FtsI was conserved when compared with interactomes from E. coli, S. aureus, and  
S. pneumoniae. However, E. faecalis and N. gonorrhoeae shared only interaction i.e. FtsZ-FtsA. 
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Proteins like FtsZEf, FtsQEf, FtsBEf, FtsWEf, and DivIVAEf exhibited self-interaction. FtsZ has been 
reported to self-interact from all FtsZ homologue containing bacterial species. The self-interaction 
ability of FtsQ and FtsB has been reported from E. coli, S. aureus, and S. pneumoniae (Karimova 
et al., 1998; Maggi et al., 2008; Steele et al., 2011), but is absent for FtsW. S. pneumoniae and  
E. faecalis DivIVA has been also reported to self-interact but no such information is available for 
DivIVASa (Fadda et al., 2003; Ramirez-Arcos, 2005; Rigden et al., 2008). Surprisingly, the self-
interaction of FtsAEf was absent but have been reported for FtsA from E. coli, S. aureus, and S. 
pneumoniae (Karimova et al., 1998; Di Lallo et al., 2001; Maggi et al., 2008; Steele et al., 2011).  
Using Co-IP, Buddelmeijer and Beckwin (2004) showed the formation of a trimeric 
complex by three membrane proteins i.e. FtsQ, FtsL, and FtsB, in E. coli and B. subtilis before 
their migration to the midcell position (Buddelmeijer and Beckwith, 2004). In E. faecalis, a 
positive interaction was observed between FtsQEf-FtsBEf, and FtsBEf-FtsLEf but no interaction 
between FtsQEf and FtsLEf was observed. This could be because the interaction between FtsQEf 
and FtsLEf is dependent on a stable interaction between FtsBEf with either FtsQEf or FtsLEf. This 
observation was in line with Steele et al. (2011) where similar interactions were observed in  
S. aureus. Future studies can focus on investigating such ternary protein complexes using Co-IP, 
TAP-MS and bacterial three-hybrid systems. The interactome observed for E. faecalis cell 
divisome proteins was very different from E. coli cell division interactome. However, the  
E. faecalis divisome interactome exhibited a blend of conserved interactions among S. pneumoniae 
and S. aureus cell division proteins with only one unique interaction between FtsZEf and FtsIEf. 
This study also showed that EF1025 is not a member of the E. faecalis divisome. This reflects that 
the majority of the DivIVA interacting partners from various bacterial species are not a part of the 
divisome. DivIVASp has been reported to interact with FtsZSp, FtsQSp, and FtsWSp, however, the 
precise function of such interactions is yet to be explained (Fadda et al., 2007). To further validate 
this interactome more efficient and sensitive methods like GST-pull down, Co-IP, and SPR assays, 
need to be employed.  
5.4. Limitations of this research 
This research does not include the specific function of the distinct domains of EF1025 i.e. HTH 
domain and CBS domains. Although, the two CBS domains together interacted with DivIVAEf 
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and are responsible for the self-interaction property of EF1025, the precise function of CBS 
domains in EF1025 is unknown. EF1025 homologue in B. subtilis, CcpN, is a transcriptional 
regulator which utilizes its HTH domain to bind to the conserved upstream promoter regions of 
gapB and pckA (Licht et al., 2005; Servant et al., 2005; Tännler et al., 2008; Licht and Brantl, 
2009). Preliminary bioinformatic searches have shown that the conserved upstream promoter 
sequences from B. subtilis are absent for its homologues in E. faecalis (i.e. type I gapB and pckA). 
This might reflect that EF1025 might be regulating the expression of a different set of genes. Thus, 
it is necessary to investigate the function of the HTH domain in E. faecalis. Future studies should 
also include studying the effects of ccpN overexpression on B. subtilis cell morphology. The cell 
division interactome of E. faecalis included eight divisome proteins (i.e. FtsZEf, FtsAEf, FtsQEf, 
FtsLEf, FtsIEf, FtsWEf, DivIVAEf, and FtsBEf )  but did not include other divisome protein 
homologues of FtsK, EzrA and ZapA that are present in E. faecalis. Potential interactions of the 
E. faecalis FtsK, EzrA and ZapA with other divisome proteins can be examined using B2H and 
GST-pull down assay to obtain a complete divisome interactome for E. faecalis. 
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Appendix 
A. Ascertaining the interaction between EF1025 and DivIVAEf using steady-state anisotropy 
and Surface Plasmon Resonance (SPR) assay. 
The interaction between EF1025 and DivIVAEf was ascertained using B2H, GST-pull 
down and co-immunoprecipitation previously in Chapter 2. These assays were qualitative and did 
not permit the quantification of these protein interactions in the micro- and nanomolar 
concentration range (James and Jameson, 2014; Douzi, 2017).  To understand the binding affinities 
and association/dissociation kinetics of the protein complexes formed when EF1025 interacted 
with DivIVAEf, steady-state anisotropy and SPR was used. In steady-state anisotropy,  
Material and methods 
His-EF1025 or GST-DivIVAEf fusions were overexpressed in E. coli BL21 cells and 
purified to homogeneity as described in Chapter 2. His-DivIVAEf (Rigden et al., 2008) was 
overexpressed in E. coli C41 cells and purified to homogeneity as previously described (Rigden et 
al., 2008). GST-tag was removed from GST-DivIVAEf by digestion with Thrombin (Thermofisher, 
CA) and was used for steady state anisotropy fluorescence measurement experiment which 
measures any change in the intensity of fluorescence of a fluorophore-labeled protein when it 
interacts with the unlabelled protein.  
A steady-state rotational anisotropy experiment was performed to test the interaction 
between DivIVAEf and EF1025. EF1025 was labelled with Flourscein EX dye as per manufacturer 
instructions (Thermofischer, CA) and titrated against unlabeled His-DivIVAEf in a QuantaMaster 
QM-4 spectrofluorometer (Photon Technology International, USA) with a dual emission channel 
to collect data and calculate anisotropy. The sample was excited with vertically polarized light at 
495 nm (6 nm band pass). Vertical and horizontal emissions were measured at 520 nm (6 nm band 
pass) to calculate the change in anisotropy. Flourscein labelled EF1025 was found to be highly 
unstable so DivIVAEf without GST-tag was labelled with Flourscein EX dye and titrated against 
unlabeled His-EF1025 to observe a change in anisotropy. 
For SPR spectrometry, purified His-EF1025 and GST-DivIVAEf were used to test for 
potential protein-protein interactions using a Bio-Rad XPR36 (Bio-Rad Laboratories, CA) 
instrument with ProteOnTM HTE and GLC sensor Chips (Bio-Rad Laboratories, CA). For HTE 
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chip: chip surface was regenerated (0.5% SDS, 50 mM NaOH, 100 mM HCl and 300 mM EDTA), 
activated (500 μM of NiSO4) and immobilized with His-EF1025 as ligand molecule at a 
concentration of 100 nM. This chip was then flooded with a one-fold dilution of analyte protein 
(GST-DivIVAEf) in PBST buffer (PBS buffer with Tween-20 i.e. 137 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4, 1.8 mM KH2PO4, 0.1% BSA, 0.05% Tween-20, pH 7.9), followed by an injection 
of PBST buffer. A reference channel flowed with only PBST buffer, and a chip surface 
immobilized with His-EF1025 flowed with GST in PBST served as negative controls. For the GLC 
sensor chip: immobilization step was performed using an anti-GST antibody (Genscrpit, USA) 
which was then coupled to DivIVAEf and was flooded with analyte protein (i.e. His-EF1025) for 
binding experiments. Each experiment was performed in triplicates and titrated with 10-12 
dilutions of the unlabelled protein. 
All SPR data were analyzed with ProteOn Manager™ (Bio-Rad Laboratories) to test the 
binding affinity of these two proteins and calculate any change in the response Units (RU) due to 
the interaction between ligand and analyte molecule. The raw signal detected by the machine for 
was first subtracted from the signal from interspot that did not have immobilized proteins (EF1025 
or DivIVAEf) and then from the reference channel. Then, the signal was subtracted with the RU 
signal with running buffer and ligand immobilized on the chip.   
Results and discussion 
A change in anisotropy was observed when unlabeled EF1025 was titrated against 
unlabeled DivIVAEf but a saturation stage could not be achieved. During the experiment, the initial 
change in anisotropy was slow but data points were scattered (data not shown). A small change in 
anisotropy was observed when the anisotropy for an unbound fraction (no GST-DivIVAEf) was 
subtracted from bound fraction (with GST-DivIVAEf) (Fig. A.1). A similar observation was made 
when labelled DivIVAEf was titrated with EF1025, therefore, a change in anisotropy was calculated 
for the bound and unbound fractions of EF1025. An interaction between DivIVAEf, a decamer 
(Ramirez et al., 2008) and EF1025, a decamer (this study) might collectively be forming a massive 
complex. Such a small change in total anisotropy could have been due to the breakdown of one 
decamer into monomeric units which might be associating with each other. Weak binding between 
DivIVAEf and EF1025 could have caused the monomeric units to reassemble therefore a lack of 
an equilibrium stage. Such a breakdown and re-assemblage will maintain a total change in 
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anisotropy of the complex as constant. Although a change in anisotropy was detected, labelled 
EF1025 was observed to be unstable during titration.  
In SPR, the sensorgram for EF1025 binding to DivIVAEf indicated nonspecific binding of 
EF1025 to the interspot/empty regions when HTE or the GLC sensor chip was used (Fig. A.2). To 
minimize nonspecific binding of EF1025 to the chip surface, various concentrations of bovine 
serum albumin (BSA), Arginine, and Glutathione S-transferase (GST) were used in the running 
buffer. A small decrease in non-specific interactions was observed, however, after comparing with 
reference channels, the interaction was inconclusive due to the presence of non-specific 
interactions. This indicated that SPR was not a suitable technique to study this interaction.  
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Figure A.1. Binding affinities of EF1025 and DivIVAEf. (A) DivIVAEf was used as a substrate 
where EF1025 was fluorescently labelled. A change in anisotropy occurred when titrated with 
increasing concentrations of EF1025. The unbound fraction indicates anisotropy recorded for 
fluorescently labelled EF1025 without the substrate (i.e. DivIVAEf). B. EF1025 was used as a 
substrate where DivIVAEf was fluorescently labelled. A comparatively lower change in anisotropy 
was observed when titrated with the substrate. Values are an average from three independent 
experiments.  
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Figure A.2. SPR measurement for studying the interaction of EF1025 with DivIVAEf using a GLC 
chip. 10uM GST tagged DivIVAEf (ligand) was immobilized and flooded with 22uM of His-
EF1025 (analyte). A. Response units recorded for “Reference” channel without immobilized GST 
tagged DivIVAEf. B. Response unit recorded for “Test” channel flooded with His-EF1025. The 
reference channel and test channel recorded similar RU for the interaction.  
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B. Generation of a plasmid construct where the control the expression of EF1025 is under a 
Nisin inducible promoter using the vector pMSP3545 and transform it into E. faecalis JH2-
2 cells to study the effect of EF1025 expression on E. faecalis morphology. 
 Previously showed that insertional inactivation or deletion of EF1025 resulted in the loss 
of viability of E. faecalis unless the gene was complemented by in trans EF1025 expression. To 
control the expression of EF1025 in E. faecalis using the plasmid pMSP3545, which utilizes a 
nisin-controlled expression (NICE) system due to the presence of nisR and nisK, and a nisin 
inducible promoter (Pnis) (Bryan et al., 2000). The products of nisR and nisK constitute a regulator 
which allow transcription from Pnis in the presence of nisin. pMSP3545 has an erythromycin 
marker and can replicate in E. coli as well as in E. faecalis. 
Materials and methods 
To clone EF1025 under the control of Pnis, EF1025 was PCR amplified using primer pair 
EF1025npF/R (Chapter 2- Table S3D) from E. faecalis genomic DNA and was digested with NcoI 
and XbaI restriction enzymes. pMSP3545 was digested using NcoI and XbaI restriction enzymes. 
Digested EF1025 and pMSP3545 were ligated and electroporated into electrocompetent  
E. faecalis JH2-2 cells as previously described (Ramirez-Arcos, 2005), creating the strain  
E. faecalis NIE1. Transformants were selected on LB plates supplemented with erythromycin 150 
µg/mL. Transformed colonies were isolated and tested for the presence of EF1025 downstream of 
Pnis using primer pair EF1025npF/PnisA (Chapter 2- Table S3D and AATCTATGTTACTAAA) 
followed by DNA sequencing.  
To express EF1025 in E. faecalis NIE1, E. faecalis NIE1 was grown in five tubes for 8-10 
hrs, each containing 10 ml of BHI broth with nisin in the concentration range of 0 ng/mL to 25 
ng/mL. To identify EF1025 expression levels, cells from each tube were centrifuged and lysed in 
5 mL of PBS buffer containing 0.1mg/mL of lysozyme (Sigma, CA). An added step of sonication 
was performed to ensure cell lysis. Cell lysate containing a known amount of total cell protein was 
loaded on a 12% SDS-PAGE for separation followed by Western blotting using anti-EF1025 
antibody as described previously (Ramirez-Arcos, 2005). Nisin inducible overexpression was also 
tested at concentration range 50 ng/mL and 100 ng/mL.  
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Results and discussion 
 Cloning was successful as confirmed by DNA sequencing. However, western blotting 
revealed no change in the expression levels of EF1025 when induced with the highest 
concentration of nisin (i.e. 25 ng/mL; Fig. B.1). All samples (induced or non-induced) showed a 
band corresponding to EF1025 of equal intensity when blotted with the anti-EF1025 antibody. 
Due to unknown reasons, Pnis was observed to have a leaky expression of EF1025. At higher 
concentrations of nisin (>50 ng/mL), precipitated cell aggregates at the bottom of the growth 
medium were observed.  
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Figure B.1. Western blot probed with the anti-EF1025 antibody showing expression of EF1025 in 
E. faecalis NIE1 when induced with nisin. Lane 1- Protein ladder; Lane 2- non-induced E. faecalis 
NIE1 showing a 25 kDa band; Lane 3-7: samples induced with nisin at concentrations 5 ng/mL, 
10 ng/mL, 15 ng/mL, 20 ng/mL and 25 ng/mL. 20 kDa band is a non-specific band. 
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C. Ascertaining the interaction between CcpN and DivIVA from B. subtilis using Surface 
Plasmon Resonance (SPR) assay. 
In Chapter 3, the interaction between CcpN and DivIVABs was ascertained using B2H and 
GST-pull down. I was interested in understanding the quantitative aspects of this interaction, 
therefore, SPR was used to quantify the binding affinities and association/dissociation kinetics of 
the protein complexes formed when CcpN interacted with DivIVABs.  
Materials and method: 
GST-DivIVABs or 6His-CcpN fusions were overexpressed in E. coli C41 (DE3) and 
purified to homogeneity as described previously in Chapter 3.  A fraction of purified GST-tagged 
DivIVABs was also subjected to Thrombin cleavage to remove GST-tag for SPR experiment. 
Potential interaction between His-CcpN and DivIVABs was examined by SPR using the Reichert 
2SPR instrument with Gold plain sensor chips having HTE and GLC sensor coating (Reichert 
Technologies). HTE chip surface was regenerated (0.5% SDS, 50 mM NaOH, 100 mM HCl and 
300 mM EDTA), activated (500 μM of NiSO4) and immobilized with 10 µM of DivIVABs as ligand 
molecule. This immobilized chip was then flooded with 22 µM of analyte protein (His-CcpN) at a 
flow rate of 30 μl/min in PBST buffer (PBS buffer with Tween-20 i.e. 137 mM NaCl, 2.7 mM 
KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 0.1% BSA, 0.05% Tween-20, pH 7.9), followed by an 
injection of PBST buffer. A reference channel flowed with only PBST buffer, and a chip surface 
immobilized with DivIVABs flowed with GST in PBST served as negative controls. For GLC 
sensor chip, immobilization step was performed using anti-GST antibody which was then flooded 
with 50 µM GST-DivIVAEf and was then flooded with 22 µM of analyte protein (i.e. His-CcpN) 
for binding experiments. 
The sensorgram (i.e. a representation of the response unit versus time) was produced using 
SPR data that was analyzed with ProteOn Manager™ (Bio-Rad Laboratories) as previously 
discussed.   
Results and discussion: 
The sensorgram for CcpN binding to DivIVABs indicated a positive interaction when the 
HTE chip was used, although an equilibrium stage was absent (Fig. C.1). To improve the 
sensorgram, higher concentration of CcpN (25 µM and above) was used which resulted in the loss 
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of interaction. When a high flow rate (i.e. 30 μl/min) and a low concentration (i.e. 22 µM) of CcpN 
was used, this interaction was restored. A reduction in flow rate for the analyte protein 15 μl/min 
also resulted in the loss of this interaction. Interaction processes usually dominate more at higher 
flow rates, since mass transport is faster (Karlsson and Fält, 1997). The loss of interaction at higher 
concentrations of His-CcpN could be due to the aggregation of CcpN since CcpN was found to 
precipitate at higher concentrations (>2 mg/mL) during purification protocol. No interaction was 
observed when the GLC chip was used. Such third-party interaction showed very high non-specific 
binding to the chip surface as was noticed in Appendix A.1. 
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Figure C.1. SPR measurement for DivIVABs and CcpN interaction after subtracting reference 
channel RUs from Test channel. 10 µM DivIVABs (ligand) was immobilized and flooded with 22 
µM of His-CcpN (analyte). Red line- “Reference” channel with no immobilized DivIVABs; Black 
line- test channel with captured His-CcpN. Response unit recorded for “Test” channel after 
subtracting RUs from the reference channel. Test channel shows the change in RUs, hence a 
positive interaction. 
 
 
